Saratoga Investment
SAR
#7767
Rank
$0.37 B
Marketcap
$22.98
Share price
-0.95%
Change (1 day)
5.75%
Change (1 year)

Saratoga Investment - 10-Q quarterly report FY


Text size:
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

 

 

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarterly Period Ended November 30, 2016

 

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission File Number: 001-33376

 

 

SARATOGA INVESTMENT CORP.

(Exact name of registrant as specified in its charter)

 

 

 

Maryland 20-8700615

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

535 Madison Avenue

New York, New York

 10022
(Address of principal executive office) (Zip Code)

(212) 906-7800

(Registrant’s telephone number, including area code)

Not applicable

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ☐    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (check one):

 

Large Accelerated Filer   Accelerated Filer 
Non-Accelerated Filer   Smaller Reporting Company 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☒

The number of shares of the registrant’s common stock, $0.001 par value, outstanding as of January 10, 2017 was 5,744,147.

 

 

 


Table of Contents

TABLE OF CONTENTS

 

 

 

     Page 

PART I.

 FINANCIAL INFORMATION   3  
Item 1. Consolidated Financial Statements   3  
 Consolidated Statements of Assets and Liabilities as of November 30, 2016 (unaudited) and February 29, 2016   3  
 Consolidated Statements of Operations for the three and nine months ended November 30, 2016 and November 30, 2015 (unaudited)   4  
 Consolidated Schedules of Investments as of November 30, 2016 (unaudited) and February 29, 2016   5  
 Consolidated Statements of Changes in Net Assets for the nine months ended November 30, 2016 and November 30, 2015 (unaudited)   7  
 Consolidated Statements of Cash Flows for the nine months ended November 30, 2016 and November 30, 2015 (unaudited)   8  
 Notes to Consolidated Financial Statements as of November 30, 2016 (unaudited)   9  
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   35  
Item 3. Quantitative and Qualitative Disclosures About Market Risk   58  
Item 4. Controls and Procedures   58  
PART II. OTHER INFORMATION   59  
Item 1. Legal Proceedings   59  
Item 1A. Risk Factors   59  
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   59  
Item 3. Defaults Upon Senior Securities   59  
Item 4. Mine Safety Disclosures   59  
Item 5. Other Information   59  
Item 6. Exhibits   60  
Signatures    61  

 

2


Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements

Saratoga Investment Corp.

Consolidated Statements of Assets and Liabilities

 

   As of 
   November 30, 2016  February 29, 2016 
   (unaudited)    

ASSETS

   

Investments at fair value

   

Non-control/Non-affiliate investments (amortized cost of $270,029,200 and $268,145,090, respectively)

  $  262,303,777   $  271,168,186  

Control investments (cost of $15,448,369 and $13,030,751, respectively)

   15,265,995    12,827,980  
  

 

 

  

 

 

 

Total investments at fair value (amortized cost of $285,477,569 and $281,175,841, respectively)

   277,569,772    283,996,166  

Cash and cash equivalents

   5,770,230    2,440,277  

Cash and cash equivalents, reserve accounts

   17,521,282    4,594,506  

Interest receivable (net of reserve of $0 and $728,519, respectively)

   3,984,752    3,195,919  

Due from affiliate

   46,078    —    

Management fee receivable

   170,975    170,016  

Other assets

   184,761    350,368  

Receivable from unsettled trades

   284,903    300,000  
  

 

 

  

 

 

 

Total assets

  $305,532,753   $295,047,252  
  

 

 

  

 

 

 

LIABILITIES

   

Revolving credit facility

  $—     $—    

Deferred debt financing costs, revolving credit facility

   (456,594  (515,906

SBA debentures payable

   112,660,000    103,660,000  

Deferred debt financing costs, SBA debentures payable

   (2,622,206  (2,493,303

Notes payable

   61,793,125    61,793,125  

Deferred debt financing costs, notes payable

   (1,553,545  (1,694,586

Dividend payable

   —      875,599  

Base management and incentive fees payable

   5,932,447    5,593,956  

Accounts payable and accrued expenses

   672,791    855,873  

Interest and debt fees payable

   1,098,309    1,552,069  

Payable for repurchases of common stock

   —      20,957  

Directors fees payable

   51,000    31,500  

Due to manager

   277,696    218,093  
  

 

 

  

 

 

 

Total liabilities

  $177,853,023   $169,897,377  
  

 

 

  

 

 

 

Commitments and contingencies (See Note 7)

   

NET ASSETS

   

Common stock, par value $.001, 100,000,000 common shares authorized, 5,748,247 and 5,672,227 common shares issued and outstanding, respectively

  $5,748   $5,672  

Capital in excess of par value

   189,583,336    188,714,329  

Distribution in excess of net investment income

   (26,128,907  (26,217,902

Accumulated net realized loss from investments and derivatives

   (27,872,650  (40,172,549

Accumulated net unrealized appreciation (depreciation) on investments and derivatives

   (7,907,797  2,820,325  
  

 

 

  

 

 

 

Total net assets

   127,679,730    125,149,875  
  

 

 

  

 

 

 

Total liabilities and net assets

  $305,532,753   $295,047,252  
  

 

 

  

 

 

 

NET ASSET VALUE PER SHARE

  $22.21   $22.06  
  

 

 

  

 

 

 

See accompanying notes to consolidated financial statements.

 

3


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Operations

(unaudited)

 

   For the three months ended
November 30
   For the nine months ended
November 30
 
   2016  2015   2016  2015 

INVESTMENT INCOME

      

Interest from investments

      

Non-control/Non-affiliate investments

  $6,787,898   $5,435,083    $19,969,849   $16,961,744  

Payment-in-kind interest income from Non-control/Non-affiliate investments

   169,332    41,322     482,687    995,465  

Control investments

   498,599    750,605     1,587,925    2,020,301  
  

 

 

  

 

 

   

 

 

  

 

 

 

Total interest income

   7,455,829    6,227,010     22,040,461    19,977,510  

Interest from cash and cash equivalents

   6,239    1,307     16,426    2,774  

Management fee income

   375,218    369,388     1,123,559    1,121,286  

Other income

   605,009    338,219     1,618,238    1,153,838  
  

 

 

  

 

 

   

 

 

  

 

 

 

Total investment income

   8,442,295    6,935,924     24,798,684    22,255,408  
  

 

 

  

 

 

   

 

 

  

 

 

 

EXPENSES

      

Interest and debt financing expenses

   2,369,108    2,129,105     7,106,869    6,240,946  

Base management fees

   1,219,916    1,091,405     3,649,867    3,366,739  

Professional fees

   330,197    347,639     991,723    1,030,616  

Administrator expenses

   341,667    325,000     991,667    850,000  

Incentive management fees

   394,509    404,218     2,331,241    2,160,772  

Insurance

   68,985    85,262     210,301    259,895  

Directors fees and expenses

   66,000    51,000     192,422    153,000  

General & administrative

   224,579    351,875     741,743    738,244  

Excise tax expense (credit)

   —      —       —      (123,338

Other expense

   8,460    —       21,647    —    
  

 

 

  

 

 

   

 

 

  

 

 

 

Total expenses

   5,023,421    4,785,504     16,237,480    14,676,874  
  

 

 

  

 

 

   

 

 

  

 

 

 

NET INVESTMENT INCOME

   3,418,874    2,150,420     8,561,204    7,578,534  
  

 

 

  

 

 

   

 

 

  

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS:

      

Net realized gain from investments

   260,244    447,813     12,299,899    4,231,006  

Net unrealized appreciation (depreciation) on investments

   (2,105,342  823,093     (10,728,122  239,354  
  

 

 

  

 

 

   

 

 

  

 

 

 

Net gain (loss) on investments

   (1,845,098  1,270,906     1,571,777    4,470,360  
  

 

 

  

 

 

   

 

 

  

 

 

 

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

  $1,573,776   $3,421,326    $10,132,981   $12,048,894  
  

 

 

  

 

 

   

 

 

  

 

 

 

WEIGHTED AVERAGE - BASIC AND DILUTED EARNINGS PER COMMON SHARE

  $0.27   $0.61    $1.77   $2.18  

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING - BASIC AND DILUTED

   5,727,933    5,632,011     5,735,443    5,533,094  

See accompanying notes to consolidated financial statements.

 

4


Table of Contents

Saratoga Investment Corp.

Consolidated Schedule of Investments

November 30, 2016

(unaudited)

 

Company

 

Industry

 

Investment Interest Rate /

Maturity

 Principal/
Number of
Shares
  Cost  Fair Value (c)  % of
Net Assets
 

Non-control/Non-affiliated investments - 205.4% (b)

    

CAMP International Systems (d)

 Aerospace and Defense Second Lien Term Loan (L+7.25%), 8.25% Cash, 8/18/2024 $1,000,000   $995,171   $1,020,000    0.8
    

 

 

  

 

 

  

 

 

 
  Total Aerospace and Defense   995,171    1,020,000    0.8
    

 

 

  

 

 

  

 

 

 

Polar Holding Company, Ltd. (a), (d), (i)

 Building Products First Lien Term Loan (L+9.00%), 10.00% Cash, 9/30/2016 $2,000,000    2,000,000    2,000,000    1.6
    

 

 

  

 

 

  

 

 

 
  Total Building Products   2,000,000    2,000,000    1.6
    

 

 

  

 

 

  

 

 

 

Apex Holdings Software Technologies, LLC

 Business Services First Lien Term Loan (L+8.00%), 9.00% Cash, 9/21/2021 $18,000,000    17,848,031    17,842,500    14.0

Avionte Holdings, LLC (g)

 Business Services Common Stock  100,000    100,000    251,000    0.2

Avionte Holdings, LLC

 Business Services First Lien Term Loan (L+8.25%), 9.75% Cash, 1/8/2019 $2,279,278    2,257,229    2,279,278    1.8

Avionte Holdings, LLC (j), (k)

 Business Services Delayed Draw Term Loan A (L+8.25%), 9.75% Cash, 1/8/2019 $—      —      —      0.0

BMC Software, Inc. (d)

 Business Services First Lien Term Loan (L+4.00%), 5.00% Cash, 9/10/2020 $5,626,667    5,594,987    5,493,315    4.3

Courion Corporation

 Business Services Second Lien Term Loan (L+10.00%), 11.00% Cash, 6/1/2021 $15,000,000    14,872,231    13,932,000    10.9

Dispensing Dynamics International (d)

 Business Services Senior Secured Note 12.50% Cash, 1/1/2018 $12,000,000    12,015,235    11,640,000    9.1

Easy Ice, LLC (d)

 Business Services First Lien Term Loan (L+8.75%), 9.50% Cash, 1/15/2020 $16,000,000    15,876,901    16,080,000    12.6

Emily Street Enterprises, L.L.C.

 Business Services Senior Secured Note (L+8.50%), 10.00% Cash, 1/23/2020 $3,300,000    3,277,195    3,318,810    2.6

Emily Street Enterprises, L.L.C. (g)

 Business Services Warrant Membership Interests, Expires 12/28/2022  49,318    400,000    476,541    0.3

Erwin, Inc.

 Business Services Second Lien Term Loan (L+11.50%), 13.50% (11.50% Cash/1.00% PIK), 8/28/2021 $13,077,419    12,957,650    13,077,419    10.2

GreyHeller LLC

 Business Services First Lien Term Loan (L+11.00%), 12.00% Cash, 11/16/2021 $7,000,000    6,930,320    6,930,000    5.4

GreyHeller LLC (j), (k)

 Business Services Delayed Draw Term Loan B (L+11.00%), 12.00% Cash, 11/16/2021 $—      —      —      0.0

GreyHeller LLC (g)

 Business Services Common Stock  850,000    850,000    850,000    0.7

Help/Systems Holdings, Inc.(Help/Systems, LLC)

 Business Services First Lien Term Loan (L+5.25%), 6.25% Cash, 10/8/2021 $4,962,500    4,878,301    4,921,311    3.9

Help/Systems Holdings, Inc.(Help/Systems, LLC)

 Business Services Second Lien Term Loan (L+9.50%), 10.50% Cash, 10/8/2022 $3,000,000    2,919,579    2,820,000    2.2

Identity Automation Systems

 Business Services Convertible Promissory Note 13.50% (6.75% Cash/6.75% PIK), 8/18/2018  611,517    611,521    611,521    0.5

Identity Automation Systems (g)

 Business Services Common Stock Class A Units  232,616    232,616    549,258    0.4

Identity Automation Systems

 Business Services First Lien Term Loan (L+9.25%), 12.00% (9.25% Cash/1.75% PIK) 12/18/2020 $10,248,887    10,172,877    10,248,887    8.0

Knowland Technology Holdings, L.L.C.

 Business Services First Lien Term Loan (L+8.75%), 9.75% Cash, 11/29/2017 $17,777,730    17,664,387    17,777,730    13.9

Microsystems Company

 Business Services Second Lien Term Loan (L+10.00%), 11.00% Cash, 7/1/2022 $8,000,000    7,924,524    7,920,000    6.2

Vector Controls Holding Co., LLC (d)

 Business Services First Lien Term Loan, 14.00% (12.00% Cash/2.00% PIK), 3/6/2018 $8,877,910    8,826,316    8,877,910    7.0

Vector Controls Holding Co., LLC (d), (g)

 Business Services Warrants to Purchase Limited Liability Company Interests, Expires 5/31/2025  343    —      352,260    0.3
    

 

 

  

 

 

  

 

 

 
  Total Business Services   146,209,900    146,249,740    114.5
    

 

 

  

 

 

  

 

 

 

Targus Holdings, Inc. (d), (g)

 Consumer Products Common Stock  210,456    1,791,242    —      0.0

Targus Holdings, Inc. (d)

 Consumer Products Second Lien Term Loan A-2 15.00% PIK, 12/31/2019 $228,909    228,909    228,909    0.2

Targus Holdings, Inc. (d)

 Consumer Products Second Lien Term Loan B 15.00% PIK, 12/31/2019 $686,726    686,726    558,171    0.4
    

 

 

  

 

 

  

 

 

 
  Total Consumer Products   2,706,877    787,080    0.6
    

 

 

  

 

 

  

 

 

 

My Alarm Center, LLC

 Consumer Services Second Lien Term Loan (L+11.00%), 12.00% Cash, 7/9/2019 $9,375,000    9,357,973    9,345,938    7.3

PrePaid Legal Services, Inc. (d)

 Consumer Services First Lien Term Loan (L+5.25%), 6.50% Cash, 7/1/2019 $1,488,754    1,483,515    1,487,266    1.1

PrePaid Legal Services, Inc. (d)

 Consumer Services Second Lien Term Loan (L+9.25%), 10.25% Cash, 7/1/2020 $10,000,000    9,968,634    9,904,000    7.8
    

 

 

  

 

 

  

 

 

 
  Total Consumer Services   20,810,122    20,737,204    16.2
    

 

 

  

 

 

  

 

 

 

M/C Acquisition Corp., L.L.C. (d), (g)

 Education Class A Common Stock  544,761    30,241    —      0.0

M/C Acquisition Corp., L.L.C. (d)

 Education First Lien Term Loan 1.00% Cash, 3/31/2018 $2,321,073    1,193,790    8,087    0.0

Teachers of Tomorrow, LLC (g), (h)

 Education Common Stock  750    750,000    910,545    0.8

Teachers of Tomorrow, LLC

 Education Second Lien Term Loan (L+9.75%), 10.75% Cash, 6/2/2021 $10,000,000    9,914,485    10,000,000    7.8
    

 

 

  

 

 

  

 

 

 
  Total Education   11,888,516    10,918,632    8.6
    

 

 

  

 

 

  

 

 

 

TM Restaurant Group L.L.C.

 Food and Beverage First Lien Term Loan (L+8.50%), 9.75% Cash, 7/16/2017 $9,358,694    9,313,879    8,422,825    6.6
    

 

 

  

 

 

  

 

 

 
  Total Food and Beverage   9,313,879    8,422,825    6.6
    

 

 

  

 

 

  

 

 

 

Censis Technologies, Inc.

 Healthcare Services First Lien Term Loan B (L+10.00%), 11.00% Cash, 7/24/2019 $11,250,000    11,114,850    10,871,661    8.4

Censis Technologies, Inc. (g), (h)

 Healthcare Services Limited Partner Interests  999    999,000    725,936    0.6

Roscoe Medical, Inc. (d), (g)

 Healthcare Services Common Stock  5,081    508,077    678,931    0.5

Roscoe Medical, Inc.

 Healthcare Services Second Lien Term Loan 11.25% Cash, 9/26/2019 $4,200,000    4,151,963    4,154,220    3.3

Ohio Medical, LLC (g)

 Healthcare Services Common Stock  5,000    500,000    329,096    0.3

Ohio Medical, LLC

 Healthcare Services Senior Subordinated Note 12.00%, 7/15/2021 $7,300,000    7,235,173    7,234,300    5.7

Zest Holdings, LLC (d)

 Healthcare Services First Lien Term Loan (L+4.75%), 5.75% Cash, 8/16/2020 $4,136,911    4,081,904    4,134,015    3.2
    

 

 

  

 

 

  

 

 

 
  Total Healthcare Services   28,590,967    28,128,159    22.0
    

 

 

  

 

 

  

 

 

 

HMN Holdco, LLC

 Media First Lien Term Loan 10.00% Cash, 5/16/2019 $8,581,357    8,485,902    8,581,357    6.7

HMN Holdco, LLC

 Media Delayed Draw First Lien Term Loan 10.00% Cash, 5/16/2019 $4,800,000    4,748,026    4,800,000    3.7

HMN Holdco, LLC (g)

 Media Class A Series, Expires 1/16/2025  4,264    61,647    282,106    0.2

HMN Holdco, LLC (g)

 Media Class A Warrant, Expires 1/16/2025  30,320    438,353    1,616,966    1.3

HMN Holdco, LLC (g)

 Media Warrants to Purchase Limited Liability Company Interests (Common), Expires 5/16/2024  57,872    —      2,791,745    2.2

HMN Holdco, LLC (g)

 Media Warrants to Purchase Limited Liability Company Interests (Preferred), Expires 5/16/2024  8,139    —      449,761    0.4
    

 

 

  

 

 

  

 

 

 
  Total Media   13,733,928    18,521,935    14.5
    

 

 

  

 

 

  

 

 

 

Elyria Foundry Company, L.L.C. (d), (g)

 Metals Common Stock  35,000    9,217,564    357,350    0.3

Elyria Foundry Company, L.L.C. (d)

 Metals Revolver (L+8.50%), 10.00% Cash, 3/31/2017 $8,500,000    8,500,000    8,500,000    6.6
    

 

 

  

 

 

  

 

 

 
  Total Metals   17,717,564    8,857,350    6.9
    

 

 

  

 

 

  

 

 

 

Mercury Network, LLC

 Real Estate First Lien Term Loan 10.5% Cash, 8/24/2021 $15,791,286    15,649,233    15,871,821    12.5

Mercury Network, LLC (g)

 Real Estate Common Stock  413,043    413,043    789,031    0.6
    

 

 

  

 

 

  

 

 

 
  Total Real Estate   16,062,276    16,660,852    13.1
    

 

 

  

 

 

  

 

 

 

Sub Total Non-control/Non-affiliated investments

   270,029,200    262,303,777    205.4
    

 

 

  

 

 

  

 

 

 

Control investments - 12.0% (b)

      

Saratoga Investment Corp. CLO 2013-1, Ltd. (a), (d), (e), (f)

 Structured Finance Securities Other/Structured Finance Securities 13.26%, 10/17/2025 $30,000,000    10,948,369    10,986,945    8.6

Saratoga Investment Corp. Class F
Note (a), (d), (f)

 Structured Finance Securities Other/Structured Finance Securities (L+8.50%), 9.22%, 10/20/2025 $4,500,000    4,500,000    4,279,050    3.4
    

 

 

  

 

 

  

 

 

 

Sub Total Control investments

     15,448,369    15,265,995    12.0
    

 

 

  

 

 

  

 

 

 

TOTAL INVESTMENTS - 217.4% (b)

    $  285,477,569   $  277,569,772    217.4
    

 

 

  

 

 

  

 

 

 
      Principal  Cost  Fair Value  % of
Net Assets
 

Cash and cash equivalents and cash and cash equivalents, reserve accounts - 18.2%

    

U.S. Bank Money Market (l)

   $23,291,512   $23,291,512   $23,291,512    18.2
   

 

 

  

 

 

  

 

 

  

 

 

 

Total cash and cash equivalents and cash and cash equivalents, reserve accounts

 $23,291,512   $23,291,512   $23,291,512    18.2
   

 

 

  

 

 

  

 

 

  

 

 

 

 

(a)Represents a non-qualifying investment as defined under Section 55 (a) of the Investment Company Act of 1940, as amended. Non-qualifying assets represent 6.2% of the Company’s portfolio at fair value. As a BDC, the Company can only invest 30% of its portfolio in non-qualifying assets.
(b)Percentages are based on net assets of $127,679,730 as of November 30, 2016.
(c)Because there is no readily available market value for these investments, the fair value of these investments is approved in good faith by our board of directors (see Note 3 to the consolidated financial statements).
(d)These securities are pledged as collateral under a senior secured revolving credit facility (see Note 6 to the consolidated financial statements).
(e)This investment does not have a stated interest rate that is payable thereon. As a result, the 13.26% interest rate in the table above represents the effective interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.
(f)As defined in the Investment Company Act, we “Control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:

 

        Sales
(Cost)
  Interest
Income
  Management
Fee Income
  Net Realized
Gains
(Losses)
  Net Unrealized 

Company

 Purchases  Redemptions      Appreciation
(Depreciation)
 

Saratoga Investment Corp. CLO
2013-1, Ltd.

 $—     $—     $—     $1,569,492   $1,123,559   $—     $241,347  

Saratoga Investment Corp. Class F Note

 $4,500,000   $—     $—     $18,433   $—     $—     $(220,950
 

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

 

(g)Non-income producing at November 30, 2016.
(h)Includes securities issued by an affiliate of the Company.
(i)Non-U.S. company. The principal place of business for Polar Holding Company, Ltd. is Canada.
(j)The investment has an unfunded commitment as of November 30, 2016 (see Note 7 to the consolidated financial statements).
(k)The entire commitment was unfunded at November 30, 2016. As such, no interest is being earned on this investment.
(l)Included within cash and cash equivalents and cash and cash equivalents, reserve accounts in the Company’s Consolidated Statements of Assets and Liabilities as of November 30, 2016.

 

5


Table of Contents

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2016

 

Company

 

Industry

 

Investment Interest Rate / Maturity

 Principal/
Number

of Shares
  Cost  Fair Value (c)  % of
Net Assets
 

Non-control/Non-affiliated investments - 216.6% (b)

  

   

National Truck Protection Co., Inc. (d), (g)

 Automotive Aftermarket Common Stock  1,116   $1,000,000   $1,695,303    1.4

National Truck Protection Co., Inc. (d)

 Automotive Aftermarket First Lien Term Loan 15.50% Cash, 9/13/2018 $6,776,770    6,776,770    6,776,770    5.4

Take 5 Oil Change, L.L.C. (d), (g)

 Automotive Aftermarket Common Stock  7,128    480,535    6,235,209    5.0
    

 

 

  

 

 

  

 

 

 
  Total Automotive Aftermarket   8,257,305    14,707,282    11.8
    

 

 

  

 

 

  

 

 

 

Legacy Cabinets Holdings (d), (g)

 Building Products Common Stock Voting A-1  2,535    220,900    2,676,909    2.1

Legacy Cabinets Holdings (d), (g)

 Building Products Common Stock Voting B-1  1,600    139,424    1,689,568    1.3

Polar Holding Company,
Ltd. (a), (d), (i)

 Building Products First Lien Term Loan (L+9.00%), 10.00% Cash, 9/30/2016 $2,000,000    2,000,000    2,000,000    1.6
    

 

 

  

 

 

  

 

 

 
  Total Building Products   2,360,324    6,366,477    5.0
    

 

 

  

 

 

  

 

 

 

Avionte Holdings, LLC (g)

 Business Services Common Stock  100,000    100,000    169,850    0.1

Avionte Holdings, LLC

 Business Services First Lien Term Loan (L+8.25%), 9.75% Cash, 1/8/2019 $2,406,342    2,376,045    2,382,844    1.9

Avionte Holdings, LLC (j), (k)

 Business Services Delayed Draw Term Loan A (L+8.25%), 9.75% Cash, 1/8/2019 $—      —      —      0.0

BMC Software, Inc. (d)

 Business Services Syndicated Loan (L+4.00%), 5.00% Cash, 9/10/2020 $5,671,667    5,633,920    4,520,318    3.6

Courion Corporation

 Business Services Second Lien Term Loan (L+10.00%), 11.00% Cash, 6/1/2021 $15,000,000    14,856,720    14,850,000    11.9

Dispensing Dynamics
International (d)

 Business Services Senior Secured Note 12.50% Cash, 1/1/2018 $12,000,000    12,025,101    10,950,000    8.8

Easy Ice, LLC (d)

 Business Services First Lien Term Loan (L+8.75%), 9.50% Cash, 1/15/2020 $14,000,000    13,873,485    13,806,098    11.0

Emily Street Enterprises, L.L.C.

 Business Services Senior Secured Note (L+8.50%), 10.00% Cash, 1/23/2020 $8,400,000    8,305,033    8,568,000    6.8

Emily Street Enterprises, L.L.C. (g)

 Business Services Warrant Membership Interests, Expires 12/28/2022  49,318    400,000    577,020    0.5

Erwin, Inc.

 Business Services Second Lien Term Loan (L+11.50%), 13.50% (12.50% Cash/1.00% PIK), 8/28/2021 $13,000,000    12,870,023    12,870,000    10.3

Finalsite Holdings, Inc.

 Business Services Second Lien Term Loan (L+9.00%), 10.25% Cash, 5/21/2020 $7,500,000    7,440,729    7,500,000    6.0

Help/Systems Holdings, Inc.(Help/Systems, LLC)

 Business Services First Lien Term Loan (L+5.25%), 6.25% Cash, 10/8/2021 $5,000,000    4,904,573    4,895,000    3.9

Help/Systems Holdings, Inc.(Help/Systems, LLC)

 Business Services Second Lien Term Loan (L+9.50%), 10.50% Cash, 10/8/2022 $3,000,000    2,912,784    2,910,000    2.3

Identity Automation Systems (g)

 Business Services Common Stock Class A Units  232,616    232,616    427,409    0.3

Identity Automation Systems

 Business Services First Lien Term Loan (L+9.25%), 10.25% Cash, 12/18/2020 $6,900,000    6,842,573    6,900,000    5.5

Identity Automation Systems (j), (k)

 Business Services Delayed Draw Term Loan 10.25% Cash, 12/18/2020 $—      —      —      0.0

Knowland Technology Holdings, L.L.C.

 Business Services First Lien Term Loan 8.00% Cash, 11/29/2017 $5,259,171    5,224,422    5,259,171    4.2

Vector Controls Holding Co.,
LLC (d)

 Business Services First Lien Term Loan, 14.00% (12.00% Cash/2.00% PIK), 3/6/2018 $9,035,515    8,952,442    9,035,515    7.2

Vector Controls Holding Co.,
LLC (d), (g)

 Business Services Warrants to Purchase Limited Liability Company Interests, Expires 5/31/2025  343    —      354,819    0.3
    

 

 

  

 

 

  

 

 

 
  Total Business Services   106,950,466    105,976,044    84.6
    

 

 

  

 

 

  

 

 

 

Advanced Air & Heat of Florida, LLC

 Consumer Products First Lien Term Loan 9.50% Cash, 7/17/2020 $6,800,000    6,733,661    6,800,000    5.4

Targus Holdings, Inc. (d), (g)

 Consumer Products Common Stock  210,456    1,791,242    —      0.0

Targus Holdings, Inc. (d)

 Consumer Products Second Lien Term Loan A-2 15.00% PIK, 12/31/2019 $210,456    210,456    210,456    0.2

Targus Holdings, Inc. (d)

 Consumer Products Second Lien Term Loan B 15.00% PIK, 12/31/2019 $631,369    631,369    631,369    0.5
    

 

 

  

 

 

  

 

 

 
  Total Consumer Products   9,366,728    7,641,825    6.1
    

 

 

  

 

 

  

 

 

 

Expedited Travel L.L.C. (g)

 Consumer Services Common Stock  1,000,000    1,000,000    1,647,767    1.3

Expedited Travel L.L.C.

 Consumer Services First Lien Term Loan 10.00% Cash, 10/10/2019 $11,475,490    11,401,380    11,647,623    9.3

My Alarm Center, LLC

 Consumer Services Second Lien Term Loan (L+11.00%), 12.00% Cash, 7/9/2019 $7,500,000    7,500,000    7,450,500    6.0

PrePaid Legal Services, Inc. (d)

 Consumer Services First Lien Term Loan (L+5.25%), 6.50% Cash, 7/1/2019 $1,572,921    1,562,787    1,556,248    1.2

PrePaid Legal Services, Inc. (d)

 Consumer Services Second Lien Term Loan (L+9.00%), 10.25% Cash, 7/1/2020 $10,000,000    9,962,104    9,827,000    7.9

Prime Security Services, LLC

 Consumer Services Second Lien Term Loan (L+8.75%), 9.75% Cash, 7/1/2022 $12,000,000    11,829,030    10,980,000    8.8
    

 

 

  

 

 

  

 

 

 
  Total Consumer Services   43,255,301    43,109,138    34.5
    

 

 

  

 

 

  

 

 

 

M/C Acquisition Corp., L.L.C. (d), (g)

 Education Class A Common Stock  544,761    30,241    —      0.0

M/C Acquisition Corp., L.L.C. (d)

 Education First Lien Term Loan 1.00% Cash, 3/31/2016 $2,321,073    1,193,790    8,087    0.0

Teachers of Tomorrow, LLC (g), (h)

 Education Common Stock  750    750,000    785,475    0.6

Teachers of Tomorrow, LLC

 Education Second Lien Term Loan (L+9.75%), 10.75% Cash, 6/2/2021 $10,000,000    9,902,816    9,900,000    7.9
    

 

 

  

 

 

  

 

 

 
  Total Education   11,876,847    10,693,562    8.5
    

 

 

  

 

 

  

 

 

 

TM Restaurant Group L.L.C.

 Food and Beverage First Lien Term Loan (L+8.50%), 9.75% Cash, 7/16/2017 $9,622,319    9,527,041    9,131,048    7.3
    

 

 

  

 

 

  

 

 

 
  Total Food and Beverage   9,527,041    9,131,048    7.3
    

 

 

  

 

 

  

 

 

 

Bristol Hospice, LLC

 Healthcare Services Senior Secured Note 11.00% (10.00% Cash/1.00% PIK), 11/29/2018 $5,404,747    5,339,820    5,404,747    4.3

Censis Technologies, Inc.

 Healthcare Services First Lien Term Loan B (L+10.00%), 11.00% Cash, 7/24/2019 $11,550,000    11,377,810    11,459,418    9.2

Censis Technologies, Inc. (g), (h)

 Healthcare Services Limited Partner Interests  999    999,000    810,642    0.7

Roscoe Medical, Inc. (d), (g)

 Healthcare Services Common Stock  5,000    500,000    334,000    0.3

Roscoe Medical, Inc.

 Healthcare Services Second Lien Term Loan 11.25% Cash, 9/26/2019 $4,200,000    4,141,519    3,822,000    3.0

Ohio Medical, LLC (g)

 Healthcare Services Common Stock  5,000    500,000    500,000    0.4

Ohio Medical, LLC

 Healthcare Services Senior Subordinated Note 12.00%, 7/15/2021 $7,300,000    7,228,452    7,227,000    5.8

Smile Brands Group Inc. (d)

 Healthcare Services Syndicated Loan (L+7.75%), 10.50% (9.00% Cash/1.50% PIK), 8/16/2019 $4,420,900    4,362,266    3,216,647    2.6

Zest Holdings, LLC (d)

 Healthcare Services Syndicated Loan (L+4.25%), 5.25% Cash, 8/16/2020 $4,207,821    4,142,093    4,130,692    3.3
    

 

 

  

 

 

  

 

 

 
  Total Healthcare Services   38,590,960    36,905,146    29.6
    

 

 

  

 

 

  

 

 

 

HMN Holdco, LLC

 Media First Lien Term Loan 10.00% Cash, 5/16/2019 $8,937,982    8,812,479    8,937,983    7.1

HMN Holdco, LLC

 Media First Lien Term Loan 10.00% Cash, 5/16/2019 $1,600,000    1,572,821    1,600,000    1.3

HMN Holdco, LLC (g)

 Media Class A Series, Expires 1/16/2025  4,264    61,647    314,683    0.3

HMN Holdco, LLC (g)

 Media Class A Warrant, Expires 1/16/2025  30,320    438,353    1,889,542    1.5

HMN Holdco, LLC (g)

 Media Warrants to Purchase Limited Liability Company Interests (Common), Expires 5/16/2024  57,872    —      3,309,121    2.6

HMN Holdco, LLC (g)

 Media Warrants to Purchase Limited Liability Company Interests, Expires 5/16/2024  8,139    —      523,012    0.4
    

 

 

  

 

 

  

 

 

 
  Total Media   10,885,300    16,574,341    13.2
    

 

 

  

 

 

  

 

 

 

Elyria Foundry Company,
L.L.C. (d), (g)

 Metals Common Stock  35,000    9,217,564    2,026,150    1.6

Elyria Foundry Company,
L.L.C. (d)

 Metals Revolver 10.00% Cash, 3/31/2017 $8,500,000    8,500,000    8,500,000    6.8
    

 

 

  

 

 

  

 

 

 
  Total Metals   17,717,564    10,526,150    8.4
    

 

 

  

 

 

  

 

 

 

Mercury Network, LLC

 Real Estate First Lien Term Loan (L+9.25%), 10.25% Cash, 4/24/2020 $9,025,000    8,944,211    9,025,000    7.2

Mercury Network, LLC (g)

 Real Estate Common Stock  413,043    413,043    512,173    0.4
    

 

 

  

 

 

  

 

 

 
  Total Real Estate   9,357,254    9,537,173    7.6
    

 

 

  

 

 

  

 

 

 

Sub Total Non-control/Non-affiliated investments

   268,145,090    271,168,186    216.6
    

 

 

  

 

 

  

 

 

 

Control investments - 10.3% (b)

     

Saratoga Investment Corp. CLO 2013-1, Ltd. (a), (d), (e), (f)

 Structured Finance Securities Other/Structured Finance Securities 16.14%, 10/17/2023 $30,000,000    13,030,751    12,827,980    10.3
    

 

 

  

 

 

  

 

 

 

Sub Total Control investments

     13,030,751    12,827,980    10.3
    

 

 

  

 

 

  

 

 

 

TOTAL INVESTMENTS - 226.9% (b)

  $281,175,841   $283,996,166    226.9
    

 

 

  

 

 

  

 

 

 
      Principal  Cost  Fair Value  % of
Net Assets
 

Cash and cash equivalents and cash and cash equivalents, reserve accounts - 5.6%

    

U.S. Bank Money Market (l)

   $7,034,783   $7,034,783   $7,034,783    5.6
   

 

 

  

 

 

  

 

 

  

 

 

 

Total cash and cash equivalents and cash and cash equivalents, reserve accounts

 $7,034,783   $7,034,783   $7,034,783    5.6
   

 

 

  

 

 

  

 

 

  

 

 

 

 

(a)Represents a non-qualifying investment as defined under Section 55 (a) of the Investment Company Act of 1940, as amended. Non-qualifying assets represent 5.2% of the Company’s portfolio at fair value. As a BDC, the Company can only invest 30% of its portfolio in non-qualifying assets.
(b)Percentages are based on net assets of $125,149,875 as of February 29, 2016.
(c)Because there is no readily available market value for these investments, the fair value of these investments is approved in good faith by our board of directors (see Note 3 to the consolidated financial statements).
(d)These securities are pledged as collateral under a senior secured revolving credit facility (see Note 6 to the consolidated financial statements).
(e)This investment does not have a stated interest rate that is payable thereon. As a result, the 16.14% interest rate in the table above represents the effective interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.
(f)As defined in the Investment Company Act, we “Control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:

 

               Interest   Management   Net
Realized
   Net Unrealized 

Company

  Purchases   Redemptions   Sales (Cost)   Income   Fee Income   Gains
(Losses)
   Depreciation 

Saratoga Investment Corp. CLO 2013-1, Ltd.

  $—      $—      $—      $2,665,648    $1,494,779    $—      $(1,280,916
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(g)Non-income producing at February 29, 2016.
(h)Includes securities issued by an affiliate of the Company.
(i)Non-U.S. company. The principal place of business for Polar Holding Company, Ltd. is Canada.
(j)The investment has an unfunded commitment as of February 29, 2016 (see Note 7 to the consolidated financial statements).
(k)The entire commitment was unfunded at February 29, 2016. As such, no interest is being earned on this investment.
(l)Included within cash and cash equivalents and cash and cash equivalents, reserve accounts in the Company’s Consolidated Statements of Assets and Liabilities as of February 29, 2016.

 

 

6


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Changes in Net Assets

(unaudited)

 

   For the nine months ended
November 30, 2016
  For the nine months ended
November 30, 2015
 

INCREASE FROM OPERATIONS:

   

Net investment income

  $8,561,204   $7,578,534  

Net realized gain from investments

   12,299,899    4,231,006  

Net unrealized appreciation (depreciation) on investments

   (10,728,122  239,354  
  

 

 

  

 

 

 

Net increase in net assets from operations

   10,132,981    12,048,894  
  

 

 

  

 

 

 

DECREASE FROM SHAREHOLDER DISTRIBUTIONS:

   

Distributions declared

   (8,472,209  (10,767,093
  

 

 

  

 

 

 

Net decrease in net assets from shareholder distributions

   (8,472,209  (10,767,093
  

 

 

  

 

 

 

CAPITAL SHARE TRANSACTIONS:

   

Stock dividend distribution

   4,125,696    3,778,630  

Repurchases of common stock

   (3,256,613  (38,981

Offering costs

   —      (346,826
  

 

 

  

 

 

 

Net increase in net assets from capital share transactions

   869,083    3,392,823  
  

 

 

  

 

 

 

Total increase in net assets

   2,529,855    4,674,624  

Net assets at beginning of period

   125,149,875    122,598,742  
  

 

 

  

 

 

 

Net assets at end of period

  $127,679,730   $127,273,366  
  

 

 

  

 

 

 

Net asset value per common share

  $22.21   $22.59  

Common shares outstanding at end of period

   5,748,247    5,634,115  

Distribution in excess of net investment income

  $(26,128,907 $(27,094,304

See accompanying notes to consolidated financial statements.

 

7


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Cash Flows

(unaudited)

 

   For the nine months ended
November 30, 2016
  For the nine months ended
November 30, 2015
 

Operating activities

   

NET INCREASE IN NET ASSETS FROM OPERATIONS

  $10,132,981   $12,048,894  

ADJUSTMENTS TO RECONCILE NET INCREASE IN NET ASSETS FROM OPERATIONS TO NET CASH PROVIDED BY OPERATING ACTIVITIES:

   

Payment-in-kind interest income

   (433,609  (900,398

Net accretion of discount on investments

   (408,557  (377,279

Amortization of deferred debt financing costs

   775,707    669,831  

Net realized gain from investments

   (12,299,899  (4,231,006

Net unrealized (appreciation) depreciation on investments

   10,728,122    (239,354

Proceeds from sales and repayments of investments

   94,691,232    62,676,779  

Purchase of investments

   (85,850,895  (57,428,806

(Increase) decrease in operating assets:

   

Interest receivable

   (788,833  (504,339

Due from affiliate

   (46,078  —    

Management fee receivable

   (959  1,657  

Other assets

   106,195    (163,557

Receivable from unsettled trades

   15,097    —    

Increase (decrease) in operating liabilities:

   

Base management and incentive fees payable

   338,491    (178,074

Accounts payable and accrued expenses

   (183,082  (176,414

Interest and debt fees payable

   (453,760  (555,104

Payable for repurchases of common stock

   (20,957  —    

Directors fees payable

   19,500    (10,500

Due to manager

   59,603    (3,958
  

 

 

  

 

 

 

NET CASH PROVIDED BY OPERATING ACTIVITIES

   16,380,299    10,628,372  
  

 

 

  

 

 

 

Financing activities

   

Borrowings on debt

   9,000,000    10,600,000  

Paydowns on debt

   —      (20,200,000

Issuance of notes

   —      13,074,525  

Payments of deferred debt financing costs

   (644,845  (458,753

Repurchases of common stock

   (3,256,613  (38,981

Payments of cash dividends

   (5,222,112  (6,503,846
  

 

 

  

 

 

 

NET CASH USED IN FINANCING ACTIVITIES

   (123,570  (3,527,055
  

 

 

  

 

 

 

NET INCREASE IN CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS

   16,256,729    7,101,317  

CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS, BEGINNING OF PERIOD

   7,034,783    20,063,372  
  

 

 

  

 

 

 

CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS, END OF PERIOD

  $23,291,512   $27,164,689  
  

 

 

  

 

 

 

Supplemental information:

   

Interest paid during the period

  $6,784,922   $6,126,220  

Supplemental non-cash information:

   

Payment-in-kind interest income

  $433,609   $900,398  

Net accretion of discount on investments

  $408,557   $377,279  

Amortization of deferred debt financing costs

  $775,707   $669,831  

Stock dividend distribution

  $4,125,696   $3,778,630  

See accompanying notes to consolidated financial statements.

 

8


Table of Contents

SARATOGA INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

November 30, 2016

(unaudited)

Note 1. Organization

Saratoga Investment Corp. (the “Company”, “we”, “our” and “us”) is a non-diversified closed-end management investment company incorporated in Maryland that has elected to be treated and is regulated as a business development company (“BDC”) under the Investment Company Act of 1940 (the “1940 Act”). The Company commenced operations on March 23, 2007 as GSC Investment Corp. and completed the initial public offering (“IPO”) on March 28, 2007. The Company has elected to be treated as a regulated investment company (“RIC”) under subchapter M of the Internal Revenue Code (the “Code”). The Company expects to continue to qualify and to elect to be treated, for tax purposes, as a RIC. The Company’s investment objective is to generate current income and, to a lesser extent, capital appreciation from its investments.

GSC Investment, LLC (the “LLC”) was organized in May 2006 as a Maryland limited liability company. As of February 28, 2007, the LLC had not yet commenced its operations and investment activities.

On March 21, 2007, the Company was incorporated and concurrently therewith the LLC was merged with and into the Company, with the Company as the surviving entity, in accordance with the procedure for such merger in the LLC’s limited liability company agreement and Maryland law. In connection with such merger, each outstanding limited liability company interest of the LLC was converted into a share of common stock of the Company.

On July 30, 2010, the Company changed its name from “GSC Investment Corp.” to “Saratoga Investment Corp.” in connection with the consummation of a recapitalization transaction.

The Company is externally managed and advised by the investment adviser, Saratoga Investment Advisors, LLC (the “Manager”), pursuant to a management agreement (the “Management Agreement”). Prior to July 30, 2010, the Company was managed and advised by GSCP (NJ), L.P.

The Company has established wholly-owned subsidiaries, SIA Avionte, Inc., SIA GH, Inc., SIA Mercury, Inc., SIA TT, Inc., and SIA Vector, Inc., which are structured as Delaware entities, or tax blockers, to hold equity or equity-like investments in portfolio companies organized as limited liability companies, or LLCs (or other forms of pass through entities). Tax blockers are consolidated for accounting purposes, but are not consolidated for income tax purposes and may incur income tax expense as a result of their ownership of portfolio companies.

On March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP (“SBIC LP”), received a Small Business Investment Company (“SBIC”) license from the Small Business Administration (“SBA”).

On April 2, 2015, the SBA issued a “green light” letter inviting the Company to continue the application process to obtain a license to form and operate its second SBIC subsidiary. On September 27, 2016, the SBA informed us that as part of their continued review of our application for a second license, and in order to ensure that they were reviewing the most current information available, we would need to update all previously submitted materials and invited us to reapply. As a result of this request, with which we are in the process of complying, the existing “green light” letter that the SBA issued to us will expire. If approved in the future, a second SBIC license would provide us an incremental source of long-term capital by permitting us to issue up to $150.0 million of additional SBA-guaranteed debentures in addition to the $150.0 million already approved under the first license.

Note 2. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”), are stated in U.S. Dollars and include the accounts of the Company and its special purpose financing subsidiary, Saratoga Investment Funding, LLC (previously known as GSC Investment Funding LLC). All intercompany accounts and transactions have been eliminated in consolidation. All references made to the “Company,” “we,” and “us” herein include Saratoga Investment Corp. and its consolidated subsidiaries, except as stated otherwise.

 

9


Table of Contents

The Company and SBIC LP are both considered to be investment companies for financial reporting purposes and have applied the guidance in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, “Financial Services — Investment Companies” (“ASC Topic 946”). There have been no changes to the Company or SBIC LP’s status as investment companies during the nine months ended November 30, 2016.

Use of Estimates in the Preparation of Financial Statements

The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements, and income, gains (losses) and expenses during the period reported. Actual results could differ materially from those estimates.

Cash and Cash Equivalents

Cash and cash equivalents include short-term, liquid investments in a money market fund. Cash and cash equivalents are carried at cost which approximates fair value. Per section 12(d)(1)(A) of the 1940 Act, the Company may not invest in another registered investment company such as a money market fund if such investment would cause the Company to exceed any of the following limitations:

 

  we were to own more than 3.0% of the total outstanding voting stock of the money market fund;

 

  we were to hold securities in the money market fund having an aggregate value in excess of 5.0% of the value of our total assets; or

 

  we were to hold securities in money market funds and other registered investment companies and BDCs having an aggregate value in excess of 10.0% of the value of our total assets.

As of November 30, 2016, the Company did not exceed any of these limitations.

Cash and Cash Equivalents, Reserve Accounts

Cash and cash equivalents, reserve accounts include amounts held in designated bank accounts, in the form of cash and short-term liquid investments in money market funds, representing payments received on secured investments or other reserved amounts associated with our $45.0 million senior secured revolving credit facility with Madison Capital Funding LLC. The Company is required to use these amounts to pay interest expense, reduce borrowings, or pay other amounts in accordance with the terms of the senior secured revolving credit facility.

In addition, cash and cash equivalents, reserve accounts also include amounts held in designated bank accounts, in the form of cash and short-term liquid investments in money market funds, within our wholly-owned subsidiary, SBIC LP.

In November 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (“ASU 2016-18”). ASU 2016-18 requires that the statements of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statements of cash flows. The new guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, and early adoption is permitted and is to be applied on a retrospective basis. The Company has adopted the provisions of ASU 2016-18 as of November 30, 2016. The adoption of the provisions of ASU 2016-18 did not materially impact the Company’s consolidated financial position or results of operations. Prior period amounts were reclassified to conform to the current period presentation.

The following table provides a reconciliation of cash and cash equivalents and cash and cash equivalents, reserve accounts reported within the consolidated statements of assets and liabilities that sum to the total of the same such amounts shown in the consolidated statements of cash flows:

 

10


Table of Contents
   November 30,
2016
   November 30,
2015
 

Cash and cash equivalents

  $5,770,230   $6,019,448  

Cash and cash equivalents, reserve accounts

   17,521,282     21,145,241  
  

 

 

   

 

 

 

Total cash and cash equivalents, and cash and cash equivalents, reserve accounts

  $23,291,512    $27,164,689  
  

 

 

   

 

 

 

Investment Classification

The Company classifies its investments in accordance with the requirements of the 1940 Act. Under the 1940 Act, “Control Investments” are defined as investments in companies in which we own more than 25.0% of the voting securities or maintain greater than 50.0% of the board representation. Under the 1940 Act, “Affiliated Investments” are defined as those non-control investments in companies in which we own between 5.0% and 25.0% of the voting securities. Under the 1940 Act, “Non-affiliated Investments” are defined as investments that are neither Control Investments nor Affiliated Investments.

Investment Valuation

The Company accounts for its investments at fair value in accordance with the FASB ASC Topic 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold at the balance sheet date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from our Manager, the audit committee of our board of directors and a third party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors.

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

 

  Each investment is initially valued by the responsible investment professionals of our Manager and preliminary valuation conclusions are documented and discussed with the senior management of our Manager; and

 

  An independent valuation firm, engaged by our board of directors, reviews a selection of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least once each fiscal year.

In addition, all our investments are subject to the following valuation process:

 

  The audit committee of our board of directors reviews and approves each preliminary valuation and our Manager and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

  Our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of our Manager, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

Our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by our Manager and recommended to our

 

11


Table of Contents

board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rates and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO. Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. Our net asset value could be materially affected if the determinations regarding the fair value of our investments were materially higher or lower than the values that we ultimately realize upon the disposal of such investments.

Derivative Financial Instruments

We account for derivative financial instruments in accordance with ASC Topic 815, Derivatives and Hedging(“ASC 815”). ASC 815 requires recognizing all derivative instruments as either assets or liabilities on the consolidated statements of assets and liabilities at fair value. The Company values derivative contracts at the closing fair value provided by the counterparty. Changes in the values of derivative contracts are included in the consolidated statements of operations.

Investment Transactions and Income Recognition

Purchases and sales of investments and the related realized gains or losses are recorded on a trade-date basis. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortization of premiums on investments.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets, (“ASC 325-40”), based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Other Income

Other income includes dividends received, origination fees, structuring fees and advisory fees, and is recorded in the consolidated statements of operations when earned.

Payment-in-Kind Interest

The Company holds debt investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

Deferred Debt Financing Costs

Financing costs incurred in connection with our credit facility and notes are deferred and amortized using the straight line method over the life of the respective facility and debt securities. Financing costs incurred in connection with our SBA debentures are deferred and amortized using the effective yield method over the life of the debentures.

ASU 2015-03, Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs (“ASU 2015-03”) requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction

 

12


Table of Contents

from the carrying amount of that debt liability, consistent with debt discounts. The Company has adopted the provisions of ASU 2015-03 as of February 28, 2015, by reclassifying deferred debt financing costs from within total assets to within total liabilities as a contra-liability. Prior period amounts were reclassified to conform to the current period presentation.

Contingencies

In the ordinary course of business, the Company may enter into contracts or agreements that contain indemnifications or warranties. Future events could occur that lead to the execution of these provisions against the Company. Based on its history and experience, management feels that the likelihood of such an event is remote. Therefore, the Company has not accrued any liabilities in connection with such indemnifications.

In the ordinary course of business, the Company may directly or indirectly be a defendant or plaintiff in legal actions with respect to bankruptcy, insolvency or other types of proceedings. Such lawsuits may involve claims that could adversely affect the value of certain financial instruments owned by the Company.

Income Taxes

The Company has filed an election to be treated, for tax purposes, as a RIC under the Code and, among other things, intends to make the requisite distributions to its stockholders which will relieve the Company from federal income taxes. Therefore, no provision has been recorded for federal income taxes.

In order to qualify as a RIC, among other requirements, the Company is required to timely distribute to its stockholders at least 90.0% of its investment company taxable income, as defined by the Code, for each fiscal tax year. The Company will be subject to a nondeductible U.S. federal excise tax of 4.0% on undistributed income if it does not distribute at least 98.0% of its ordinary income in any calendar year and 98.2% of its capital gain net income for each one-year period ending on October 31.

Depending on the level of taxable income earned in a tax year, the Company may choose to carry forward taxable income in excess of current year dividend distributions into the next tax year and pay a 4.0% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year dividend distributions for excise tax purposes, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned.

In accordance with certain applicable U.S. Treasury regulations and private letter rulings issued by the Internal Revenue Service (“IRS”), a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution. If too many stockholders elect to receive cash, each stockholder electing to receive cash will receive a pro rata amount of cash (with the balance of the distribution paid in stock). In no event will any stockholder, electing to receive cash, receive less than 20.0% of his or her entire distribution in cash. If these and certain other requirements are met, for U.S federal income tax purposes, the amount of the dividend paid in stock will be equal to the amount of cash that could have been received instead of stock.

ASC 740, Income Taxes, (“ASC 740”), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax positions deemed to meet a “more-likely-than-not” threshold would be recorded as a tax benefit or expense in the current period. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense on the consolidated statements of operations. During the fiscal year ended February 29, 2016, the Company did not incur any interest or penalties. Although we file federal and state tax returns, our major tax jurisdiction is federal. The 2013, 2014, 2015 and 2016 federal tax years for the Company remain subject to examination by the IRS. As of November 30, 2016 and February 29, 2016, there were no uncertain tax positions. The Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change significantly in the next 12 months.

Dividends

Dividends to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the board of directors. Net realized capital gains, if any, are generally distributed at least annually, although we may decide to retain such capital gains for reinvestment.

We have adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of our dividend distributions on behalf of our stockholders unless a stockholder elects to receive cash. As a result, if our board of directors authorizes, and we declare a cash

 

13


Table of Contents

dividend, then our stockholders who have not “opted out” of the DRIP by the dividend record date will have their cash dividends automatically reinvested into additional shares of our common stock, rather than receiving the cash dividends. We have the option to satisfy the share requirements of the DRIP through the issuance of new shares of common stock or through open market purchases of common stock by the DRIP plan administrator.

Capital Gains Incentive Fee

The Company records an expense accrual on the consolidated statements of operations, relating to the capital gains incentive fee payable on the consolidated statements of assets and liabilities, by the Company to its investment adviser when the net realized and unrealized gain on its investments exceed all net realized and unrealized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the investment adviser if the Company were to liquidate its investment portfolio at such time. The actual incentive fee payable to the Company’s investment adviser related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains, net of realized and unrealized losses for the period.

New Accounting Pronouncements

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”), which is intended to reduce the existing diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The guidance is effective for annual periods beginning after December 15, 2017, and interim periods therein. Early adoption is permitted. Management is currently evaluating the impact ASU 2016-15 will have on the Company’s consolidated financial statements and disclosures.

In February 2016, the FASB issued ASU 2016-02, Amendments to the Leases (“ASC Topic 842”), which will require for all operating leases the recognition of a right-of-use asset and a lease liability, in the statement of financial position. The lease cost will be allocated over the lease term on a straight-line basis. This guidance is effective for annual and interim periods beginning after December 15, 2018. Management is currently evaluating the impact these changes will have on the Company’s consolidated financial statements and disclosures.

In January 2016, the FASB issued ASU 2016-01,Financial Instruments — Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities (“ASU 2016-01”). ASU 2016-01 retains many current requirements for the classification and measurement of financial instruments; however, it significantly revises an entity’s accounting related to (1) the classification and measurement of investments in equity securities and (2) the presentation of certain fair value changes for financial liabilities measured at fair value. ASU 2016-01 also amends certain disclosure requirements associated with the fair value of financial instruments. This guidance is effective for annual and interim periods beginning after December 15, 2017, and early adoption is not permitted for public business entities. Management is currently evaluating the impact the adoption of this standard has on the Company’s consolidated financial statements and disclosures.

In August 2014, the FASB issued new accounting guidance that requires management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. The amendments provide a definition of the term “substantial doubt” and include principles for considering the mitigating effect of management’s plans. The amendments also require an evaluation every reporting period, including interim periods for a period of one year after the date that the financial statements are issued (or available to be issued), and certain disclosures when substantial doubt is alleviated or not alleviated. The amendments in this update are effective for reporting periods ending after December 15, 2016. Management does not believe these changes will have a material impact on the Company’s consolidated financial statements and disclosures.

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in Revenue Recognition (Topic 605). Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In May 2016, ASU 2016-12 amended ASU 2014-09 and deferred the effective period to December 15, 2017. Management is currently evaluating the impact these changes will have on the Company’s consolidated financial statements and disclosures.

Risk Management

In the ordinary course of its business, the Company manages a variety of risks, including market risk and credit risk. Market risk is the risk of potential adverse changes to the value of investments because of changes in market conditions such as interest rate movements and volatility in investment prices.

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount.

 

14


Table of Contents

The Company is also exposed to credit risk related to maintaining all of its cash and cash equivalents, including those in reserve accounts, at a major financial institution and credit risk related to any of its derivative counterparties.

The Company has investments in lower rated and comparable quality unrated high yield bonds and bank loans. Investments in high yield investments are accompanied by a greater degree of credit risk. The risk of loss due to default by the issuer is significantly greater for holders of high yield securities, because such investments are generally unsecured and are often subordinated to other creditors of the issuer.

Note 3. Investments

As noted above, the Company values all investments in accordance with ASC 820. ASC 820 requires enhanced disclosures about assets and liabilities that are measured and reported at fair value. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

ASC 820 establishes a hierarchal disclosure framework which prioritizes and ranks the level of market price observability of inputs used in measuring investments at fair value. Market price observability is affected by a number of factors, including the type of investment and the characteristics specific to the investment. Investments with readily available active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.

Based on the observability of the inputs used in the valuation techniques, the Company is required to provide disclosures on fair value measurements according to the fair value hierarchy. The fair value hierarchy ranks the observability of the inputs used to determine fair values. Investments carried at fair value are classified and disclosed in one of the following three categories:

 

  Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

 

  Level 2—Valuations based on inputs other than quoted prices in active markets, which are either directly or indirectly observable.

 

  Level 3—Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The inputs used in the determination of fair value may require significant management judgment or estimation. Such information may be the result of consensus pricing information or broker quotes which include a disclaimer that the broker would not be held to such a price in an actual transaction. The non-binding nature of consensus pricing and/or quotes accompanied by a disclaimer would result in classification as a Level 3 asset, assuming no additional corroborating evidence.

In addition to using the above inputs in investment valuations, the Company continues to employ the valuation policy approved by the board of directors that is consistent with ASC 820 and the 1940 Act (see Note 2). Consistent with our valuation policy, we evaluate the source of inputs, including any markets in which our investments are trading, in determining fair value.

The following table presents fair value measurements of investments, by major class, as of November 30, 2016 (dollars in thousands), according to the fair value hierarchy:

 

   Fair Value Measurements 
   Level 1   Level 2   Level 3   Total 

Syndicated loans

  $—     $—     $9,627    $9,627  

First lien term loans

   —      —      160,460     160,460  

Second lien term loans

   —      —      80,195     80,195  

Structured finance securities

   —      —      15,266     15,266  

Equity interests

   —      —      12,022     12,022  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $—     $—     $277,570    $277,570  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

15


Table of Contents

The following table presents fair value measurements of investments, by major class, as of February 29, 2016 (dollars in thousands), according to the fair value hierarchy:

 

   Fair Value Measurements 
   Level 1   Level 2   Level 3   Total 

Syndicated loans

  $—     $—     $11,868    $11,868  

First lien term loans

   —      —      144,643     144,643  

Second lien term loans

   —      —      88,178     88,178  

Structured finance securities

   —      —      12,828     12,828  

Equity interests

   —      —      26,479     26,479  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $—     $—     $283,996    $283,996  
  

 

 

   

 

 

   

 

 

   

 

 

 

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the nine months ended November 30, 2016 (dollars in thousands):

 

   Syndicated
loans
  First lien
term loans
  Second
lien
term loans
  Structured
finance
securities
  Common
stock/
equities
  Total 

Balance as of February 29, 2016

  $11,868   $144,643   $88,178   $12,828   $26,479   $283,996  

Net unrealized appreciation/(depreciation) on investments

   2,221    (174  290    20    (13,085  (10,728

Purchases and other adjustments to cost

   56    69,671    10,996    4,500    1,470    86,693  

Sales and repayments

   (4,571  (54,033  (19,500  (2,082  (14,505  (94,691

Net realized gain from investments

   53    353    231       11,663    12,300  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Balance as of November 30, 2016

  $9,627   $160,460   $80,195   $15,266   $12,022   $277,570  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:

       

Net change in unrealized gains (losses):

  $1,075   $204   $(500 $20   $(1,981 $(1,182
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Purchases and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK.

Sales and repayments represent net proceeds received from investments sold, and principal paydowns received, during the period.

Transfers and restructurings, if any, are recognized at the beginning of the period in which they occur.

 

16


Table of Contents

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the nine months ended November 30, 2015 (dollars in thousands):

 

   Syndicated
loans
  First lien
term loans
  Second
lien
term loans
  Unsecured
notes
  Structured
finance
securities
  Common
stock/
equities
  Total 

Balance as of February 28, 2015

  $18,302   $145,207   $35,603   $4,230   $17,031   $20,165   $240,538  

Net unrealized appreciation/(depreciation) on investments

   (1,442  (1,271  (67  656    1,030    1,333    239  

Purchases and other adjustments to cost

   30    30,254    27,341    669       413    58,707  

Sales and repayments

   (2,370  (28,657  (19,502  (5,917  (2,285  (3,946  (62,677

Net realized gain from investments

   18    106    186    261       3,660    4,231  

Restructures in

   —     —     —     101    —     —      101  

Restructures out

   —     —     —     —      —     (101  (101
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Balance as of November 30, 2015

  $14,538   $145,639   $43,561   $—    $15,776   $21,524   $241,038  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:

        

Net change in unrealized gains (losses):

  $(1,458 $(1,270 $(187 $92   $1,030   $1,577   $(216
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Purchases and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK.

Sales and repayments represent net proceeds received from investments sold, and principal paydowns received, during the period.

Transfers and restructurings, if any, are recognized at the beginning of the period in which they occur.

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of November 30, 2016 were as follows (dollars in thousands):

 

   Fair Value   Valuation Technique  Unobservable Input  Range

Syndicated loans

  $9,627    Market Comparables  Third-Party Bid (%)  97.6%  - 99.9%

First lien term loans

   160,460    Market Comparables  Market Yield (%)  6.4%  - 16.4%
      EBITDA Multiples (x)  1.0x  - 6.8x
      Third-Party Bid (%)  96.0%  - 99.9%

Second lien term loans

   80,195    Market Comparables  Market Yield (%)  8.3%  - 15.0%
      Third-Party Bid (%)  94.0% - 102.0%

Structured finance securities

   15,266    Discounted Cash Flow  Discount Rate (%)  10.5%  - 15.0%

Equity interests

   12,022    Market Comparables  EBITDA Multiples (x)  2.9x  - 11.9x

 

17


Table of Contents

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of February 29, 2016 were as follows (dollars in thousands):

 

   Fair Value   Valuation Technique  Unobservable Input  Range

Syndicated loans

  $11,868    Market Comparables  Third-Party Bid (%)  72.5% - 98.2%

First lien term loans

   144,643    Market Comparables  Market Yield (%)  6.8% - 15.5%
      EBITDA Multiples (x)  1.0x
      Revenue Multiples (x)

Third-Party Bid (%)

  91.3% - 98.9%

Second lien term loans

   88,178    Market Comparables  Market Yield (%)  0.0% - 15.0%
      Third-Party Bid (%)  91.5% - 98.6%

Structured finance securities

   12,828    Discounted Cash Flow  Discount Rate (%)  20.0%

Equity interests

   26,479    Market Comparables  EBITDA Multiples (x)

Revenue Multiples (x)

  6.8x - 16.4x

For investments utilizing a market comparables valuation technique, a significant increase (decrease) in the market yield, in isolation, would result in a significantly lower (higher) fair value measurement, and a significant increase (decrease) in any of the EBITDA or revenue valuation multiples, in isolation, would result in a significantly higher (lower) fair value measurement. For investments utilizing a discounted cash flow valuation technique, a significant increase (decrease) in the discount rate, in isolation, would result in a significantly lower (higher) fair value measurement. For investments utilizing a market quote in deriving a value, a significant increase (decrease) in the market quote, in isolation, would result in a significantly higher (lower) fair value measurement.

The composition of our investments as of November 30, 2016, at amortized cost and fair value was as follows (dollars in thousands):

 

   Investments at
Amortized Cost
   Amortized Cost
Percentage of
Total Portfolio
  Investments at
Fair Value
   Fair Value
Percentage of
Total Portfolio
 

Syndicated loans

  $9,677     3.4 $9,627     3.5

First lien term loans

   162,236     56.8    160,460     57.8  

Second lien term loans

   81,213     28.5    80,195     28.9  

Structured finance securities

   15,448     5.4    15,266     5.5  

Equity interests

   16,904     5.9    12,022     4.3  
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $285,478     100.0 $277,570     100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

The composition of our investments as of February 29, 2016, at amortized cost and fair value was as follows (dollars in thousands):

 

   Investments at
Amortized Cost
   Amortized Cost
Percentage of
Total Portfolio
  Investments at
Fair Value
   Fair Value
Percentage of
Total Portfolio
 

Syndicated loans

  $14,138     5.0 $11,868     4.2

First lien term loans

   146,246     52.0    144,643     50.9  

Second lien term loans

   89,486     31.9    88,178     31.1  

Structured finance securities

   13,031     4.6    12,828     4.5  

Equity interests

   18,275     6.5    26,479     9.3  
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $281,176     100.0 $283,996     100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

For loans and debt securities for which market quotations are not available, we determine their fair value based on third party indicative broker quotes, where available, or the assumptions that a hypothetical market participant would use to value the security in a current hypothetical sale using a market yield valuation methodology. In applying the market yield valuation methodology, we determine the fair value based on such factors as market participant assumptions including synthetic credit ratings, estimated remaining life, current market yield and interest rate spreads of similar securities as of the measurement date. If, in our judgment, the market yield methodology is not sufficient or appropriate, we may use additional methodologies such as an asset liquidation or expected recovery model.

 

18


Table of Contents

For equity securities of portfolio companies and partnership interests, we determine the fair value based on the market approach with value then attributed to equity or equity like securities using the enterprise value waterfall valuation methodology. Under the enterprise value waterfall valuation methodology, we determine the enterprise fair value of the portfolio company and then waterfall the enterprise value over the portfolio company’s securities in order of their preference relative to one another. To estimate the enterprise value of the portfolio company, we weigh some or all of the traditional market valuation methods and factors based on the individual circumstances of the portfolio company in order to estimate the enterprise value. The methodologies for performing investments may be based on, among other things: valuations of comparable public companies, recent sales of private and public comparable companies, discounting the forecasted cash flows of the portfolio company, third party valuations of the portfolio company, considering offers from third parties to buy the company, estimating the value to potential strategic buyers and considering the value of recent investments in the equity securities of the portfolio company. For non-performing investments, we may estimate the liquidation or collateral value of the portfolio company’s assets and liabilities. We also take into account historical and anticipated financial results.

Our investment in Saratoga CLO is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by our Manager and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. For the quarter ended November 30, 2013, in connection with the refinancing of the Saratoga CLO liabilities, we ran Intex models based on assumptions about the refinanced Saratoga CLO’s structure, including capital structure, cost of liabilities and reinvestment period. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO at November 30, 2016. The significant inputs for the valuation model include:

 

  Default rates: 2.0%

 

  Recovery rates: 35-70%

 

  Prepayment rate: 20.0%

 

  Reinvestment rate / price: L+375bps / $99.50

Note 4. Investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”)

On January 22, 2008, we invested $30.0 million in all of the outstanding subordinated notes of GSC Investment Corp. CLO 2007, Ltd., a collateralized loan obligation fund managed by us that invests primarily in senior secured loans. Additionally, we entered into a collateral management agreement with GSC Investment Corp. CLO 2007, Ltd. pursuant to which we act as collateral manager to it. The Saratoga CLO was initially refinanced in October 2013 and its reinvestment period ended in October 2016. On November 15, 2016, we completed the second refinancing of the Saratoga CLO. The Saratoga CLO refinancing, among other things, extended its reinvestment period to October 2018, and extended its legal maturity date to October 2025. Following the refinancing, the Saratoga CLO portfolio remained at the same size and with a similar capital structure of approximately $300.0 million in aggregate principal amount of predominantly senior secured first lien term loans. In addition to refinancing its liabilities, we also purchased $4.5 million in aggregate principal amount of the Class F notes tranche of the Saratoga CLO at par, with a coupon of LIBOR plus 8.5%.

The Saratoga CLO remains 100% owned and managed by Saratoga Investment Corp. Following the refinancing, we receive a base management fee of 0.10% and a subordinated management fee of 0.40% of the fee basis amount at the beginning of the collection period, paid quarterly to the extent of available proceeds. We are also entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return paid in cash equal to or greater than 12.0%. For the three months ended November 30, 2016 and November 30, 2015, we accrued $0.4 million and $0.4 million in management fee income, respectively, and $0.5 million and $0.8 million in interest income, respectively, from Saratoga CLO. For the nine months ended November 30, 2016 and November 30, 2015, we accrued $1.1 million and $1.1 million in management fee income, respectively, and $1.6 million and $2.0 million in interest income, respectively, from Saratoga CLO. We did not accrue any amounts related to the incentive management fee from Saratoga CLO as the 12.0% hurdle rate has not yet been achieved.

At November 30, 2016, the Company determined that the fair value of its investment in the subordinated notes of Saratoga CLO was $11.0 million. The Company determines the fair value of its investment in the subordinated notes of Saratoga CLO based on the present value of the projected future cash flows of the subordinated notes over the life of Saratoga CLO. At November 30, 2016, Saratoga CLO had investments with a principal balance of $297.5 million and a weighted average spread over LIBOR of 4.31%, and had debt with a principal balance of $282.4 million with a weighted average spread over LIBOR of 2.35%. As a result, Saratoga CLO earns a “spread” between the interest income it receives on its investments and the interest expense it pays on its debt and other

 

19


Table of Contents

operating expenses, which is distributed quarterly to the Company as the holder of its subordinated notes. At November 30, 2016, the present value of the projected future cash flows of the subordinated notes was approximately $11.0 million, using an 15.0% discount rate. Saratoga Investment Corp. invested $32.8 million into the CLO since January 2008, and to date has since received distributions of $48.5 million and management fees of $16.1 million.

Below is certain financial information from the separate financial statements of Saratoga CLO as of November 30, 2016 (unaudited) and February 29, 2016 and for the three and nine months ended November 30, 2016 and November 30, 2015 (unaudited).

 

20


Table of Contents

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Assets and Liabilities

 

   As of 
   November 30, 2016  February 29, 2016 
   (unaudited)    

ASSETS

   

Investments

   

Fair Value Loans (amortized cost of $294,551,697 and $300,112,538, respectively)

  $289,961,397   $284,652,926  

Fair Value Other/Structured finance securities (amortized cost of $3,531,218 and $3,531,218, respectively)

   37,455    191,863  
  

 

 

  

 

 

 

Total investments at fair value (amortized cost of $298,082,915 and $303,643,756, respectively)

   289,998,852    284,844,789  

Cash and cash equivalents

   16,002,200    2,349,633  

Receivable from open trades

   2,500    2,691,831  

Interest receivable

   1,734,794    1,698,562  
  

 

 

  

 

 

 

Total assets

  $307,738,346   $291,584,815  
  

 

 

  

 

 

 

LIABILITIES

   

Interest payable

  $883,263   $626,040  

Payable from open trades

   11,925,775    7,123,854  

Due to affiliate

   46,078    —    

Accrued base management fee

   65,471    85,008  

Accrued subordinated management fee

   105,504    85,008  

Class A-1 Notes - SIC CLO 2013-1, Ltd.

   170,000,000    170,000,000  

Discount on Class A-1 Notes - SIC CLO 2013-1, Ltd.

   —      (1,319,258

Class A-2 Notes - SIC CLO 2013-1, Ltd.

   20,000,000    20,000,000  

Discount on Class A-2 Notes - SIC CLO 2013-1, Ltd.

   —      (136,750

Class B Notes - SIC CLO 2013-1, Ltd.

   44,800,000    44,800,000  

Discount on Class B Notes - SIC CLO 2013-1, Ltd.

   —      (888,328

Class C Notes - SIC CLO 2013-1, Ltd.

   16,000,000    16,000,000  

Discount on Class C Notes - SIC CLO 2013-1, Ltd.

   (79,605  (553,078

Class D Notes - SIC CLO 2013-1, Ltd.

   14,000,000    14,000,000  

Discount on Class D Notes - SIC CLO 2013-1, Ltd.

   (369,566  (717,938

Class E Notes - SIC CLO 2013-1, Ltd.

   13,100,000    13,100,000  

Discount on Class E Notes - SIC CLO 2013-1, Ltd.

   —      (1,353,521

Class F Notes - SIC CLO 2013-1, Ltd.

   4,500,000    4,500,000  

Discount on Class F Notes - SIC CLO 2013-1, Ltd.

   —      (492,300

Deferred debt financing costs, SIC CLO 2013-1, Ltd. Notes

   (973,665  (1,716,554

Subordinated Notes

   30,000,000    30,000,000  
  

 

 

  

 

 

 

Total liabilities

  $324,003,255   $313,142,183  
  

 

 

  

 

 

 

Commitments and contingencies

   

NET ASSETS

   

Ordinary equity, par value $1.00, 250 ordinary shares authorized, 250 and 250 issued and outstanding, respectively

  $250   $250  

Accumulated loss

   (21,557,623  (5,803,406

Net gain (loss)

   5,292,464    (15,754,212
  

 

 

  

 

 

 

Total net assets

   (16,264,909  (21,557,368
  

 

 

  

 

 

 

Total liabilities and net assets

  $  307,738,346   $  291,584,815  
  

 

 

  

 

 

 

 

21


Table of Contents

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Operations

(unaudited)

 

   For the three months ended
November 30
  For the nine months ended
November 30
 
   2016  2015  2016  2015 

INVESTMENT INCOME

     

Interest from investments

  $4,006,052   $3,559,889   $11,823,053   $10,711,063  

Interest from cash and cash equivalents

   3,095    158    5,804    663  

Other income

   82,239    14,064    515,376    248,057  
  

 

 

  

 

 

  

 

 

  

 

 

 

Total investment income

   4,091,386    3,574,111    12,344,233    10,959,783  
  

 

 

  

 

 

  

 

 

  

 

 

 

EXPENSES

     

Interest expense

   2,457,705    2,912,974    9,347,508    8,772,617  

Professional fees

   39,694    66,203    79,120    178,602  

Miscellaneous fee expense

   25,974    9,758    48,365    20,446  

Base management fee

   167,592    184,694    541,763    560,643  

Subordinated management fee

   207,625    184,694    581,796    560,643  

Trustee expenses

   30,871    26,528    95,398    94,549  

Amortization expense

   302,635    237,966    782,561    717,892  

Loss on extinguishment of debt

   6,641,915    —      6,641,915    —    
  

 

 

  

 

 

  

 

 

  

 

 

 

Total expenses

   9,874,011    3,622,817    18,118,426    10,905,392  
  

 

 

  

 

 

  

 

 

  

 

 

 

NET INVESTMENT INCOME (LOSS)

   (5,782,625  (48,706  (5,774,193  54,391  
  

 

 

  

 

 

  

 

 

  

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS:

     

Net realized gain on investments

   130,337    217,472    351,753    349,117  

Net unrealized appreciation (depreciation) on investments

   926,507    (6,609,496  10,714,904    (10,319,542
  

 

 

  

 

 

  

 

 

  

 

 

 

Net gain (loss) on investments

   1,056,844    (6,392,024  11,066,657    (9,970,425
  

 

 

  

 

 

  

 

 

  

 

 

 

NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS

  $(4,725,781 $(6,440,730 $5,292,464   $(9,916,034
  

 

 

  

 

 

  

 

 

  

 

 

 

 

22


Table of Contents

Saratoga Investment Corp. CLO 2013-1 Ltd.

Schedule of Investments

November 30, 2016

(unaudited)

 

Issuer Name

 

Industry

 

Asset Name

 Asset
Type
 Spread  LIBOR
Floor
  PIK  Current
Rate
(All In)
  Maturity
Date
  Principal /
Number of
Shares
  Cost  Fair Value 

Education Management II, LLC

 Leisure Goods/Activities/Movies A-1 Preferred Shares Equity  0.00  0.00  0.00  0.00   6,692   $669,214   $13,384  

Education Management II, LLC

 Leisure Goods/Activities/Movies A-2 Preferred Shares Equity  0.00  0.00  0.00  0.00   18,975    1,897,538    —    

New Millennium Holdco, Inc.

 Healthcare & Pharmaceuticals Common Stock Equity  0.00  0.00  0.00  0.00   14,813    964,466    24,071  

24 Hour Holdings III, LLC

 Leisure Goods/Activities/Movies Term Loan Loan  3.75  1.00  0.00  4.75  5/28/2021   $488,750    485,341    473,477  

ABB Con-Cise Optical Group, LLC

 Healthcare & Pharmaceuticals Term Loan B Loan  5.00  1.00  0.00  6.00  5/28/2021   $2,000,000    1,998,314    2,012,500  

Acosta Holdco, Inc.

 Media Term Loan B1 Loan  3.25  1.00  0.00  4.25  9/26/2021   $1,960,150    1,948,749    1,853,577  

Aspen Dental Management, Inc.

 Healthcare & Pharmaceuticals Term Loan Initial Loan  4.25  1.00  0.00  5.25  4/29/2022   $1,488,710    1,484,608    1,497,092  

Advantage Sales & Marketing, Inc.

 Services: Business Delayed Draw Term Loan Loan  3.25  1.00  0.00  4.25  7/25/2021   $2,452,462    2,449,784    2,432,033  

Aegis Toxicology Science Corporation

 Healthcare & Pharmaceuticals Term B Loan Loan  4.50  1.00  0.00  5.50  2/24/2021   $2,469,866    2,336,816    2,290,801  

Agrofresh, Inc.

 Food Services Term Loan Loan  4.75  1.00  0.00  5.75  7/30/2021   $1,975,000    1,966,724    1,866,375  

Akorn, Inc.

 Healthcare & Pharmaceuticals Term Loan B Loan  4.25  1.00  0.00  5.25  4/16/2021   $398,056    396,882    401,042  

Albertson’s LLC

 Retailers (Except Food and Drugs) Term Loan B-4 Loan  3.50  1.00  0.00  4.50  8/25/2021   $2,896,193    2,886,672    2,897,641  

Alere Inc. (fka IM US Holdings, LLC)

 Healthcare & Pharmaceuticals Term Loan B Loan  3.25  1.00  0.00  4.25  6/20/2022   $920,276    918,381    909,923  

Alion Science and Technology Corporation

 High Tech Industries Term Loan B (First Lien) Loan  4.50  1.00  0.00  5.50  8/19/2021   $2,962,500    2,950,476    2,899,547  

Alliance Healthcare Services, Inc.

 Healthcare & Pharmaceuticals Term Loan B Loan  3.25  1.00  0.00  4.25  6/3/2019   $987,141    983,080    962,462  

Anchor Glass T/L (11/16)

 Containers/Glass Products Term Loan Loan  3.25  1.00  0.00  4.25  11/22/2023   $500,000    497,511    502,190  

APCO Holdings, Inc.

 Automotive Term Loan Loan  6.00  1.00  0.00  7.00  1/31/2022   $1,966,351    1,916,134    1,917,192  

American Beacon Advisors, Inc.

 Financial Intermediaries Term Loan (First Lien) Loan  4.25  1.00  0.00  5.25  4/30/2022   $241,440    240,465    240,762  

Aramark Corporation

 Food Products U.S. Term F Loan Loan  2.50  0.75  0.00  3.25  2/24/2021   $3,126,374    3,126,374    3,149,822  

Astoria Energy T/L B

 Utilities Term Loan Loan  4.00  1.00  0.00  5.00  12/24/2021   $1,500,000    1,493,873    1,473,750  

Asurion, LLC (fka Asurion Corporation)

 Insurance Incremental Tranche B-1 Term Loan Loan  3.75  1.25  0.00  5.00  5/24/2019   $531,422    527,619    533,915  

Asurion, LLC (fka Asurion Corporation)

 Insurance Term Loan B4 (First Lien) Loan  4.00  1.00  0.00  5.00  8/4/2022   $2,440,625    2,430,001    2,454,048  

Auction.com, LLC

 Banking, Finance, Insurance & Real Estate Term Loan Loan  5.00  1.00  0.00  6.00  5/13/2019   $2,725,552    2,725,288    2,725,552  

Avantor Performance Materials Holdings, Inc.

 Chemicals/Plastics Term Loan Loan  5.00  1.00  0.00  6.00  6/21/2022   $2,791,407    2,767,475    2,807,681  

Bass Pro Group, LLC

 Retailers (Except Food and Drugs) Term Loan Loan  3.25  0.75  0.00  4.00  6/5/2020   $1,477,500    1,477,457    1,465,104  

Belmond Interfin Ltd.

 Lodging & Casinos Term Loan Loan  3.00  1.00  0.00  4.00  3/19/2021   $2,487,500    2,490,779    2,478,172  

BJ’s Wholesale Club, Inc.

 Food/Drug Retailers New 2013 (November) Replacement Loan (First Lien) Loan  3.50  1.00  0.00  4.50  9/26/2019   $2,432,199    2,434,086    2,434,996  

Blackboard T/L B4

 High Tech Industries Term Loan B4 Loan  5.00  1.00  0.00  6.00  6/30/2021   $3,000,000    2,975,510    2,975,640  

BMC Software

 Technology Term Loan Loan  4.00  1.00  0.00  5.00  9/10/2020   $1,964,646    1,919,231    1,917,495  

BMC Software T/L US

 Technology Term Loan Loan  4.00  1.00  0.00  5.00  9/10/2020   $678,000    666,468    661,335  

Brickman Group Holdings, Inc.

 Brokers/Dealers/Investment Houses Initial Term Loan (First Lien) Loan  3.00  1.00  0.00  4.00  12/18/2020   $1,464,943    1,454,843    1,464,254  

BWAY Holding Company

 Leisure Goods/Activities/Movies Term Loan B Loan  4.50  1.00  0.00  5.50  8/14/2020   $942,307    935,335    944,267  

Camp International Holding Company

 Aerospace and Defense 2013 Replacement Term Loan (First Lien) Loan  3.75  1.00  0.00  4.75  5/31/2019   $1,930,150    1,930,627    1,928,954  

Candy Intermediate Holdings, Inc.

 Beverage, Food & Tobacco Term Loan Loan  4.50  1.00  0.00  5.50  6/15/2023   $498,750    496,429    498,750  

Capital Automotive L.P.

 Conglomerate Tranche B-1 Term Loan Facility Loan  3.00  1.00  0.00  4.00  4/10/2019   $1,491,216    1,493,090    1,501,282  

Catalent Pharma Solutions, Inc

 Drugs Initial Term B Loan Loan  3.25  1.00  0.00  4.25  5/20/2021   $488,752    487,090    489,885  

Cengage Learning Acquisitions, Inc.

 Publishing Term Loan Loan  4.25  1.00  0.00  5.25  6/7/2023   $1,496,250    1,495,685    1,433,033  

Charter Communications Operating, LLC

 Cable and Satellite Television Term F Loan Loan  2.25  0.75  0.00  3.00  12/31/2020   $1,613,703    1,609,776    1,616,624  

CHS/Community Health Systems, Inc.

 Healthcare & Pharmaceuticals Term G Loan Loan  2.75  1.00  0.00  3.75  12/31/2019   $1,014,862    992,398    959,683  

CHS/Community Health Systems, Inc.

 Healthcare & Pharmaceuticals Term H Loan Loan  3.00  1.00  0.00  4.00  1/27/2021   $1,867,318    1,822,085    1,763,458  

CITGO Petroleum Corporation

 Oil & Gas Term Loan B Loan  3.50  1.00  0.00  4.50  7/29/2021   $1,969,899    1,950,189    1,964,974  

Communications Sales & Leasing, Inc.

 Telecommunications Term Loan B (First Lien) Loan  3.50  1.00  0.00  4.50  10/24/2022   $1,975,000    1,964,807    1,984,381  

Consolidated Aerospace Manufacturing, LLC

 Aerospace and Defense Term Loan (First Lien) Loan  3.75  1.00  0.00  4.75  8/11/2022   $1,437,500    1,431,231    1,322,500  

Concordia Healthcare Corporation

 Healthcare & Pharmaceuticals Term Loan B Loan  4.25  1.00  0.00  5.25  10/21/2021   $1,985,000    1,892,204    1,660,175  

CPI Acquisition Inc.

 Technology Term Loan B (First Lien) Loan  4.50  1.00  0.00  5.50  8/17/2022   $1,436,782    1,418,072    1,303,879  

CPI International Acquisition, Inc. (f/k/a Catalyst Holdings, Inc.)

 Electronics/Electric Term B Loan Loan  3.25  1.00  0.00  4.25  11/17/2017   $2,552,242    2,551,083    2,533,100  

Crosby US Acquisition Corporation

 Industrial Equipment Initial Term Loan (First Lien) Loan  3.00  1.00  0.00  4.00  11/23/2020   $729,375    728,747    616,322  

CT Technologies Intermediate Hldgs, Inc

 Healthcare & Pharmaceuticals Term Loan Loan  4.25  1.00  0.00  5.25  12/1/2021   $1,473,844    1,462,088    1,414,890  

Culligan International Company-T/L

 Conglomerate Term Loan Loan  4.00  1.00  0.00  5.00  11/17/2023   $2,005,000    2,004,975    2,006,263  

Culligan International Company

 Conglomerate Dollar Loan (First Lien) Loan  4.75  1.50  0.00  6.25  12/19/2017   $3,757,779    3,716,494    3,738,990  

Culligan International Company

 Conglomerate Dollar Loan (Second Lien) Loan  8.00  1.50  0.00  9.50  6/19/2018   $783,162    762,650    780,225  

Cumulus Media Holdings Inc.

 Broadcast Radio and Television Term Loan Loan  3.25  1.00  0.00  4.25  12/23/2020   $470,093    467,173    283,231  

DAE Aviation (StandardAero)

 Aerospace and Defense Term Loan Loan  4.25  1.00  0.00  5.25  7/7/2022   $1,980,000    1,971,835    1,980,495  

DCS Business Services, Inc.

 Financial Intermediaries Term B Loan Loan  7.25  1.50  0.00  8.75  3/19/2018   $2,109,675    2,102,627    2,109,675  

Delta 2 (Lux) S.a.r.l.

 Lodging & Casinos Term Loan B-3 Loan  3.75  1.00  0.00  4.75  7/30/2021   $1,000,000    996,370    1,005,000  

Deluxe Entertainment Service Group, Inc.

 Leisure Goods/Activities/Movies Term Loan (Incremental) Loan  6.00  1.00  0.00  7.00  2/28/2020   $1,000,000    970,592    971,250  

Deluxe Entertainment Service Group, Inc.

 Leisure Goods/Activities/Movies Term Loan (First Lien) Loan  5.50  1.00  0.00  6.50  2/28/2020   $1,880,622    1,881,696    1,837,518  

Diebold, Inc.

 High Tech Industries Term Loan B Loan  4.50  0.75  0.00  5.25  11/6/2023   $400,000    396,246    403,668  

DJO Finance, LLC

 Healthcare & Pharmaceuticals Term Loan Loan  3.25  1.00  0.00  4.25  6/8/2020   $493,750    492,061    472,766  

DPX Holdings B.V.

 Healthcare & Pharmaceuticals Term Loan 2015 Incr Dollar Loan  3.25  1.00  0.00  4.25  3/11/2021   $2,932,500    2,927,036    2,936,166  

Drew Marine Group, Inc.

 Chemicals/Plastics Term Loan (First Lien) Loan  3.25  1.00  0.00  4.25  11/19/2020   $2,956,135    2,927,349    2,882,232  

DTZ U.S. Borrower, LLC

 Construction & Building Term Loan B Add-on Loan  3.25  1.00  0.00  4.25  11/4/2021   $1,967,538    1,959,096    1,957,700  

Edelman Financial Group, Inc.

 Banking, Finance, Insurance & Real Estate Term Loan Loan  5.50  1.00  0.00  6.50  12/19/2022   $1,488,750    1,462,163    1,489,986  

Education Management II, LLC

 Leisure Goods/Activities/Movies Term Loan A Loan  4.50  1.00  0.00  5.50  7/2/2020   $501,970    487,866    115,453  

Education Management II, LLC

 Leisure Goods/Activities/Movies Term Loan B (2.00% Cash/6.50% PIK) Loan  1.00  1.00  6.50  8.50  7/2/2020   $938,381    916,819    35,968  

Emerald Performance Materials, LLC

 Chemicals/Plastics Term Loan (First Lien) Loan  3.50  1.00  0.00  4.50  8/1/2021   $480,909    479,214    482,712  

Emerald Performance Materials, LLC

 Chemicals/Plastics Term Loan (Second Lien) Loan  6.75  1.00  0.00  7.75  8/1/2022   $500,000    498,071    497,710  

Emerald 2 Limited

 Chemicals/Plastics Term Loan B1A Loan  4.00  1.00  0.00  5.00  5/14/2021   $1,000,000    993,485    925,000  

Endo International plc

 Healthcare & Pharmaceuticals Term Loan B Loan  3.00  0.75  0.00  3.75  9/26/2022   $992,500    990,394    984,749  

EnergySolutions, LLC

 Environmental Industries Term Loan B Loan  5.75  1.00  0.00  6.75  5/29/2020   $795,000    784,985    800,963  

Engility Corporation

 Aerospace and Defense Term Loan B-1 Loan  4.25  0.70  0.00  4.95  8/12/2020   $250,000    248,811    251,770  

Evergreen Acqco 1 LP

 Retailers (Except Food and Drugs) New Term Loan Loan  3.75  1.25  0.00  5.00  7/9/2019   $957,600    956,486    886,383  

EWT Holdings III Corp. (fka WTG Holdings III Corp.)

 Industrial Equipment Term Loan (First Lien) Loan  3.75  1.00  0.00  4.75  1/15/2021   $1,952,349    1,948,532    1,954,789  

EWT Holdings III Corp.

 Capital Equipment Term Loan Loan  4.50  1.00  0.00  5.50  1/15/2021   $995,000    986,153    996,662  

Extreme Reach, Inc.

 Media Term Loan B Loan  6.25  1.00  0.00  7.25  2/7/2020   $2,943,750    2,914,312    2,969,508  

Federal-Mogul Corporation

 Automotive Tranche C Term Loan Loan  3.75  1.00  0.00  4.75  4/15/2021   $2,932,500    2,922,802    2,841,270  

First Data Corporation

 Financial Intermediaries First Data T/L Ext (2021) Loan  3.00  0.70  0.00  3.70  3/24/2021   $1,909,673    1,821,389    1,917,140  

First Eagle Investment Management

 Banking, Finance, Insurance & Real Estate Term Loan Loan  4.00  0.75  0.00  4.75  12/1/2022   $1,488,750    1,462,691    1,493,871  

Fitness International, LLC

 Leisure Goods/Activities/Movies Term Loan B Loan  5.00  1.00  0.00  6.00  7/1/2020   $1,934,146    1,908,664    1,934,146  

FMG Resources (August 2006) Pty LTD (FMG America Finance, Inc.)

 Nonferrous Metals/Minerals Loan Loan  2.75  1.00  0.00  3.75  6/28/2019   $1,207,069    1,208,510    1,207,371  

Garda World Security Corporation

 Services: Business Term B Delayed Draw Loan Loan  3.00  1.00  0.00  4.00  11/6/2020   $197,592    196,978    194,012  

Garda World Security Corporation

 Services: Business Term B Loan Loan  3.00  1.00  0.00  4.00  11/6/2020   $772,408    770,060    758,411  

Gardner Denver, Inc.

 High Tech Industries Initial Dollar Term Loan Loan  3.25  1.00  0.00  4.25  7/30/2020   $2,432,330    2,427,218    2,363,009  

Gates Global LLC

 Leisure Goods/Activities/Movies Term Loan (First Lien) Loan  3.25  1.00  0.00  4.25  7/5/2021   $482,906    478,077    480,139  

General Nutrition Centers, Inc.

 Retailers (Except Food and Drugs) Amended Tranche B Term Loan Loan  2.50  0.75  0.00  3.25  3/4/2019   $2,123,160    2,119,206    2,025,856  

Global Tel*Link Corporation

 Services: Business Term Loan (First Lien) Loan  3.75  1.25  0.00  5.00  5/26/2020   $2,675,183    2,668,213    2,635,884  

Goodyear Tire & Rubber Company, The

 Chemicals/Plastics Loan (Second Lien) Loan  3.00  0.75  0.00  3.75  4/30/2019   $2,000,000    1,978,530    2,013,500  

Grosvenor Capital Management Holdings, LP

 Brokers/Dealers/Investment Houses Initial Term Loan Loan  2.75  1.00  0.00  3.75  1/4/2021   $1,014,560    1,011,388    1,006,109  

GTCR Valor Companies, Inc.

 Services: Business Term Loan B Loan  6.00  1.00  0.00  7.00  5/17/2023   $1,496,250    1,438,257    1,442,954  

Harland Clarke Holdings Corp. (fka Clarke American Corp.)

 Publishing Tranche B-4 Term Loan Loan  5.99  1.00  0.00  6.99  8/2/2019   $2,452,292    2,359,268    2,439,000  

Headwaters Incorporated

 Building & Development Term Loan Loan  3.00  1.00  0.00  4.00  3/24/2022   $246,875    245,872    247,904  

Help/Systems Holdings, Inc.

 High Tech Industries Term Loan Loan  5.25  1.00  0.00  6.25  10/8/2021   $1,488,750    1,435,008    1,476,349  

Hemisphere Media Holdings, LLC

 Media Term Loan B Loan  4.00  1.00  0.00  5.00  7/30/2020   $2,500,000    2,511,306    2,493,750  

Hercules Achievement Holdings, Inc.

 Retailers (Except Food and Drugs) Term Loan B Loan  4.00  1.00  0.00  5.00  12/10/2021   $247,481    245,345    249,585  

Hoffmaster Group, Inc.

 Containers/Glass Products Term Loan Loan  4.50  1.00  0.00  5.50  11/10/2023   $1,000,000    1,003,750    999,380  

Hostess Brand, LLC

 Beverage, Food & Tobacco Term Loan B (First Lien) Loan  3.00  1.00  0.00  4.00  8/3/2022   $1,490,000    1,486,283    1,497,823  

Huntsman International LLC

 Chemicals/Plastics Term Loan B (First Lien) Loan  3.00  0.70  0.00  3.70  4/19/2019   $2,809,046    2,793,042    2,813,260  

Husky Injection Molding Systems Ltd.

 Services: Business Term Loan B Loan  3.25  1.00  0.00  4.25  6/30/2021   $487,465    485,699    486,490  

Hyperion Refinance T/L

 Banking, Finance, Insurance & Real Estate Term Loan Loan  4.50  1.00  0.00  5.50  4/29/2022   $2,000,000    1,982,160    1,982,500  

Imagine! Print Solutions, Inc.

 Media Term Loan B Loan  6.00  1.00  0.00  7.00  3/30/2022   $497,500    490,794    500,923  

Infor (US), Inc. (fka Lawson Software Inc.)

 Services: Business Tranche B-5 Term Loan Loan  2.75  1.00  0.00  3.75  6/3/2020   $2,134,125    2,122,744    2,129,686  

Insight Global

 Services: Business Term Loan Loan  5.00  1.00  0.00  6.00  10/29/2021   $3,459,111    3,442,956    3,473,536  

Informatica Corporation

 High Tech Industries Term Loan B Loan  3.50  1.00  0.00  4.50  8/5/2022   $495,000    493,929    483,556  

J. Crew Group, Inc.

 Retailers (Except Food and Drugs) Term B-1 Loan Retired 03/05/2014 Loan  3.00  1.00  0.00  4.00  3/5/2021   $948,188    948,188    606,840  

Jazz Acquisition, Inc

 Aerospace and Defense First Lien 6/14 Loan  3.50  1.00  0.00  4.50  6/19/2021   $489,091    488,214    453,940  

J.Jill Group, Inc.

 Retailers (Except Food and Drugs) Term Loan (First Lien) Loan  5.00  1.00  0.00  6.00  5/9/2022   $987,505    983,403    965,286  

Kinetic Concepts, Inc.

 Healthcare & Pharmaceuticals Term Loan F-1 Loan  4.00  1.00  0.00  5.00  11/4/2020   $2,434,098    2,409,562    2,390,284  

Koosharem, LLC

 Services: Business Term Loan Loan  6.50  1.00  0.00  7.50  5/15/2020   $2,942,588    2,923,892    2,648,329  

Kraton Polymers, LLC

 Chemicals/Plastics Term Loan (Initial) Loan  5.00  1.00  0.00  6.00  1/6/2022   $2,500,000    2,277,562    2,513,675  

Lannett Company, Inc.

 Healthcare & Pharmaceuticals Term Loan B Loan  5.38  1.00  0.00  6.38  11/25/2022   $1,925,000    1,865,075    1,872,063  

Learfield Communications Initial T/L (A-L Parent)

 Healthcare & Pharmaceuticals Initial Term Loan (A-L Parent) Loan  3.25  1.00  0.00  4.25  11/17/2023   $500,000    497,500    501,250  

LPL Holdings

 Banking, Finance, Insurance & Real Estate Term Loan B (2022) Loan  4.00  0.75  0.00  4.75  11/21/2022   $1,985,000    1,967,639    1,999,054  

McGraw-Hill Global Education Holdings, LLC

 Publishing Term Loan Loan  4.00  1.00  0.00  5.00  5/4/2022   $997,500    993,085    987,884  

Mauser Holdings, Inc.

 Containers/Glass Products Term Loan Loan  3.50  1.00  0.00  4.50  7/31/2021   $490,000    488,278    491,838  

Michaels Stores, Inc.

 Retailers (Except Food and Drugs) Term Loan B1 Loan  2.75  1.00  0.00  3.75  1/30/2023   $1,684,412    1,678,497    1,696,000  

Micro Holding Corporation

 High Tech Industries Term Loan Loan  3.75  1.00  0.00  4.75  7/8/2021   $985,413    981,373    988,803  

Microsemi Corporation

 Electronics/Electric Term Loan B Loan  3.00  0.75  0.00  3.75  1/17/2023   $892,985    868,970    897,950  

Midas Intermediate Holdco II, LLC

 Automotive Term Loan (Initial) Loan  3.50  1.00  0.00  4.50  8/18/2021   $245,000    244,071    245,919  

Milk Specialties Company

 Beverage, Food & Tobacco Term Loan Loan  5.00  1.00  0.00  6.00  8/16/2023   $1,000,000    990,342    1,008,750  

MSC Software Corporation

 Services: Business Term Loan Loan  4.00  1.00  0.00  5.00  5/29/2020   $1,974,949    1,934,256    1,970,012  

MWI Holdings, Inc.

 Capital Equipment Term Loan (First Lien) Loan  5.50  1.00  0.00  6.50  6/29/2020   $2,992,500    2,986,899    2,992,500  

National Veterinary Associates, Inc

 Healthcare & Pharmaceuticals Term Loan B Loan  3.75  1.00  0.00  4.75  8/14/2021   $980,038    977,191    981,675  

National Vision, Inc.

 Retailers (Except Food and Drugs) Term Loan (Second Lien) Loan  5.75  1.00  0.00  6.75  3/11/2022   $250,000    249,780    238,437  

New Media Holdings II T/L (NEW)

 Retailers (Except Food and Drugs) Term Loan Loan  6.25  1.00  0.00  7.25  6/4/2020   $2,674,923    2,662,001    2,644,830  

New Millennium Holdco, Inc.

 Healthcare & Pharmaceuticals Term Loan Loan  6.50  1.00  0.00  7.50  12/21/2020   $1,935,123    1,771,899    1,154,630  

NorthStar Asset Management Group, Inc.

 Banking, Finance, Insurance & Real Estate Term Loan B Loan  3.88  0.75  0.00  4.63  1/30/2023   $1,990,000    1,926,727    1,988,348  

Novelis, Inc.

 Conglomerate Term Loan B Loan  3.25  0.75  0.00  4.00  6/2/2022   $4,735,095    4,715,782    4,740,256  

Novetta Solutions

 Aerospace and Defense Term Loan (200MM) Loan  5.00  1.00  0.00  6.00  10/16/2022   $1,985,000    1,967,682    1,890,712  

Novetta Solutions

 Aerospace and Defense Term Loan (2nd Lien) Loan  8.50  1.00  0.00  9.50  9/29/2023   $1,000,000    990,986    930,000  

NPC International, Inc.

 Food Services Term Loan (2013) Loan  3.75  1.00  0.00  4.75  12/28/2018   $477,298    477,298    477,598  

NVA Holdings, Inc.

 Services: Consumer Term Loan B1 Loan  4.50  1.00  0.00  5.50  8/14/2021   $157,841    157,485    158,236  

NXT Capital T/L (11/16)

 Banking, Finance, Insurance & Real Estate Term Loan Loan  4.50  1.00  0.00  5.50  11/23/2022   $1,000,000    995,000    1,000,000  

Om Group

 Banking, Finance, Insurance & Real Estate Term Loan Loan  6.00  1.00  0.00  7.00  10/28/2021   $994,987    903,045    991,883  

ON Semiconductor Corporation

 High Tech Industries Term Loan B Loan  3.25  0.70  0.00  3.95  3/31/2023   $500,000    499,320    502,500  

Onex Carestream Finance LP

 Healthcare & Pharmaceuticals Term Loan (First Lien 2013) Loan  4.00  1.00  0.00  5.00  6/7/2019   $3,668,306    3,659,647    3,232,695  

OnexYork Acquisition Co

 Healthcare & Pharmaceuticals Term Loan B Loan  3.75  1.00  0.00  4.75  10/1/2021   $490,000    487,264    452,637  

OpenLink International, LLC

 Services: Business Term B Loan Loan  6.50  1.25  0.00  7.75  7/29/2019   $2,921,492    2,920,807    2,947,055  

P.F. Chang’s China Bistro, Inc. (Wok Acquisition Corp.)

 Food/Drug Retailers Term Borrowing Loan  3.25  1.00  0.00  4.25  6/24/2019   $1,421,386    1,417,039    1,400,065  

P2 Upstream Acquisition Co. (P2 Upstream Canada BC ULC)

 Services: Business Term Loan (First Lien) Loan  4.00  1.00  0.00  5.00  10/30/2020   $972,500    969,216    914,150  

Petsmart, Inc. (Argos Merger Sub, Inc.)

 Retailers (Except Food and Drugs) Term Loan B1 Loan  3.00  1.00  0.00  4.00  3/11/2022   $985,000    980,220    987,728  

PGX Holdings, Inc.

 Financial Intermediaries Term Loan Loan  4.75  1.00  0.00  5.75  9/29/2020   $911,429    905,316    911,046  

Planet Fitness Holdings LLC

 Leisure Goods/Activities/Movies Term Loan Loan  3.50  0.75  0.00  4.25  3/31/2021   $2,398,337    2,390,948    2,392,341  

Polycom Term Loan (9/16)

 Telecommunications Term Loan Loan  6.50  1.00  0.00  7.50  9/27/2023   $2,000,000    1,972,500    1,966,260  

PrePaid Legal Services, Inc.

 Services: Business Term Loan B Loan  5.25  1.25  0.00  6.50  7/1/2019   $3,392,467    3,396,014    3,389,651  

Presidio, Inc.

 Services: Business Term Loan Loan  4.25  1.00  0.00  5.25  2/2/2022   $2,385,390    2,331,907    2,398,319  

Prime Security Services (Protection One)

 Services: Business Term Loan Loan  3.75  1.00  0.00  4.75  7/1/2021   $1,985,025    1,977,124    1,996,876  

Ranpak Holdings, Inc.

 Services: Business Term Loan Loan  3.25  1.00  0.00  4.25  10/1/2021   $931,264    928,935    923,115  

Ranpak Holdings, Inc.

 Services: Business Term Loan (Second Lien) Loan  7.25  1.00  0.00  8.25  10/3/2022   $500,000    498,073    470,000  

Redtop Acquisitions Limited

 Electronics/Electric Initial Dollar Term Loan (First Lien) Loan  3.50  1.00  0.00  4.50  12/3/2020   $486,259    484,109    485,044  

Regal Cinemas Corporation

 Services: Consumer Term Loan Loan  2.75  0.75  0.00  3.50  4/1/2022   $495,009    493,772    496,868  

Research Now Group, Inc

 Media Term Loan B Loan  4.50  1.00  0.00  5.50  3/18/2021   $2,042,890    2,034,414    1,981,603  

Rexnord LLC/RBS Global, Inc.

 Industrial Equipment Term B Loan Loan  3.00  1.00  0.00  4.00  8/21/2020   $1,540,540    1,541,627    1,544,607  

Reynolds Group Holdings Inc.

 Industrial Equipment Incremental U.S. Term Loan Loan  3.25  1.00  0.00  4.25  2/6/2023   $1,765,548    1,765,548    1,773,458  

Rovi Solutions Corporation / Rovi Guides, Inc.

 Electronics/Electric Tranche B-3 Term Loan Loan  3.00  0.75  0.00  3.75  7/2/2021   $1,466,250    1,461,232    1,469,549  

Royal Adhesives and Sealants

 Chemicals/Plastics Term Loan (First Lien) Loan  3.50  1.00  0.00  4.50  6/20/2022   $493,750    491,669    496,219  

Royal Adhesives and Sealants

 Chemicals/Plastics Term Loan (Second Lien) Loan  7.50  1.00  0.00  8.50  6/19/2023   $500,000    496,621    493,750  

RPI Finance Trust

 Financial Intermediaries Term B-4 Term Loan Loan  2.50  0.70  0.00  3.20  10/14/2022   $2,561,167    2,561,167    2,581,758  

Russell Investment Management T/L B

 Banking, Finance, Insurance & Real Estate Term Loan B Loan  5.75  1.00  0.00  6.75  6/1/2023   $1,995,000    1,879,384    2,006,232  

Sable International Finance Ltd

 Telecommunications Term Loan B1 Loan  4.75  0.75  0.00  5.50  12/2/2022   $825,000    809,615    831,922  

Sable International Finance Ltd

 Telecommunications Term Loan B2 Loan  4.75  0.75  0.00  5.50  12/2/2022   $675,000    662,412    680,663  

SBP Holdings LP

 Industrial Equipment Term Loan (First Lien) Loan  4.00  1.00  0.00  5.00  3/27/2021   $975,000    971,747    819,000  

Scientific Games International, Inc.

 Electronics/Electric Term Loan B2 Loan  5.00  1.00  0.00  6.00  10/1/2021   $982,500    973,672    990,684  

SCS Holdings (Sirius Computer)

 High Tech Industries Term Loan (First Lien) Loan  4.25  1.00  0.00  5.25  10/31/2022   $1,977,528    1,942,888    1,987,416  

Seadrill Operating LP

 Oil & Gas Term Loan B Loan  3.00  1.00  0.00  4.00  2/21/2021   $979,849    921,734    554,428  

Shearers Foods LLC

 Food Services Term Loan (First Lien) Loan  3.94  1.00  0.00  4.94  6/30/2021   $980,000    978,146    980,000  

Sitel Worldwide

 Telecommunications Term Loan Loan  5.50  1.00  0.00  6.50  9/18/2021   $1,980,000    1,963,403    1,968,239  

Sonneborn, LLC

 Chemicals/Plastics Term Loan (First Lien) Loan  3.75  1.00  0.00  4.75  12/10/2020   $208,512    208,136    208,860  

Sonneborn, LLC

 Chemicals/Plastics Initial US Term Loan Loan  3.75  1.00  0.00  4.75  12/10/2020   $1,181,569    1,179,439    1,183,542  

Sophia, L.P.

 Electronics/Electric Term Loan (Closing Date) Loan  3.75  1.00  0.00  4.75  9/30/2022   $1,965,897    1,957,501    1,967,136  

SourceHOV LLC

 Services: Business Term Loan B (First Lien) Loan  6.75  1.00  0.00  7.75  10/31/2019   $1,862,500    1,826,426    1,642,259  

SRAM, LLC

 Industrial Equipment Term Loan (First Lien) Loan  3.00  1.00  0.00  4.00  4/10/2020   $2,772,070    2,765,804    2,723,559  

Steak ‘n Shake Operations, Inc.

 Food Services Term Loan Loan  3.75  1.00  0.00  4.75  3/19/2021   $925,673    919,596    918,730  

SuperMedia Inc. (fka Idearc Inc.)

 Publishing Loan Loan  8.60  3.00  0.00  11.60  12/30/2016   $200,478    200,472    77,685  

Survey Sampling International

 Services: Business Term Loan B Loan  5.00  1.00  0.00  6.00  12/16/2020   $2,728,677    2,713,545    2,715,033  

Sybil Finance BV

 High Tech Industries Term Loan B Loan  4.00  1.00  0.00  5.00  8/3/2022   $1,000,000    995,154    1,008,500  

Syniverse Holdings, Inc.

 Telecommunications Initial Term Loan Loan  3.00  1.00  0.00  4.00  4/23/2019   $468,977    466,744    416,386  

TaxACT, Inc.

 Services: Business Term Loan B Loan  6.00  1.00  0.00  7.00  1/3/2023   $1,350,000    1,313,620    1,353,375  

Tectum Holdings, Inc.

 Transportation Delayed Draw Term Loan (Initial) Loan  4.75  1.00  0.00  5.75  8/24/2023   $1,000,000    990,340    1,005,000  

TGI Friday’s, Inc.

 Food Services Term Loan B Loan  4.25  1.00  0.00  5.25  7/15/2020   $1,651,816    1,648,636    1,629,104  

Townsquare Media, Inc.

 Media Term Loan B Loan  3.25  1.00  0.00  4.25  4/1/2022   $932,522    928,849    932,522  

TPF II Power LLC and TPF II Covert Midco LLC

 Utilities Term Loan B Loan  4.00  1.00  0.00  5.00  10/2/2021   $1,413,873    1,362,183    1,420,235  

TransDigm, Inc.

 Aerospace and Defense Tranche C Term Loan Loan  3.00  0.75  0.00  3.75  2/28/2020   $4,244,222    4,249,544    4,249,952  

Travel Leaders Group, LLC

 Hotel, Gaming and Leisure Term Loan B Loan  6.00  1.00  0.00  7.00  12/7/2020   $2,629,084    2,615,196    2,603,898  

Trugreen Limited Partnership

 Services: Business Term Loan B Loan  5.50  1.00  0.00  6.50  4/13/2023   $498,750    491,925    502,491  

Twin River Management Group, Inc.

 Lodging & Casinos Term Loan B Loan  4.25  1.00  0.00  5.25  7/10/2020   $864,021    865,348    868,886  

Univar Inc.

 Chemicals/Plastics Term B Loan Loan  3.25  1.00  0.00  4.25  7/1/2022   $2,970,000    2,957,757    2,979,296  

Univision Communications Inc.

 Telecommunications Replacement First-Lien Term Loan Loan  3.00  1.00  0.00  4.00  3/1/2020   $2,893,389    2,883,224    2,892,347  

Valeant Pharmaceuticals International, Inc.

 Drugs Series D2 Term Loan B Loan  4.25  0.75  0.00  5.00  2/13/2019   $2,468,721    2,460,512    2,445,588  

Verint Systems Inc.

 Services: Business Term Loan Loan  2.75  0.75  0.00  3.50  9/6/2019   $1,008,871    1,006,624    1,014,551  

Vistra Operations (Tex Operations) Exit T/L B

 Services: Business Exit Term Loan B Loan  4.00  1.00  0.00  5.00  8/4/2023   $814,286    814,286    821,069  

Vistra Operations (Tex Operations) Exit T/L C

 Services: Business Exit Term Loan C Loan  4.00  1.00  0.00  5.00  8/4/2023   $185,714    185,714    187,261  

Vizient Inc.

 Healthcare & Pharmaceuticals Term Loan Loan  4.00  1.00  0.00  5.00  2/13/2023   $879,853    856,015    887,552  

Vouvray US Finance

 Industrial Equipment Term Loan Loan  3.75  1.00  0.00  4.75  6/27/2021   $488,750    487,038    489,566  

Washington Inventory Service

 Services: Business U.S. Term Loan (First Lien) Loan  4.50  1.25  0.00  5.75  12/20/2018   $1,731,518    1,741,101    1,294,309  

Western Digital Corporation

 High Tech Industries Term Loan B (USD) Loan  3.75  0.75  0.00  4.50  5/1/2023   $1,596,000    1,585,323    1,613,955  

Windstream Services, LLC

 Telecommunications Term Loan B6 Loan  4.00  0.75  0.00  4.75  3/29/2021   $1,000,000    990,071    1,001,000  

Xerox Business Services T/L B (Conduent)

 Services: Business Term Loan Loan  5.50  0.75  0.00  6.25  11/22/2023   $500,000    487,536    500,000  

ZEP, Inc.

 Chemicals/Plastics Term Loan B Loan  4.00  1.00  0.00  5.00  6/27/2022   $2,962,500    2,950,232    2,973,609  

Zest Holdings 1st Lien T/L (2014 Replacement)

 Healthcare & Pharmaceuticals Term Loan Loan  4.75  1.00  0.00  5.75  8/17/2020   $1,000,000    995,127    1,002,500  
          

 

 

  

 

 

 
          $298,082,915   $289,998,852  
          

 

 

  

 

 

 
                       Principal  Cost  Fair Value 

Cash and cash equivalents

           

U.S. Bank Money Market (a)

         $16,002,200   $16,002,200   $16,002,200  
         

 

 

  

 

 

  

 

 

 

Total cash and cash equivalents

        $16,002,200   $16,002,200   $16,002,200  
         

 

 

  

 

 

  

 

 

 

(a)    Included within cash and cash equivalents in Saratoga CLO’s Statements of Assets and Liabilities as of November 30, 2016.

 

23


Table of Contents

Saratoga Investment Corp. CLO 2013-1 Ltd.

Schedule of Investments

February 29, 2016

 

Issuer Name

 

Industry

 

Asset Name

 Asset
Type
  Spread  LIBOR
Floor
  PIK  Current
Rate
(All In)
  Maturity
Date
  Principal/
Number
of Shares
  Cost  Fair Value 

Education Management II, LLC

 Leisure Goods/Activities/Movies A-1 Preferred Shares  Equity    0.00  0.00  0.00  0.00   6,692   $669,214   $1,673  

Education Management II, LLC

 Leisure Goods/Activities/Movies A-2 Preferred Shares  Equity    0.00  0.00  0.00  0.00   18,975    1,897,538    95  

New Millennium Holdco, Inc.

 Healthcare & Pharmaceuticals Common Stock  Equity    0.00  0.00  0.00  0.00   14,813    964,466    190,095  

24 Hour Holdings III, LLC

 Leisure Goods/Activities/Movies Term Loan  Loan    3.75  1.00  0.00  4.75  5/28/2021   $492,500    488,586    455,154  

Acosta Holdco, Inc.

 Media Term Loan B1  Loan    3.25  1.00  0.00  4.25  9/26/2021   $1,972,936    1,959,834    1,855,389  

Aspen Dental Management, Inc.

 Healthcare & Pharmaceuticals Term Loan Initial  Loan    4.50  1.00  0.00  5.50  4/29/2022   $497,500    495,228    495,221  

Advantage Sales & Marketing, Inc.

 Services: Business Delayed Draw Term Loan  Loan    3.25  1.00  0.00  4.25  7/25/2021   $2,471,231    2,468,039    2,342,826  

Agrofresh, Inc.

 Food Services Term Loan  Loan    4.75  1.00  0.00  5.75  7/30/2021   $1,990,000    1,980,704    1,935,275  

Aegis Toxicology Science Corporation

 Healthcare & Pharmaceuticals Term B Loan  Loan    4.50  1.00  0.00  5.50  2/24/2021   $985,000    985,000    797,850  

Akorn, Inc.

 Healthcare & Pharmaceuticals Term Loan B  Loan    5.00  1.00  0.00  6.00  4/16/2021   $398,056    396,681    396,066  

Albertson’s LLC

 Retailers (Except Food and Drugs) Term Loan B-4  Loan    4.50  1.00  0.00  5.50  8/25/2021   $3,384,425    3,367,410    3,302,623  

Alere Inc. (fka IM US Holdings, LLC)

 Healthcare & Pharmaceuticals Term Loan B  Loan    3.25  1.00  0.00  4.25  6/20/2022   $927,265    925,091    925,365  

Alion Science and Technology Corporation

 High Tech Industries Term Loan B (First Lien)  Loan    4.50  1.00  0.00  5.50  8/19/2021   $2,985,000    2,971,074    2,824,555  

Alliance Healthcare Services, Inc.

 Healthcare & Pharmaceuticals Term Loan B  Loan    3.25  1.00  0.00  4.25  6/3/2019   $994,856    990,161    906,981  

Alliant Holdings I, LLC

 Banking, Finance, Insurance & Real Estate Term Loan B (First Lien)  Loan    3.50  1.00  0.00  4.50  8/12/2022   $995,000    992,679    960,921  

Alvogen Pharma US, Inc

 Healthcare & Pharmaceuticals Term Loan  Loan    5.00  1.00  0.00  6.00  4/4/2022   $480,447    478,240    456,425  

American Beacon Advisors, Inc.

 Financial Intermediaries Term Loan (First Lien)  Loan    4.50  1.00  0.00  5.50  4/30/2022   $248,749    247,612    244,190  

Aramark Corporation

 Food Products LC-2 Facility  Loan    3.50  0.62  0.00  4.12  7/26/2016   $9,447    9,445    9,305  

Aramark Corporation

 Food Products LC-3 Facility  Loan    3.50  0.62  0.00  4.12  7/26/2016   $5,244    5,244    5,166  

Aramark Corporation

 Food Products U.S. Term F Loan  Loan    2.50  0.75  0.00  3.25  2/24/2021   $3,150,423    3,150,423    3,126,133  

Asurion, LLC (fka Asurion Corporation)

 Insurance Incremental Tranche B-1 Term Loan  Loan    3.75  1.25  0.00  5.00  5/24/2019   $2,596,480    2,573,245    2,441,237  

Asurion, LLC (fka Asurion Corporation)

 Insurance Term Loan B4 (First Lien)  Loan    4.00  1.00  0.00  5.00  8/4/2022   $2,478,125    2,466,303    2,270,582  

Auction.com, LLC

 Banking, Finance, Insurance & Real Estate Term Loan  Loan    5.00  1.00  0.00  6.00  5/13/2019   $2,522,992    2,522,722    2,491,455  

Avantor Performance Materials Holdings, Inc.

 Chemicals/Plastics Term Loan  Loan    4.00  1.25  0.00  5.25  6/24/2017   $2,156,953    2,153,896    2,135,384  

Bass Pro Group, LLC

 Retailers (Except Food and Drugs) Term Loan  Loan    3.25  0.75  0.00  4.00  6/5/2020   $1,488,750    1,485,895    1,397,564  

Belmond Interfin Ltd.

 Lodging & Casinos Term Loan  Loan    3.00  1.00  0.00  4.00  3/19/2021   $491,249    489,361    477,127  

Berry Plastics Corporation

 Chemicals/Plastics Term E Loan  Loan    2.75  1.00  0.00  3.75  1/6/2021   $1,314,499    1,305,069    1,291,903  

BJ’s Wholesale Club, Inc.

 Food/Drug Retailers New 2013 (November) Replacement Loan (First Lien)  Loan    3.50  1.00  0.00  4.50  9/26/2019   $1,476,196    1,475,409    1,401,161  

Blue Coat Systems

 Technology Term Loan B  Loan    3.50  1.00  0.00  4.50  5/20/2022   $997,500    995,159    945,131  

BMC Software

 Technology Term Loan  Loan    4.00  1.00  0.00  5.00  9/10/2020   $1,979,798    1,926,080    1,571,821  

Brickman Group Holdings, Inc.

 Brokers/Dealers/Investment Houses Initial Term Loan (First Lien)  Loan    3.00  1.00  0.00  4.00  12/18/2020   $1,476,212    1,464,327    1,426,390  

Brock Holdings III, Inc.

 Industrial Equipment Term Loan (First Lien)  Loan    4.50  1.50  0.00  6.00  3/16/2017   $1,917,168    1,924,101    1,802,138  

Burlington Coat Factory Warehouse Corporation

 Retailers (Except Food and Drugs) Term B-2 Loan  Loan    3.25  1.00  0.00  4.25  8/13/2021   $1,861,667    1,853,426    1,845,843  

BWAY Holding Company

 Leisure Goods/Activities/Movies Term Loan B  Loan    4.50  1.00  0.00  5.50  8/14/2020   $985,000    976,335    930,826  

Caesars Entertainment Corp.

 Lodging & Casinos Term B-7 Loan  Loan    8.75  1.00  3.50  13.25  3/1/2017   $995,000    991,037    814,656  

Camp International Holding Company

 Aerospace and Defense 2013 Replacement Term Loan (First Lien)  Loan    3.75  1.00  0.00  4.75  5/31/2019   $1,940,113    1,940,984    1,806,730  

Capital Automotive L.P.

 Conglomerate Tranche B-1 Term Loan Facility  Loan    3.00  1.00  0.00  4.00  4/10/2019   $2,051,828    2,055,060    2,044,564  

Catalent Pharma Solutions, Inc

 Drugs Initial Term B Loan  Loan    3.25  1.00  0.00  4.25  5/20/2021   $492,501    490,549    487,271  

Cengage Learning Acquisitions, Inc.

 Publishing Term Loan  Loan    6.00  1.00  0.00  7.00  3/31/2020   $2,647,871    2,670,807    2,539,758  

Charter Communications Operating, LLC

 Cable and Satellite Television Term F Loan  Loan    2.25  0.75  0.00  3.00  12/31/2020   $2,628,783    2,621,343    2,566,823  

CHS/Community Health Systems, Inc.

 Healthcare & Pharmaceuticals Term G Loan  Loan    2.75  1.00  0.00  3.75  12/31/2019   $1,022,569    994,876    974,212  

CHS/Community Health Systems, Inc.

 Healthcare & Pharmaceuticals Term H Loan  Loan    3.00  1.00  0.00  4.00  1/27/2021   $1,881,500    1,828,566    1,785,920  

Cinedigm Digital Funding I, LLC

 Services: Business Term Loan  Loan    2.75  1.00  0.00  3.75  2/28/2018   $298,828    297,362    295,840  

CITGO Petroleum Corporation

 Oil & Gas Term Loan B  Loan    3.50  1.00  0.00  4.50  7/29/2021   $1,984,975    1,962,423    1,865,876  

Communications Sales & Leasing, Inc.

 Telecommunications Term Loan B (First Lien)  Loan    4.00  1.00  0.00  5.00  10/24/2022   $1,990,000    1,978,594    1,847,596  

CommScope, Inc.

 Telecommunications Term Loan B  Loan    3.00  0.75  0.00  3.75  12/29/2022   $498,750    497,568    494,176  

Consolidated Aerospace Manufacturing, LLC

 Aerospace and Defense Term Loan (First Lien)  Loan    3.75  1.00  0.00  4.75  8/11/2022   $1,437,500    1,430,556    1,329,688  

Concordia Healthcare Corp

 Healthcare & Pharmaceuticals Term Loan B  Loan    4.25  1.00  0.00  5.25  10/21/2021   $2,000,000    1,894,483    1,920,000  

CPI Acquisition Inc.

 Technology Term Loan B (First Lien)  Loan    4.50  1.00  0.00  5.50  8/17/2022   $1,436,782    1,415,977    1,396,667  

CPI International Acquisition, Inc. (f/k/a Catalyst Holdings, Inc.)

 Electronics/Electric Term B Loan  Loan    3.25  1.00  0.00  4.25  11/17/2017   $1,564,182    1,564,182    1,501,615  

Crosby US Acquisition Corp.

 Industrial Equipment Initial Term Loan (First Lien)  Loan    3.00  1.00  0.00  4.00  11/23/2020   $735,000    734,245    536,550  

CT Technologies Intermediate Hldgs, Inc

 Healthcare & Pharmaceuticals Term Loan  Loan    4.25  1.00  0.00  5.25  12/1/2021   $1,485,038    1,471,665    1,433,061  

Culligan International Company

 Conglomerate Dollar Loan (First Lien)  Loan    4.75  1.50  0.00  6.25  12/19/2017   $771,625    742,910    721,469  

Culligan International Company

 Conglomerate Dollar Loan (Second Lien)  Loan    8.00  1.50  0.00  9.50  6/19/2018   $783,162    754,065    734,214  

Cumulus Media Holdings Inc.

 Broadcast Radio and Television Term Loan  Loan    3.25  1.00  0.00  4.25  12/23/2020   $470,093    466,690    304,973  

DAE Aviation (StandardAero)

 Aerospace and Defense Term Loan  Loan    4.25  1.00  0.00  5.25  7/7/2022   $1,995,000    1,985,759    1,970,063  

DCS Business Services, Inc.

 Financial Intermediaries Term B Loan  Loan    7.25  1.50  0.00  8.75  3/19/2018   $2,409,739    2,397,948    2,409,739  

Dell International LLC

 Technology Term Loan B2  Loan    3.25  0.75  0.00  4.00  4/29/2020   $2,904,989    2,892,348    2,889,854  

Delta 2 (Lux) S.a.r.l.

 Lodging & Casinos Term Loan B-3  Loan    3.75  1.00  0.00  4.75  7/30/2021   $1,000,000    995,870    925,000  

Deluxe Entertainment Service Group, Inc.

 Leisure Goods/Activities/Movies Term Loan (First Lien)  Loan    5.50  1.00  0.00  6.50  2/28/2020   $1,882,983    1,884,279    1,751,174  

Diamond Resorts International

 Lodging & Casinos Term Loan  Loan    4.50  1.00  0.00  5.50  5/7/2021   $926,971    923,222    897,614  

Diamond Resorts International

 Lodging & Casinos Term Loan (Add-On)  Loan    4.50  1.00  0.00  5.50  5/7/2021   $1,000,000    980,687    968,330  

DJO Finance, LLC

 Healthcare & Pharmaceuticals Term Loan  Loan    3.25  1.00  0.00  4.25  6/8/2020   $497,500    495,435    478,222  

DPX Holdings B.V.

 Healthcare & Pharmaceuticals Term Loan 2015 Incr Dollar  Loan    3.25  1.00  0.00  4.25  3/11/2021   $2,955,000    2,948,456    2,799,863  

Drew Marine Group, Inc.

 Chemicals/Plastics Term Loan (First Lien)  Loan    3.25  1.00  0.00  4.25  11/19/2020   $2,472,161    2,445,601    2,299,110  

DTZ U.S. Borrower, LLC

 Construction & Building Term Loan B Add-on  Loan    3.25  1.00  0.00  4.25  11/4/2021   $2,985,000    2,970,317    2,869,331  

Edelman Financial Group, Inc.

 Banking, Finance, Insurance & Real Estate Term Loan  Loan    5.50  1.00  0.00  6.50  12/19/2022   $1,500,000    1,470,617    1,459,695  

Education Management II, LLC

 Leisure Goods/Activities/Movies Term Loan A  Loan    4.50  1.00  0.00  5.50  7/2/2020   $501,970    485,313    160,630  

Education Management II, LLC

 Leisure Goods/Activities/Movies Term Loan B (2.00% Cash/6.50% PIK)  Loan    1.00  1.00  6.50  8.50  7/2/2020   $893,447    867,647    56,582  

Emerald Performance Materials, LLC

 Chemicals/Plastics Term Loan (First Lien)  Loan    3.50  1.00  0.00  4.50  8/1/2021   $484,659    482,690    473,148  

Emerald Performance Materials, LLC

 Chemicals/Plastics Term Loan (Second Lien)  Loan    6.75  1.00  0.00  7.75  8/1/2022   $500,000    497,844    468,750  

Emerald 2 Limited

 Chemicals/Plastics Term Loan B1A  Loan    4.00  1.00  0.00  5.00  5/14/2021   $1,000,000    991,762    866,670  

Endo International plc

 Healthcare & Pharmaceuticals Term Loan B  Loan    3.00  0.75  0.00  3.75  9/26/2022   $1,000,000    997,602    987,780  

EnergySolutions, LLC

 Environmental Industries Term Loan B  Loan    5.75  1.00  0.00  6.75  5/29/2020   $937,857    923,660    731,528  

Evergreen Acqco 1 LP

 Retailers (Except Food and Drugs) New Term Loan  Loan    3.75  1.25  0.00  5.00  7/9/2019   $965,081    963,406    719,951  

EWT Holdings III Corp. (fka WTG Holdings III Corp.)

 Industrial Equipment Term Loan (First Lien)  Loan    3.75  1.00  0.00  4.75  1/15/2021   $1,967,406    1,962,950    1,908,383  

Federal-Mogul Corporation

 Automotive Tranche C Term Loan  Loan    3.75  1.00  0.00  4.75  4/15/2021   $2,955,000    2,943,580    2,345,530  

First Data Corporation

 Financial Intermediaries First Data Corp T/L (2018 New Dollar)  Loan    3.50  0.62  0.00  4.12  3/23/2018   $2,790,451    2,748,229    2,752,780  

First Data Corporation

 Financial Intermediaries First Data T/L Ext (2021)  Loan    4.00  0.62  0.00  4.62  3/24/2021   $2,111,028    2,034,284    2,077,779  

First Eagle Investment Management

 Banking, Finance, Insurance & Real Estate Term Loan  Loan    4.00  0.75  0.00  4.75  12/1/2022   $1,500,000    1,470,946    1,412,504  

Fitness International, LLC

 Leisure Goods/Activities/Movies Term Loan B  Loan    4.50  1.00  0.00  5.50  7/1/2020   $1,976,234    1,945,935    1,850,249  

FMG Resources (August 2006) Pty LTD (FMG America Finance, Inc.)

 Nonferrous Metals/Minerals Loan  Loan    3.25  1.00  0.00  4.25  6/28/2019   $1,962,387    1,962,515    1,504,738  

Garda World Security Corporation

 Services: Business Term B Delayed Draw Loan  Loan    3.00  1.00  0.00  4.00  11/6/2020   $199,120    198,391    187,344  

Garda World Security Corporation

 Services: Business Term B Loan  Loan    3.00  1.00  0.00  4.00  11/6/2020   $778,380    775,586    732,346  

Gardner Denver, Inc.

 High Tech Industries Initial Dollar Term Loan  Loan    3.25  1.00  0.00  4.25  7/30/2020   $2,451,137    2,445,005    2,016,452  

Gates Global LLC

 Leisure Goods/Activities/Movies Term Loan (First Lien)  Loan    3.25  1.00  0.00  4.25  7/5/2021   $493,750    488,813    433,883  

Generac Power Systems, Inc.

 Industrial Equipment Term Loan B  Loan    2.75  0.75  0.00  3.50  5/31/2020   $693,858    684,537    676,511  

General Nutrition Centers, Inc.

 Retailers (Except Food and Drugs) Amended Tranche B Term Loan  Loan    2.50  0.75  0.00  3.25  3/4/2019   $4,131,271    4,121,165    4,012,497  

Global Tel*Link Corporation

 Services: Business Term Loan (First Lien)  Loan    3.75  1.25  0.00  5.00  5/26/2020   $2,725,318    2,717,647    2,237,023  

Goodyear Tire & Rubber Company, The

 Chemicals/Plastics Loan (Second Lien)  Loan    3.00  0.75  0.00  3.75  4/30/2019   $2,000,000    1,974,077    2,005,000  

Grosvenor Capital Management Holdings, LP

 Brokers/Dealers/Investment Houses Initial Term Loan  Loan    2.75  1.00  0.00  3.75  1/4/2021   $1,264,036    1,259,418    1,191,354  

GTCR Valor Companies, Inc.

 Services: Business Term Loan (First Lien)  Loan    5.00  1.00  0.00  6.00  6/1/2021   $1,974,982    1,941,456    1,959,340  

Harland Clarke Holdings Corp. (fka Clarke American Corp.)

 Publishing Tranche B-4 Term Loan  Loan    5.00  1.00  0.00  6.00  8/2/2019   $475,000    473,378    421,561  

HCA Inc.

 Healthcare & Pharmaceuticals Tranche B-4 Term Loan  Loan    2.75  0.62  0.00  3.37  5/1/2018   $2,119,664    2,053,127    2,116,294  

Headwaters Incorporated

 Building & Development Term Loan  Loan    3.50  1.00  0.00  4.50  3/24/2022   $248,750    247,628    248,285  

Hercules Achievement Holdings, Inc.

 Retailers (Except Food and Drugs) Term Loan B  Loan    4.00  1.00  0.00  5.00  12/10/2021   $249,370    246,940    244,929  

Hertz Corporation, The

 Automotive Tranche B-1 Term Loan  Loan    2.75  1.00  0.00  3.75  3/12/2018   $2,910,000    2,933,230    2,879,998  

Hoffmaster Group, Inc.

 Containers/Glass Products Term Loan  Loan    4.25  1.00  0.00  5.25  5/8/2020   $1,970,000    1,955,325    1,915,825  

Hostess Brand, LLC

 Beverage, Food & Tobacco Term Loan B (First Lien)  Loan    3.50  1.00  0.00  4.50  8/3/2022   $997,500    995,241    983,784  

Huntsman International LLC

 Chemicals/Plastics Term Loan B (First Lien)  Loan    3.00  0.62  0.00  3.62  4/19/2019   $3,840,541    3,814,577    3,727,245  

Husky Injection Molding Systems Ltd.

 Services: Business Term Loan B  Loan    3.25  1.00  0.00  4.25  6/30/2021   $491,196    489,277    465,757  

Infor (US), Inc. (fka Lawson Software Inc.)

 Services: Business Tranche B-5 Term Loan  Loan    2.75  1.00  0.00  3.75  6/3/2020   $2,188,296    2,174,333    2,015,049  

Insight Global

 Services: Business Term Loan  Loan    5.00  1.00  0.00  6.00  10/29/2021   $1,979,592    1,971,967    1,961,439  

Informatica Corporation

 High Tech Industries Term Loan B  Loan    3.50  1.00  0.00  4.50  8/5/2022   $498,750    497,554    468,411  

J. Crew Group, Inc.

 Retailers (Except Food and Drugs) Term B-1 Loan Retired 03/05/2014  Loan    3.00  1.00  0.00  4.00  3/5/2021   $955,481    955,481    639,379  

Jazz Acquisition, Inc

 Aerospace and Defense First Lien 6/14  Loan    3.50  1.00  0.00  4.50  6/19/2021   $492,727    491,745    434,832  

J.Jill Group, Inc.

 Retailers (Except Food and Drugs) Term Loan (First Lien)  Loan    5.00  1.00  0.00  6.00  5/9/2022   $995,000    990,362    925,350  

Kinetic Concepts, Inc.

 Healthcare & Pharmaceuticals Dollar Term D-1 Loan  Loan    3.50  1.00  0.00  4.50  5/4/2018   $2,452,586    2,436,004    2,392,645  

Koosharem, LLC

 Services: Business Term Loan  Loan    6.50  1.00  0.00  7.50  5/15/2020   $2,965,050    2,942,458    2,683,370  

Kraton Polymers, LLC

 Chemicals/Plastics Term Loan (Initial)  Loan    5.00  1.00  0.00  6.00  1/6/2022   $2,500,000    2,252,500    2,250,000  

LPL Holdings

 Banking, Finance, Insurance & Real Estate Term Loan B (2022)  Loan    4.00  0.75  0.00  4.75  11/21/2022   $2,000,000    1,980,543    1,900,000  

Mauser Holdings, Inc.

 Containers/Glass Products Term Loan  Loan    3.50  1.00  0.00  4.50  7/31/2021   $493,750    491,750    475,234  

Michaels Stores, Inc.

 Retailers (Except Food and Drugs) Term B Loan  Loan    2.75  1.00  0.00  3.75  1/28/2020   $486,250    486,250    479,792  

Michaels Stores, Inc.

 Retailers (Except Food and Drugs) Term Loan B-2  Loan    3.00  1.00  0.00  4.00  1/28/2020   $1,212,794    1,208,220    1,201,042  

Micro Holding Corp.

 High Tech Industries Term Loan  Loan    3.75  1.00  0.00  4.75  7/8/2021   $992,447    987,851    950,268  

Microsemi Corporation

 Electronics/Electric Term Loan B  Loan    4.50  0.75  0.00  5.25  1/15/2023   $2,183,824    2,119,162    2,180,177  

Midas Intermediate Holdco II, LLC

 Automotive Term Loan (Initial)  Loan    3.50  1.00  0.00  4.50  8/18/2021   $246,875    245,802    244,098  

MPH Acquisition Holdings, LLC

 Healthcare & Pharmaceuticals Term Loan  Loan    2.75  1.00  0.00  3.75  3/31/2021   $376,136    375,400    366,500  

MSC Software Corporation

 Services: Business Term Loan  Loan    4.00  1.00  0.00  5.00  5/29/2020   $985,000    977,601    886,500  

National Veterinary Associates, Inc

 Healthcare & Pharmaceuticals Term Loan B  Loan    3.75  1.00  0.00  4.75  8/14/2021   $987,526    984,296    959,549  

National Vision, Inc.

 Retailers (Except Food and Drugs) Term Loan (Second Lien)  Loan    5.75  1.00  0.00  6.75  3/11/2022   $250,000    249,729    218,750  

Neptune Finco (CSC Holdings)

 Cable and Satellite Television Term Loan  Loan    4.00  1.00  0.00  5.00  10/7/2022   $1,000,000    985,784    989,750  

New Millennium Holdco

 Healthcare & Pharmaceuticals Term Loan  Loan    6.50  1.00  0.00  7.50  12/21/2020   $2,007,042    1,811,375    1,822,655  

Nortek, Inc.

 Electronics/Electric Term Loan B  Loan    2.75  0.75  0.00  3.50  10/30/2020   $985,022    974,747    939,464  

NorthStar Asset Management Group Inc.

 Banking, Finance, Insurance & Real Estate Term Loan B  Loan    3.88  0.75  0.00  4.63  1/30/2023   $2,000,000    1,930,000    1,950,000  

Novelis, Inc.

 Conglomerate Term Loan B  Loan    3.25  0.75  0.00  4.00  6/2/2022   $4,771,058    4,749,389    4,440,090  

Novetta Solutions

 Aerospace and Defense Term Loan (200MM)  Loan    5.00  1.00  0.00  6.00  10/16/2022   $2,000,000    1,980,636    1,940,000  

Novetta Solutions

 Aerospace and Defense Term Loan (2nd Lien)  Loan    8.50  1.00  0.00  9.50  9/29/2023   $1,000,000    990,269    950,000  

NPC International, Inc.

 Food Services Term Loan (2013)  Loan    3.75  1.00  0.00  4.75  12/28/2018   $481,250    481,250    472,829  

NRG Energy, Inc.

 Utilities Term Loan (2013)  Loan    2.00  0.75  0.00  2.75  7/2/2018   $3,821,925    3,808,282    3,751,449  

Numericable

 Broadcast Radio and Television Term Loan B-5  Loan    3.81  0.75  0.00  4.56  7/31/2022   $997,500    995,164    953,171  

NuSil Technology LLC.

 Chemicals/Plastics Term Loan  Loan    4.00  1.25  0.00  5.25  4/7/2017   $789,045    789,045    774,645  

Onex Carestream Finance LP

 Healthcare & Pharmaceuticals Term Loan (First Lien 2013)  Loan    4.00  1.00  0.00  5.00  6/7/2019   $3,832,558    3,821,232    3,244,912  

OnexYork Acquisition Co

 Healthcare & Pharmaceuticals Term Loan B  Loan    3.75  1.00  0.00  4.75  10/1/2021   $493,749    490,644    459,435  

OpenLink International, LLC

 Services: Business Term B Loan  Loan    5.00  1.25  0.00  6.25  10/30/2017   $2,944,496    2,943,282    2,811,994  

P.F. Chang’s China Bistro, Inc. (Wok Acquisition Corp.)

 Food/Drug Retailers Term Borrowing  Loan    3.25  1.00  0.00  4.25  6/24/2019   $1,432,750    1,427,110    1,336,039  

P2 Upstream Acquisition Co. (P2 Upstream Canada BC ULC)

 Services: Business Term Loan (First Lien)  Loan    4.00  1.00  0.00  5.00  10/30/2020   $980,000    976,133    774,200  

Penn Products Terminal, LLC

 Chemicals/Plastics Term Loan B  Loan    3.75  1.00  0.00  4.75  4/13/2022   $248,125    246,994    218,350  

PetCo Animal Supplies Stores, Inc.

 Retailers (Except Food and Drugs) Term Loan B-1  Loan    4.75  1.00  0.00  5.75  1/15/2023   $1,000,000    980,217    978,590  

PetCo Animal Supplies Stores, Inc.

 Retailers (Except Food and Drugs) Term Loan B-2  Loan    5.00  0.62  0.00  5.62  1/15/2023   $1,000,000    980,216    978,960  

Petsmart, Inc. (Argos Merger Sub, Inc.)

 Retailers (Except Food and Drugs) Term Loan B1  Loan    3.25  1.00  0.00  4.25  3/11/2022   $992,500    987,862    961,176  

PGX Holdings, Inc.

 Financial Intermediaries Term Loan  Loan    4.75  1.00  0.00  5.75  9/29/2020   $954,643    947,123    941,917  

Pharmaceutical Product Development, Inc. (Jaguar Holdings, LLC)

 Conglomerate Term Loan  Loan    3.25  1.00  0.00  4.25  8/18/2022   $1,920,848    1,911,850    1,872,346  

Phillips-Medisize Corporation

 Healthcare & Pharmaceuticals Term Loan  Loan    3.75  1.00  0.00  4.75  6/16/2021   $492,500    490,535    458,025  

Physio-Control International, Inc.

 Healthcare & Pharmaceuticals Term Loan B  Loan    4.50  1.00  0.00  5.50  6/6/2022   $498,750    496,371    498,127  

Pinnacle Foods Finance LLC

 Food Products New Term Loan G  Loan    2.25  0.75  0.00  3.00  4/29/2020   $2,581,332    2,577,286    2,553,737  

Planet Fitness Holdings LLC

 Leisure Goods/Activities/Movies Term Loan  Loan    3.75  1.00  0.00  4.75  3/31/2021   $2,417,118    2,410,079    2,368,776  

PrePaid Legal Services, Inc.

 Services: Business Term Loan B  Loan    5.25  1.25  0.00  6.50  7/1/2019   $724,167    721,080    716,020  

Presidio, Inc.

 Services: Business Term Loan  Loan    4.25  1.00  0.00  5.25  2/2/2022   $1,902,292    1,846,615    1,816,688  

Prime Security Services (Protection One)

 Services: Business Term Loan  Loan    4.00  1.00  0.00  5.00  7/1/2021   $1,995,000    1,985,640    1,924,178  

Ranpak Holdings, Inc.

 Services: Business Term Loan  Loan    3.25  1.00  0.00  4.25  10/1/2021   $938,354    936,008    886,745  

Ranpak Holdings, Inc.

 Services: Business Term Loan (Second Lien)  Loan    7.25  1.00  0.00  8.25  10/3/2022   $500,000    497,866    400,000  

Redtop Acquisitions Limited

 Electronics/Electric Initial Dollar Term Loan (First Lien)  Loan    3.50  1.00  0.00  4.50  12/3/2020   $490,000    487,461    482,444  

Regal Cinemas Corporation

 Services: Consumer Term Loan  Loan    3.00  0.75  0.00  3.75  4/1/2022   $497,500    496,320    496,256  

Research Now Group, Inc

 Media Term Loan B  Loan    4.50  1.00  0.00  5.50  3/18/2021   $2,058,445    2,048,627    1,996,692  

Rexnord LLC/RBS Global, Inc.

 Industrial Equipment Term B Loan  Loan    3.00  1.00  0.00  4.00  8/21/2020   $1,630,123    1,631,387    1,557,647  

Reynolds Group Holdings Inc.

 Industrial Equipment Incremental U.S. Term Loan  Loan    3.50  1.00  0.00  4.50  12/1/2018   $1,910,551    1,910,551    1,902,946  

Riverbed Technology, Inc.

 Technology Term Loan B  Loan    5.00  1.00  0.00  6.00  2/25/2022   $992,500    988,224    970,873  

Rocket Software, Inc.

 Services: Business Term Loan (First Lien)  Loan    4.50  1.25  0.00  5.75  2/8/2018   $1,901,835    1,889,759    1,889,150  

Rovi Solutions Corporation / Rovi Guides, Inc.

 Electronics/Electric Tranche B-3 Term Loan  Loan    3.00  0.75  0.00  3.75  7/2/2021   $1,477,500    1,471,640    1,422,094  

Royal Adhesives and Sealants

 Chemicals/Plastics Term Loan (First Lien)  Loan    3.50  1.00  0.00  4.50  6/20/2022   $497,500    495,187    479,675  

Royal Adhesives and Sealants

 Chemicals/Plastics Term Loan (Second Lien)  Loan    7.50  1.00  0.00  8.50  6/19/2023   $500,000    496,388    478,335  

RPI Finance Trust

 Financial Intermediaries Term B-4 Term Loan  Loan    2.75  0.75  0.00  3.50  11/9/2020   $5,155,193    5,155,193    5,132,665  

Sable International Finance Ltd

 Telecommunications Term Loan B1  Loan    4.75  0.75  0.00  5.50  12/2/2022   $825,000    808,500    800,770  

Sable International Finance Ltd

 Telecommunications Term Loan B2  Loan    4.75  0.75  0.00  5.50  12/2/2022   $675,000    661,500    655,175  

SBP Holdings LP

 Industrial Equipment Term Loan (First Lien)  Loan    4.00  1.00  0.00  5.00  3/27/2021   $982,500    978,645    707,400  

Scientific Games International, Inc.

 Electronics/Electric Term Loan B2  Loan    5.00  1.00  0.00  6.00  10/1/2021   $990,000    981,872    904,613  

SCS Holdings (Sirius Computer)

 High Tech Industries Term Loan (First Lien)  Loan    5.00  1.00  0.00  6.00  10/30/2022   $1,977,528    1,939,305    1,937,978  

Seadrill Operating LP

 Oil & Gas Term Loan B  Loan    3.00  1.00  0.00  4.00  2/21/2021   $987,406    919,799    407,305  

Sensus USA Inc. (fka Sensus Metering Systems)

 Utilities Term Loan (First Lien)  Loan    3.25  1.25  0.00  4.50  5/9/2017   $1,905,121    1,902,477    1,826,534  

ServiceMaster Company, The

 Conglomerate Tranche B Term Loan  Loan    3.25  1.00  0.00  4.25  7/1/2021   $1,975,000    1,959,254    1,956,889  

Shearers Foods LLC

 Food Services Term Loan (First Lien)  Loan    3.94  1.00  0.00  4.94  6/30/2021   $987,500    985,421    952,938  

Sitel Worldwide

 Telecommunications Term Loan  Loan    5.50  1.00  0.00  6.50  9/18/2021   $1,995,000    1,976,131    1,931,160  

Sonneborn, LLC

 Chemicals/Plastics Term Loan (First Lien)  Loan    3.75  1.00  0.00  4.75  12/10/2020   $222,750    222,282    220,801  

Sonneborn, LLC

 Chemicals/Plastics Initial US Term Loan  Loan    3.75  1.00  0.00  4.75  12/10/2020   $1,262,250    1,259,600    1,251,205  

Sophia, L.P.

 Electronics/Electric Term Loan (Closing Date)  Loan    3.75  1.00  0.00  4.75  9/30/2022   $1,995,000    1,985,507    1,911,469  

SourceHOV LLC

 Services: Business Term Loan B (First Lien)  Loan    6.75  1.00  0.00  7.75  10/31/2019   $1,937,500    1,891,680    1,541,281  

SRAM, LLC

 Industrial Equipment Term Loan (First Lien)  Loan    3.00  1.00  0.00  4.00  4/10/2020   $2,904,577    2,896,630    2,207,479  

Staples, Inc.

 Retailers (Except Food and Drugs) Term Loan 1/16  Loan    4.00  0.75  0.00  4.75  4/23/2021   $1,000,000    990,308    992,130  

Steak ‘n Shake Operations, Inc.

 Food Services Term Loan  Loan    3.75  1.00  0.00  4.75  3/19/2021   $965,341    957,952    946,034  

SuperMedia Inc. (fka Idearc Inc.)

 Publishing Loan  Loan    8.60  3.00  0.00  11.60  12/30/2016   $222,900    220,105    67,520  

Survey Sampling International

 Services: Business Term Loan B  Loan    5.00  1.00  0.00  6.00  12/16/2020   $992,500    990,554    970,169  

Sybil Finance BV

 High Tech Industries Term Loan  Loan    3.25  1.00  0.00  4.25  3/20/2020   $1,272,143    1,270,803    1,253,061  

Syniverse Holdings, Inc.

 Telecommunications Initial Term Loan  Loan    3.00  1.00  0.00  4.00  4/23/2019   $479,913    476,927    311,944  

TaxACT, Inc.

 Services: Business Term Loan B  Loan    6.00  1.00  0.00  7.00  1/3/2023   $1,860,000    1,805,035    1,804,200  

TGI Friday’s, Inc.

 Food Services Term Loan B  Loan    4.25  1.00  0.00  5.25  7/15/2020   $1,651,816    1,647,936    1,636,669  

Townsquare Media, Inc.

 Media Term Loan B  Loan    3.25  1.00  0.00  4.25  4/1/2022   $932,522    928,333    915,624  

TPF II Power LLC and TPF II Covert Midco LLC

 Utilities Term Loan B  Loan    4.50  1.00  0.00  5.50  10/2/2021   $1,491,826    1,433,943    1,396,722  

TransDigm, Inc.

 Aerospace and Defense Tranche C Term Loan  Loan    3.00  0.75  0.00  3.75  2/28/2020   $4,277,294    4,283,815    4,148,975  

Travel Leaders Group, LLC

 Hotel, Gaming and Leisure Term Loan B  Loan    6.00  1.00  0.00  7.00  12/7/2020   $1,946,300    1,939,729    1,917,107  

Tricorbraun, Inc. (fka Kranson Industries, Inc.)

 Containers/Glass Products Term Loan  Loan    3.00  1.00  0.00  4.00  5/3/2018   $1,836,625    1,831,636    1,776,935  

Truven Health Analytics Inc. (fka Thomson Reuters (Healthcare) Inc.)

 Healthcare & Pharmaceuticals New Tranche B Term Loan  Loan    3.25  1.25  0.00  4.50  6/6/2019   $482,603    476,598    480,494  

Twin River Management Group, Inc.

 Lodging & Casinos Term Loan B  Loan    4.25  1.00  0.00  5.25  7/10/2020   $886,192    887,853    875,673  

U.S. Security Associates Holdings, Inc.

 Services: Business Delayed Draw Loan  Loan    5.00  1.25  0.00  6.25  7/28/2017   $156,888    156,328    155,973  

U.S. Security Associates Holdings, Inc.

 Services: Business Term B Loan  Loan    5.00  1.25  0.00  6.25  7/28/2017   $921,426    918,393    916,054  

Univar Inc.

 Chemicals/Plastics Term B Loan  Loan    3.25  1.00  0.00  4.25  7/1/2022   $2,992,500    2,978,573    2,840,810  

Univision Communications Inc.

 Telecommunications Replacement First-Lien Term Loan  Loan    3.00  1.00  0.00  4.00  3/1/2020   $2,916,556    2,903,859    2,832,705  

Valeant Pharmaceuticals International, Inc.

 Drugs Series D2 Term Loan B  Loan    2.75  0.75  0.00  3.50  2/13/2019   $2,545,588    2,539,315    2,385,700  

Verint Systems Inc.

 Services: Business Term Loan  Loan    2.75  0.75  0.00  3.50  9/6/2019   $1,014,058    1,011,203    1,005,692  

Vertafore, Inc.

 Services: Business Term Loan (2013)  Loan    3.25  1.00  0.00  4.25  10/3/2019   $2,484,603    2,484,603    2,452,775  

Vizient Inc.

 Healthcare & Pharmaceuticals Term Loan  Loan    5.25  1.00  0.00  6.25  2/13/2023   $1,000,000    970,144    993,750  

Vouvray US Finance

 Industrial Equipment Term Loan  Loan    3.75  1.00  0.00  4.75  6/27/2021   $492,500    490,508    478,134  

Washington Inventory Service

 Services: Business U.S. Term Loan (First Lien)  Loan    4.50  1.25  0.00  5.75  12/20/2018   $1,736,392    1,749,291    1,475,934  

West Corporation

 Telecommunications Term B-10 Loan  Loan    2.50  0.75  0.00  3.25  6/30/2018   $2,534,892    2,558,782    2,490,861  

ZEP Inc.

 Chemicals/Plastics Term Loan B  Loan    4.75  1.00  0.00  5.75  6/27/2022   $2,985,000    2,971,139    2,932,763  
          

 

 

  

 

 

 
        $303,643,756   $284,844,789  
          

 

 

  

 

 

 
                   Principal  Cost  Fair Value 

Cash and cash equivalents

          

U.S. Bank Money Market (a)

       $2,349,633   $2,349,633   $2,349,633  
         

 

 

  

 

 

  

 

 

 

Total cash and cash equivalents

       $2,349,633   $2,349,633   $2,349,633  
         

 

 

  

 

 

  

 

 

 

(a)    Included within cash and cash equivalents in Saratoga CLO’s Statements of Assets and Liabilities as of February 29, 2016.

 

24


Table of Contents

Note 5. Agreements and Related Party Transactions

On July 30, 2010, the Company entered into the Management Agreement with our Manager. The initial term of the Management Agreement was two years, with automatic, one-year renewals at the end of each year, subject to certain approvals by our board of directors and/or the Company’s stockholders. On July 7, 2016, our board of directors approved the renewal of the Management Agreement for an additional one-year term. Pursuant to the Management Agreement, our Manager implements our business strategy on a day-to-day basis and performs certain services for us, subject to oversight by our board of directors. Our Manager is responsible for, among other duties, determining investment criteria, sourcing, analyzing and executing investments transactions, asset sales, financings and performing asset management duties. Under the Management Agreement, we have agreed to pay our Manager a management fee for investment advisory and management services consisting of a base management fee and an incentive fee.

The base management fee of 1.75% is calculated based on the average value of our gross assets (other than cash or cash equivalents, but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters.

The incentive fee consists of the following two parts:

The first, payable quarterly in arrears, equals 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets at the end of the immediately preceding quarter, that exceeds a 1.875% quarterly hurdle rate measured as of the end of each fiscal quarter, subject to a “catch-up” provision. Under this provision, in any fiscal quarter, our Manager receives no incentive fee unless our pre-incentive fee net investment income exceeds the hurdle rate of 1.875%. Our Manager will receive 100.0% of pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than or equal to 2.344% in any fiscal quarter; and 20.0% of the amount of the our pre-incentive fee net investment income, if any, that exceeds 2.344% in any fiscal quarter. There is no accumulation of amounts on the hurdle rate from quarter to quarter, and accordingly there is no claw back of amounts previously paid if subsequent quarters are below the quarterly hurdle rate, and there is no delay of payment if prior quarters are below the quarterly hurdle rate.

The second part of the incentive fee is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Management Agreement) and equals 20.0% of our “incentive fee capital gains,” which equals our realized capital gains on a cumulative basis from May 31, 2010 through the end of the year, if any, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fee. Importantly, the capital gains portion of the incentive fee is based on realized gains and realized and unrealized losses from May 31, 2010. Therefore, realized and unrealized losses incurred prior to such time will not be taken into account when calculating the capital gains portion of the incentive fee, and our Manager will be entitled to 20.0% of incentive fee capital gains that arise after May 31, 2010. In addition, for the purpose of the “incentive fee capital gains” calculations, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 will equal the fair value of such investments as of such date.

For the three months ended November 30, 2016 and November 30, 2015, the Company incurred $1.2 million and $1.1 million in base management fees, respectively. For the three months ended November 30, 2016 and November 30, 2015, the Company incurred $0.8 million and $0.2 million in incentive fees related to pre-incentive fee net investment income, respectively. For the three months ended November 30, 2016, there was a reduction of $0.4 million in incentive fees related to capital gains. For the three months ended November 30, 2015, we accrued $0.2 million in incentive fees related to capital gains. For the nine months ended November 30, 2016 and November 30, 2015, the Company incurred $3.6 million and $3.4 million in base management fees, respectively. For the nine months ended November 30, 2016 and November 30, 2015, the Company incurred $2.2 million and $1.7 million in incentive fees related to pre-incentive fee net investment income, respectively. For the nine months ended November 30, 2016 and November 30, 2015, we accrued $0.1 million and $0.5 million in incentive fees related to capital gains, respectively. The accrual is calculated using both realized and unrealized capital gains for the period. The actual incentive fee related to capital gains will be determined and payable in arrears at the end of the fiscal year and will include only realized capital gains for the period. As of November 30, 2016, the base management fees accrual was $1.2 million and the incentive fees accrual was $4.7 million and is included in base management and incentive fees payable in the accompanying consolidated statements of assets and liabilities. As of February 29, 2016, the base management fees accrual was $1.2 million and the incentive fees accrual was $4.4 million and is included in base management and incentive fees payable in the accompanying consolidated statements of assets and liabilities.

On July 30, 2010, the Company entered into a separate administration agreement (the “Administration Agreement”) with our Manager, pursuant to which our Manager, as our administrator, has agreed to furnish us with the facilities and administrative services necessary to conduct our day-to-day operations and provide managerial assistance on our behalf to those portfolio companies to which we are required to provide such assistance. The initial term of the Administration Agreement was two years, with automatic, one-year renewals at the end of each year subject to certain approvals by our board of directors and/or our stockholders. The amount of expenses payable or reimbursable thereunder by the Company was capped at $1.0 million for the initial two year term of the Administration Agreement and subsequent renewals. On July 8, 2015, our board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to increase the cap on the payment or reimbursement of expenses by the Company thereunder, which had not been increased since the inception of the agreement, to $1.3 million. On July 7, 2016, our board of directors approved the renewal of the Administration Agreement for an additional one-year term. On October 5, 2016, our board of directors determined to increase the cap on the payment or reimbursement of expenses by the Company under the Administration Agreement, from $1.3 million to $1.5 million, effective November 1, 2016.

 

25


Table of Contents

For the three months ended November 30, 2016 and November 30, 2015, we recognized $0.3 million and $0.3 million, in administrator expenses for the periods, respectively, pertaining to bookkeeping, record keeping and other administrative services provided to us in addition to our allocable portion of rent and other overhead related expenses. For the nine months ended November 30, 2016 and November 30, 2015, we recognized $1.0 million and $0.9 million, in administrator expenses for the periods, respectively, pertaining to bookkeeping, record keeping and other administrative services provided to us in addition to our allocable portion of rent and other overhead related expenses. As of November 30, 2016, $0.3 million of administrator expenses and other expenses payable to the Manager were accrued and included in due to manager in the accompanying consolidated statements of assets and liabilities. As of February 29, 2016, $0.2 million of administrator expenses and other expenses payable to the Manager were accrued and included in due to manager in the accompanying consolidated statements of assets and liabilities. For the nine months ended November 30, 2016 and November 30, 2015, the Company neither bought nor sold any investments from the Saratoga CLO.

Note 6. Borrowings

Credit Facility

As a BDC, we are only allowed to employ leverage to the extent that our asset coverage, as defined in the 1940 Act, equals at least 200.0% after giving effect to such leverage. The amount of leverage that we employ at any time depends on our assessment of the market and other factors at the time of any proposed borrowing.

On April 11, 2007, we entered into a $100.0 million revolving securitized credit facility (the “Revolving Facility”). On May 1, 2007, we entered into a $25.7 million term securitized credit facility (the “Term Facility” and, together with the Revolving Facility, the “Facilities”), which was fully drawn at closing. In December 2007, we consolidated the Facilities by using a draw under the Revolving Facility to repay the Term Facility. In response to the market wide decline in financial asset prices, which negatively affected the value of our portfolio, we terminated the revolving period of the Revolving Facility effective January 14, 2009 and commenced a two-year amortization period during which all principal proceeds from the collateral were used to repay outstanding borrowings. A significant percentage of our total assets had been pledged under the Revolving Facility to secure our obligations thereunder. Under the Revolving Facility, funds were borrowed from or through certain lenders and interest was payable monthly at the greater of the commercial paper rate and our lender’s prime rate plus 4.00% plus a default rate of 2.00% or, if the commercial paper market was unavailable, the greater of the prevailing LIBOR rates and our lender’s prime rate plus 6.00% plus a default rate of 3.00%.

In March 2009, we amended the Revolving Facility to increase the portion of the portfolio that could be invested in “CCC” rated investments in return for an increased interest rate and expedited amortization. As a result of these transactions, we expected to have additional cushion under our borrowing base under the Revolving Facility that would allow us to better manage our capital in times of declining asset prices and market dislocation.

On July 30, 2009, we exceeded the permissible borrowing limit under the Revolving Facility for 30 consecutive days, resulting in an event of default under the Revolving Facility. As a result of this event of default, our lender had the right to accelerate repayment of the outstanding indebtedness under the Revolving Facility and to foreclose and liquidate the collateral pledged thereunder. Acceleration of the outstanding indebtedness and/or liquidation of the collateral could have had a material adverse effect on our liquidity, financial condition and operations.

On July 30, 2010, we used the net proceeds from (i) the stock purchase transaction and (ii) a portion of the funds available to us under the $45.0 million senior secured revolving credit facility (the “Credit Facility”) with Madison Capital Funding LLC, in each case, to pay the full amount of principal and accrued interest, including default interest, outstanding under the Revolving Facility. As a result, the Revolving Facility was terminated in connection therewith. Substantially all of our total assets, other than those held by SBIC LP, have been pledged under the Credit Facility to secure our obligations thereunder.

On February 24, 2012, we amended our senior secured revolving credit facility with Madison Capital Funding LLC to, among other things:

 

  expand the borrowing capacity under the Credit Facility from $40.0 million to $45.0 million;

 

  extend the period during which we may make and repay borrowings under the Credit Facility from July 30, 2013 to February 24, 2015 (the “Revolving Period”). The Revolving Period may, upon the occurrence of an event of default, by action of the lenders or automatically, be terminated. All borrowings and other amounts payable under the Credit Facility are due and payable five years after the end of the Revolving Period; and

 

26


Table of Contents
  remove the condition that we may not acquire additional loan assets without the prior written consent of Madison Capital Funding LLC.

On September 17, 2014, we entered into a second amendment to the Credit Facility with Madison Capital Funding LLC to, among other things:

 

  extend the commitment termination date from February 24, 2015 to September 17, 2017;

 

  extend the maturity date of the Credit Facility from February 24, 2020 to September 17, 2022 (unless terminated sooner upon certain events);

 

  reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%, and on LIBOR borrowings from 5.50% to 4.75%; and

 

  reduce the floor on base rate borrowings from 3.00% to 2.25%; and on LIBOR borrowings from 2.00% to 1.25%.

As of November 30, 2016 and February 29, 2016, there were no outstanding borrowings under the Credit Facility and the Company was in compliance with all of the limitations and requirements of the Credit Facility. Financing costs of $2.7 million related to the Credit Facility have been capitalized and are being amortized over the term of the facility. For the three months ended November 30, 2016 and November 30, 2015, we recorded $0.1 million and $0.1 million of interest expense, respectively. For the nine months ended November 30, 2016 and November 30, 2015, we recorded $0.3 million and $0.6 million of interest expense, respectively. For the three months ended November 30, 2016 and November 30, 2015, we recorded $0.02 million and $0.02 million of amortization of deferred financing costs related to the Credit Facility and Revolving Facility, respectively. For the nine months ended November 30, 2016 and November 30, 2015, we recorded $0.1 million and $0.1 million of amortization of deferred financing costs related to the Credit Facility and Revolving Facility, respectively. During the three and nine months ended November 30, 2016, there were no outstanding borrowings under the Credit Facility. The interest rates during the three and nine months ended November 30, 2015 on the outstanding borrowings under the Credit Facility were 6.00%. During the three and nine months ended November 30, 2015, the average dollar amount of outstanding borrowings under the Credit Facility was $0.9 million and $5.8 million, respectively.

The Credit Facility contains limitations as to how borrowed funds may be used, such as restrictions on industry concentrations, asset size, weighted average life, currency denomination and collateral interests. The Credit Facility also includes certain requirements relating to portfolio performance, the violation of which could result in the limit of further advances and, in some cases, result in an event of default, allowing the lenders to accelerate repayment of amounts owed thereunder. The Credit Facility has an eight year term, consisting of a three year period (the “Revolving Period”), under which the Company may make and repay borrowings, and a final maturity five years from the end of the Revolving Period. Availability on the Credit Facility will be subject to a borrowing base calculation, based on, among other things, applicable advance rates (which vary from 50.0% to 75.0% of par or fair value depending on the type of loan asset) and the value of certain “eligible” loan assets included as part of the Borrowing Base. Funds may be borrowed at the greater of the prevailing LIBOR rate and 2.00%, plus an applicable margin of 5.50%. At the Company’s option, funds may be borrowed based on an alternative base rate, which in no event will be less than 3.00%, and the applicable margin over such alternative base rate is 4.50%. In addition, the Company will pay the lenders a commitment fee of 0.75% per year on the unused amount of the Credit Facility for the duration of the Revolving Period.

Our borrowing base under the Credit Facility was $24.1 million subject to the Credit Facility cap of $45.0 million at November 30, 2016. For purposes of determining the borrowing base, most assets are assigned the values set forth in our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (“SEC”). Accordingly, the November 30, 2016 borrowing base relies upon the valuations set forth in the Quarterly Report on Form 10-Q for the period ended August 31, 2016, as filed with the SEC on October 12, 2016. The valuations presented in this Quarterly Report on Form 10-Q will not be incorporated into the borrowing base until after this Quarterly Report on Form 10-Q is filed with the SEC.

SBA Debentures

SBIC LP is able to borrow funds from the SBA against regulatory capital (which approximates equity capital) that is paid in and is subject to customary regulatory requirements including but not limited to an examination by the SBA. As of November 30, 2016, we have funded SBIC LP with $75.0 million of equity capital, and have $112.7 million of SBA-guaranteed debentures outstanding. SBA debentures are non-recourse to us, have a 10-year maturity, and may be prepaid at any time without penalty. The interest rate of SBA debentures is fixed at the time of issuance, often referred to as pooling, at a market-driven spread over 10-year U.S. Treasury Notes. SBA current regulations limit the amount that SBIC LP may borrow to a maximum of $150.0 million, which is up to twice its potential regulatory capital.

SBICs are designed to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses. Under present SBA regulations,

 

27


Table of Contents

eligible small businesses include businesses that have a tangible net worth not exceeding $19.5 million and have average annual fully taxed net income not exceeding $6.5 million for the two most recent fiscal years. In addition, an SBIC must devote 25.0% of its investment activity to ‘‘smaller’’ concerns as defined by the SBA. A smaller concern is one that has a tangible net worth not exceeding $6.0 million and has average annual fully taxed net income not exceeding $2.0 million for the two most recent fiscal years. SBA regulations also provide alternative size standard criteria to determine eligibility, which depend on the industry in which the business is engaged and are based on such factors as the number of employees and gross sales. According to SBA regulations, SBICs may make long-term loans to small businesses, invest in the equity securities of such businesses and provide them with consulting and advisory services.

SBIC LP is subject to regulation and oversight by the SBA, including requirements with respect to maintaining certain minimum financial ratios and other covenants. Receipt of an SBIC license does not assure that SBIC LP will receive SBA-guaranteed debenture funding, which is dependent upon SBIC LP continuing to be in compliance with SBA regulations and policies. The SBA, as a creditor, will have a superior claim to SBIC LP’s assets over our stockholders and debtholders in the event we liquidate SBIC LP or the SBA exercises its remedies under the SBA-guaranteed debentures issued by SBIC LP upon an event of default.

The Company received exemptive relief from the SEC to permit it to exclude the debt of SBIC LP guaranteed by the SBA from the definition of senior securities in the 200.0% asset coverage test under the 1940 Act. This allows the Company increased flexibility under the 200.0% asset coverage test by permitting it to borrow up to $150.0 million more than it would otherwise be able to absent the receipt of this exemptive relief.

As of November 30, 2016 and February 29, 2016, there was $112.7 million and $103.7 million outstanding of SBA debentures, respectively. The carrying amount of the amount outstanding of SBA debentures approximates its fair value, which is based on a waterfall analysis showing adequate collateral coverage. $4.1 million of financing costs related to the SBA debentures have been capitalized and are being amortized over the term of the commitment and drawdown.

For the three months ended November 30, 2016 and November 30, 2015, we recorded $0.9 million and $0.6 million of interest expense related to the SBA debentures, respectively. For the three months ended November 30, 2016 and November 30, 2015, we recorded $0.1 million and $0.1 million of amortization of deferred financing costs related to the SBA debentures, respectively. The weighted average interest rate during the three months ended November 30, 2016 and November 30, 2015 on the outstanding borrowings of the SBA debentures was 3.08% and 3.25%, respectively.

For the nine months ended November 30, 2016 and November 30, 2015, we recorded $2.5 million and $1.9 million of interest expense related to the SBA debentures, respectively. For the nine months ended November 30, 2016 and November 30, 2015, we recorded $0.4 million and $0.3 million of amortization of deferred financing costs related to the SBA debentures, respectively. The weighted average interest rate during the nine months ended November 30, 2016 and November 30, 2015 on the outstanding borrowings of the SBA debentures was 3.12% and 3.21%, respectively. During the three and nine months ended November 30, 2016, the average dollar amount of SBA debentures outstanding was $110.7 million and $106.0 million, respectively. During the three and nine months ended November 30, 2015, the average dollar amount of SBA debentures outstanding was $79.0 million.

In December 2015, the 2016 omnibus spending bill approved by Congress and signed into law by the President increased the amount of SBA-guaranteed debentures that affiliated SBIC funds can have outstanding from $225.0 million to $350.0 million, subject to SBA approval. SBA regulations currently limit the amount of SBA-guaranteed debentures that an SBIC may issue to $150.0 million when it has at least $75.0 million in regulatory capital. Affiliated SBICs are permitted to issue up to a combined maximum amount of $350.0 million in SBA-guaranteed debentures when they have at least $175.0 million in combined regulatory capital.

On April 2, 2015, the SBA issued a “green light” letter inviting the Company to continue the application process to obtain a license to form and operate its second SBIC subsidiary. On September 27, 2016, the SBA informed us that as part of their continued review of our application for a second license, and in order to ensure that they were reviewing the most current information available, we would need to update all previously submitted materials and invited us to reapply. As a result of this request, with which we are in the process of complying, the existing “green light” letter that the SBA issued to us will expire. If approved in the future, a second SBIC license would provide us an incremental source of long-term capital by permitting us to issue up to $150.0 million of additional SBA-guaranteed debentures in addition to the $150.0 million already approved under the first license.

Notes

On May 10, 2013, the Company issued $42.0 million in aggregate principal amount of 7.50% fixed-rate notes due 2020 (the “2020 Notes”). The 2020 Notes will mature on May 31, 2020, and since May 31, 2016, may be redeemed in whole or in part at any time or from time to time at the Company’s option. Interest will be payable quarterly beginning August 15, 2013.

 

28


Table of Contents

On May 17, 2013, the Company closed an additional $6.3 million in aggregate principal amount of the 2020 Notes, pursuant to the full exercise of the underwriters’ option to purchase additional 2020 Notes. On May 29, 2015, the Company entered into a Debt Distribution Agreement with Ladenburg Thalmann & Co. through which the Company may offer for sale, from time to time, up to $20.0 million in aggregate principal amount of the 2020 Notes through an At-the-Market (“ATM”) offering. As of November 30, 2016, the Company sold 539,725 bonds with a principal of $13,493,125 at an average price of $25.31 for aggregate net proceeds of $13,385,766 (net of transaction costs).

As of November 30, 2016, the carrying amount and fair value of the 2020 Notes was $61.8 million and $62.3 million, respectively. The fair value of the 2020 Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. As of November 30, 2016, $2.7 million of financing costs related to the 2020 Notes (including underwriting commissions and net of issuance premiums) have been capitalized and are being amortized over the term of the 2020 Notes. For the three and nine months ended November 30, 2016, we recorded $1.2 million and $3.5 million, respectively, of interest expense and $0.1 million and $0.3 million, respectively, of amortization of deferred financing costs related to the 2020 Notes. For the three and nine months ended November 30, 2015, we recorded $1.1 million and $3.1 million, respectively, of interest expense and $0.1 million and $0.3 million, respectively, of amortization of deferred financing costs related to the 2020 Notes. During the three and nine months ended November 30, 2016, the average dollar amount of 2020 Notes outstanding was $61.8 million. During the three and nine months ended November 30, 2015, the average dollar amount of 2020 Notes outstanding was $59.1 million and $53.9 million, respectively.

Note 7. Commitments and contingencies

Contractual obligations

The following table shows our payment obligations for repayment of debt and other contractual obligations at November 30, 2016:

 

       Payment Due by Period 
   Total   Less Than
1 Year
   1 - 3
Years
   3 - 5
Years
   More Than
5 Years
 
   ($ in thousands) 

Long-Term Debt Obligations

  $174,453    $—     $—     $61,793    $112,660  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Off-balance sheet arrangements

The Company’s off-balance sheet arrangements consisted of $3.0 million and $2.0 million of unfunded commitments to provide debt financing to its portfolio companies or to fund limited partnership interests as of November 30, 2016 and February 29, 2016, respectively. Such commitments are generally up to the Company’s discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company’s consolidated statements of assets and liabilities and are not reflected in the Company’s consolidated statements of assets and liabilities.

A summary of the composition of the unfunded commitments as of November 30, 2016 and February 29, 2016 is shown in the table below (dollars in thousands):

 

  As of 
  November 30, 2016  February 29, 2016 

Avionte Holdings, LLC

 $1,000   $1,000  

GreyHeller LLC

  2,000    —   

Identity Automation Systems

  —     1,000  
 

 

 

  

 

 

 

Total

 $3,000   $2,000  
 

 

 

  

 

 

 

 

29


Table of Contents

Note 8. Directors Fees

The independent directors receive an annual fee of $40,000. They also receive $2,500 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each board meeting and receive $1,000 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each committee meeting. In addition, the chairman of the Audit Committee receives an annual fee of $5,000 and the chairman of each other committee receives an annual fee of $2,000 for their additional services in these capacities. In addition, we have purchased directors’ and officers’ liability insurance on behalf of our directors and officers. Independent directors have the option to receive their directors’ fees in the form of our common stock issued at a price per share equal to the greater of net asset value or the market price at the time of payment. No compensation is paid to directors who are “interested persons” of the Company (as such term is defined in the 1940 Act). For the three months ended November 30, 2016 and November 30, 2015, we incurred $0.07 million and $0.05 million for directors’ fees and expenses, respectively. For the nine months ended November 30, 2016 and November 30, 2015, we incurred $0.2 million and $0.2 million for directors’ fees and expenses, respectively. As of November 30, 2016 and February 29, 2016, $0.05 million and $0.03 million in directors’ fees and expenses were accrued and unpaid, respectively. As of November 30, 2016, we had not issued any common stock to our directors as compensation for their services.

Note 9. Stockholders’ Equity

On May 16, 2006, GSC Group, Inc. capitalized the LLC, by contributing $1,000 in exchange for 67 shares, constituting all of the issued and outstanding shares of the LLC.

On March 20, 2007, the Company issued 95,995.5 and 8,136.2 shares of common stock, priced at $150.00 per share, to GSC Group and certain individual employees of GSC Group, respectively, in exchange for the general partnership interest and a limited partnership interest in GSC Partners CDO III GP, LP, collectively valued at $15.6 million. At this time, the 6.7 shares owned by GSC Group in the LLC were exchanged for 6.7 shares of the Company.

On March 28, 2007, the Company completed its IPO of 725,000 shares of common stock, priced at $150.00 per share, before underwriting discounts and commissions. Total proceeds received from the IPO, net of $7.1 million in underwriter’s discount and commissions, and $1.0 million in offering costs, were $100.7 million.

On November 13, 2009, we declared a dividend of $18.25 per share payable on December 31, 2009. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.1 million or $2.50 per share. Based on shareholder elections, the dividend consisted of $2.1 million in cash and 864,872.5 of newly issued shares of common stock.

On July 30, 2010, our Manager and its affiliates purchased 986,842 shares of common stock at $15.20 per share. Total proceeds received from this sale were $15.0 million.

On August 12, 2010, we effected a one-for-ten reverse stock split of our outstanding common stock. As a result of the reverse stock split, every ten shares of our common stock were converted into one share of our common stock. Any fractional shares received as a result of the reverse stock split were redeemed for cash. The total cash payment in lieu of shares was $230. Immediately after the reverse stock split, we had 2,680,842 shares of our common stock outstanding.

On November 12, 2010, we declared a dividend of $4.40 per share payable on December 29, 2010. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $1.2 million or $0.44 per share. Based on shareholder elections, the dividend consisted of approximately $1.2 million in cash and 596,235 shares of common stock.

On November 15, 2011, we declared a dividend of $3.00 per share payable on December 30, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.0 million or $0.60 per share. Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 599,584 shares of common stock.

On November 9, 2012, the Company declared a dividend of $4.25 per share payable on December 31, 2012. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $3.3 million or $0.85 per share. Based on shareholder elections, the dividend consisted of approximately $3.3 million in cash and 853,455 shares of common stock.

 

30


Table of Contents

On October 30, 2013, the Company declared a dividend of $2.65 per share payable on December 27, 2013. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.5 million or $0.53 per share. Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock.

On September 24, 2014, the Company declared a dividend of $0.18 per share payable on November 28, 2014. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to the Company’s DRIP. Based on shareholder elections, the dividend consisted of approximately $0.6 million in cash and 22,283 newly issued shares of common stock.

On September 24, 2014, the Company declared a dividend of $0.22 per share payable on February 27, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.8 million in cash and 26,858 newly issued shares of common stock.

On April 9, 2015, the Company declared a dividend of $0.27 per share payable on May 29, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.9 million in cash and 33,766 newly issued shares of common stock.

On May 14, 2015, the Company declared a special dividend of $1.00 per share payable on June 5, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 126,230 newly issued shares of common stock.

On July 8, 2015, the Company declared a dividend of $0.33 per share payable on August 31, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 47,861 newly issued shares of common stock.

On October 7, 2015, the Company declared a dividend of $0.36 per share payable on November 30, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 61,029 newly issued shares of common stock.

On January 12, 2016, the Company declared a dividend of $0.40 per share payable on February 29, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.4 million in cash and 66,765 newly issued shares of common stock.

On March 31, 2016, the Company declared a dividend of $0.41 per share payable on April 27, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 56,728 newly issued shares of common stock.

On July 7, 2016, the Company declared a dividend of $0.43 per share payable on August 9, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,167 newly issued shares of common stock.

On August 8, 2016, the Company declared a special dividend of $0.20 per share payable on September 5, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.7 million in cash and 24,786 newly issued shares of common stock.

On October 5, 2016, the Company declared a dividend of $0.44 per share payable on November 9, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,548 newly issued shares of common stock.

On September 24, 2014, the Company announced the approval of an open market share repurchase plan that allowed it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published consolidated financial statements. On October 7, 2015, the Company’s board of directors extended the open market share repurchase plan for another year and increased the number of shares the Company is permitted to repurchase at prices below its NAV, as reported in its then most recently published consolidated financial statements, to 400,000 shares of its common stock. On October 5, 2016, the Company’s board of directors extended the open market share repurchase plan for another year to October 15, 2017 and increased the number of shares the Company is permitted to repurchase at prices below its NAV, as reported in its then most recently published consolidated financial statements, to 600,000 shares of its common stock. As of November 30, 2016, the Company purchased 214,391 shares of common stock, at the average price of $16.84 for approximately $3.6 million pursuant to this repurchase plan.

 

31


Table of Contents

Note 10. Earnings Per Share

In accordance with the provisions of FASB ASC 260, Earnings per Share (“ASC 260”), basic earnings per share is computed by dividing earnings available to common shareholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis.

The following information sets forth the computation of the weighted average basic and diluted net increase in net assets per share from operations for the three and nine months ended November 30, 2016 and November 30, 2015 (dollars in thousands except share and per share amounts):

 

   For the three months ended   For the nine months ended 

Basic and diluted

  November 30,
2016
   November 30,
2015
   November 30,
2016
   November 30,
2015
 

Net increase in net assets from operations

  $1,574    $3,421    $10,133    $12,049  

Weighted average common shares outstanding

   5,727,933     5,632,011     5,735,443     5,533,094  

Weighted average earnings per common share-basic and diluted

  $0.27    $0.61    $1.77    $2.18  

Note 11. Dividend

On October 5, 2016, the Company declared a dividend of $0.44 per share, which was paid on November 9, 2016, to common stockholders of record as of October 31, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to our DRIP.

Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,548 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.12 per share, which equaled the volume weighted average trading price per share of the common stock on October 27, 28, 31 and November 1, 2, 3, 4, 7, 8 and 9, 2016.

On August 8, 2016, the Company declared a special dividend of $0.20 per share, which was paid on September 5, 2016, to common stockholders of record as of August 24, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to our DRIP.

Based on shareholder elections, the dividend consisted of approximately $0.7 million in cash and 24,786 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.06 per share, which equaled the volume weighted average trading price per share of the common stock on August 22, 23, 24, 25, 26, 29, 30, 31 and September 1 and 2, 2016.

On July 7, 2016, the Company declared a dividend of $0.43 per share, which was paid on August 9, 2016, to common stockholders of record as of July 29, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to our DRIP.

Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,167 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.32 per share, which equaled the volume weighted average trading price per share of the common stock on July 27, 28, 29 and August 1, 2, 3, 4, 5, 8 and 9, 2016.

On March 31, 2016, the Company declared a dividend of $0.41 per share, which was paid on April 27, 2016, to common stockholders of record as of April 15, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to our DRIP.

Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 56,728 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.43 per share, which equaled the volume weighted average trading price per share of the common stock on April 14, 15, 18, 19, 20, 21, 22, 25, 26 and 27, 2016.

 

32


Table of Contents

The following table summarizes dividends declared during the nine months ended November 30, 2016 (dollars in thousands except per share amounts):

 

Date Declared

  Record Date   Payment Date   Amount
Per Share*
   Total
Amount
 

October 5, 2016

   October 31, 2016     November 9, 2016    $0.44    $2,509  

August 8, 2016

   August 24, 2016     September 5, 2016    $0.20    $1,151  

July 7, 2016

   July 29, 2016     August 9, 2016    $0.43    $2,466  

March 31, 2016

   April 15, 2016     April 27, 2016    $0.41    $2,346  
      

 

 

   

 

 

 

Total dividends declared

      $1.48    $8,472  
      

 

 

   

 

 

 

 

*Amount per share is calculated based on the number of shares outstanding at the date of declaration.

The following table summarizes dividends declared during the nine months ended November 30, 2015 (dollars in thousands except per share amounts):

 

Date Declared

  Record Date   Payment Date   Amount
Per Share*
   Total
Amount
 

October 7, 2015

   November 2, 2015     November 30, 2015    $0.36    $2,028  

July 8, 2015

   August 3, 2015     August 31, 2015    $0.33    $1,844  

May 14, 2015

   May 26, 2015     June 5, 2015    $1.00    $5,429  

April 9, 2015

   May 4, 2015     May 29, 2015    $0.27    $1,466  
      

 

 

   

 

 

 

Total dividends declared

      $1.96    $10,767  
      

 

 

   

 

 

 

 

*Amount per share is calculated based on the number of shares outstanding at the date of declaration.

Note 12. Financial Highlights

The following is a schedule of financial highlights for the nine months ended November 30, 2016 and November 30, 2015:

 

  November 30, 2016  November 30, 2015 

Per share data:

 

Net asset value at beginning of period

 $22.06   $22.70  

Net investment income(1)

  1.49    1.37  

Net realized and unrealized gains and losses on investments

  0.28    0.81  
 

 

 

  

 

 

 

Net increase in net assets from operations

  1.77    2.18  

Distributions declared from net investment income

  (1.48  (1.96
 

 

 

  

 

 

 

Total distributions to stockholders

  (1.48  (1.96

Dilution(4)

  (0.14  (0.33

Net asset value at end of period

 $22.21   $22.59  

Net assets at end of period

 $127,679,730   $127,273,366  

Shares outstanding at end of period

  5,748,247    5,634,115  

Per share market value at end of period

 $20.18   $15.63  

Total return based on market value(2)

  56.98  11.29

Total return based on net asset value(3)

  11.37  11.67

Ratio/Supplemental data:

 

Ratio of net investment income to average net assets(8)

  9.54  8.64

Ratio of operating expenses to average net assets(7)

  7.10  6.68

Ratio of incentive management fees to average net assets(6)

  1.83  1.73

Ratio of interest and debt financing expenses to average net assets(7)

  7.42  6.65

Ratio of total expenses to average net assets(8)

  16.35  15.06

Portfolio turnover rate(5)

  31.25  23.05

 

33


Table of Contents

 

(1)Net investment income per share is calculated using the weighted average shares outstanding during the period.
(2)Total investment return is calculated assuming a purchase of common shares at the current market value on the first day and a sale at the current market value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s DRIP. Total investment return does not reflect brokerage commissions. Total investment returns covering less than a full period are not annualized.
(3)Total investment return is calculated assuming a purchase of common shares at the current net asset value on the first day and a sale at the current net asset value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s DRIP. Total investment return does not reflect brokerage commissions.
(4)Represents the dilutive effect of issuing common stock below net asset value per share during the period in connection with the satisfaction of the Company’s annual RIC distribution requirement. See Note 11, Dividend.
(5)Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value.
(6)Ratios are not annualized.
(7)Ratios are annualized.
(8)Ratios are annualized. Incentive management fees included within the ratio are not annualized.

Note 13. Subsequent Events

The Company has evaluated subsequent events through the filing of this Form 10-Q and determined that there have been no events that have occurred that would require adjustments to the Company’s disclosures in the consolidated financial statements except for the following:

On January 12, 2017, the Company declared a dividend of $0.45 per share payable for the fiscal quarter ended November 30, 2016 to all stockholders of record at the close of business on January 31, 2017, with a payment date on February 9, 2017. Shareholders will have the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to the Company’s DRIP.

On December 21, 2016, the Company issued $74.5 million in aggregate principal amount of 6.75% fixed-rate notes due 2023 (the “2023 Notes”) for net proceeds of $72.1 million after deducting underwriting commissions of approximately $2.0 million and offering costs of approximately $0.5 million. The issuance included the exercise of substantially all of the underwriters’ option to purchase an additional $9.8 million aggregate principal amount of 2023 Notes within 30 days. Interest on the 2023 Notes is paid quarterly in arrears on March 15, June 15, September 15 and December 15, at a rate of 6.75% per year, beginning March 30, 2017. The 2023 Notes mature on December 20, 2023, and commencing December 21, 2019, may be redeemed in whole or in part at any time or from time to time at our option. The proceeds from the offering will be used to repay all of the outstanding indebtedness under the 2020 Notes, which amounts to $61.8 million.

 

34


Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with our consolidated financial statements and related notes and other financial information appearing elsewhere in this Quarterly Report on Form 10-Q. In addition to historical information, the following discussion and other parts of this Quarterly Report contain forward-looking information that involves risks and uncertainties. Our actual results could differ materially from those anticipated by such forward-looking information due to the factors discussed under Part I, Item 1A in our Annual Report on Form 10-K for the fiscal year ended February 29, 2016.

The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us or are within our control. If a change occurs, our business, financial condition, liquidity and results of operations may vary materially from those expressed in our forward-looking statements.

The forward-looking statements contained in this Quarterly Report on Form 10-Q involve risks and uncertainties, including statements as to:

 

  our future operating results;

 

  our business prospects and the prospects of our portfolio companies;

 

  the impact of investments that we expect to make;

 

  our contractual arrangements and relationships with third parties;

 

  the dependence of our future success on the general economy and its impact on the industries in which we invest;

 

  the ability of our portfolio companies to achieve their objectives;

 

  our expected financings and investments;

 

  our regulatory structure and tax treatment, including our ability to operate as a business development company (“BDC”), or to operate our small business investment company (“SBIC”) subsidiary, and to continue to qualify to be taxed as a regulated investment company (“RIC”);

 

  the adequacy of our cash resources and working capital;

 

  the timing of cash flows, if any, from the operations of our portfolio companies; and

 

  the ability of our investment adviser to locate suitable investments for us and to monitor and effectively administer our investments.

You should not place undue reliance on these forward-looking statements. The forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statement to reflect events or circumstances occurring after the date of this Quarterly Report on Form 10-Q.

OVERVIEW

We are a Maryland corporation that has elected to be treated as a BDC under the Investment Company Act of 1940 (the “1940 Act”). Our investment objective is to generate current income and, to a lesser extent, capital appreciation from our investments. We invest primarily in leveraged loans and mezzanine debt issued by private U.S. middle market companies, which we define as companies having EBITDA of between $2 million and $50 million, both through direct lending and through participation in loan syndicates. We may also invest up to 30.0% of the portfolio in opportunistic investments in order to seek to enhance returns to stockholders. Such investments may include investments in distressed debt, which may include securities of companies in bankruptcy, foreign debt, private equity, securities of public companies that are not thinly traded and structured finance vehicles such as collateralized loan obligation funds. Although we have no current intention to do so, to the extent we invest in private equity funds, we will limit our investments in entities that are excluded from the definition of “investment company” under Section 3(c)(1) or Section 3(c)(7) of the 1940 Act, which includes private equity funds, to no more than 15% of its net assets. We have elected and qualified to be treated as a RIC under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

Corporate History and Recent Developments

We commenced operations, at the time known as GSC Investment Corp., on March 23, 2007 and completed an initial public offering of shares of common stock on March 28, 2007. Prior to July 30, 2010, we were externally managed and advised by GSCP (NJ), L.P., an entity affiliated with GSC Group, Inc. In connection with the consummation of a recapitalization transaction on July 30, 2010, as described below we engaged Saratoga Investment Advisors (“SIA”) to replace GSCP (NJ), L.P. as our investment adviser and changed our name to Saratoga Investment Corp.

 

35


Table of Contents

As a result of the event of default under a revolving securitized credit facility with Deutsche Bank we previously had in place, in December 2008 we engaged the investment banking firm of Stifel, Nicolaus & Company to evaluate strategic transaction opportunities and consider alternatives for us. On April 14, 2010, GSC Investment Corp. entered into a stock purchase agreement with Saratoga Investment Advisors and certain of its affiliates and an assignment, assumption and novation agreement with Saratoga Investment Advisors, pursuant to which GSC Investment Corp. assumed certain rights and obligations of Saratoga Investment Advisors under a debt commitment letter Saratoga Investment Advisors received from Madison Capital Funding LLC, which indicated Madison Capital Funding’s willingness to provide GSC Investment Corp. with a $40.0 million senior secured revolving credit facility, subject to the satisfaction of certain terms and conditions. In addition, GSC Investment Corp. and GSCP (NJ), L.P. entered into a termination and release agreement, to be effective as of the closing of the transaction contemplated by the stock purchase agreement, pursuant to which GSCP (NJ), L.P., among other things, agreed to waive any and all accrued and unpaid deferred incentive management fees up to and as of the closing of the transaction contemplated by the stock purchase agreement but continued to be entitled to receive the base management fees earned through the date of the closing of the transaction contemplated by the stock purchase agreement.

On July 30, 2010, the transactions contemplated by the stock purchase agreement with Saratoga Investment Advisors and certain of its affiliates were completed, the private sale of 986,842 shares of our common stock for $15.0 million in aggregate purchase price to Saratoga Investment Advisors and certain of its affiliates closed, the Company entered into the Credit Facility, and the Company began doing business as Saratoga Investment Corp.

We used the net proceeds from the private sale transaction and a portion of the funds available to us under the Credit Facility to pay the full amount of principal and accrued interest, including default interest, outstanding under our revolving securitized credit facility with Deutsche Bank. The revolving securitized credit facility with Deutsche Bank was terminated in connection with our payment of all amounts outstanding thereunder on July 30, 2010.

On August 12, 2010, we effected a one-for-ten reverse stock split of our outstanding common stock. As a result of the reverse stock split, every ten shares of our common stock were converted into one share of our common stock. Any fractional shares received as a result of the reverse stock split were redeemed for cash. The total cash payment in lieu of shares was $230. Immediately after the reverse stock split, we had 2,680,842 shares of our common stock outstanding.

In January 2011, we registered for public resale of the 986,842 shares of our common stock issued to Saratoga Investment Advisors and certain of its affiliates.

On March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP (“SBIC LP”), received an SBIC license from the Small Business Administration (“SBA”).

In May 2013, we issued $48.3 million in aggregate principal amount of our 7.50% unsecured notes due 2020 (the “2020 Notes”) for net proceeds of $46.1 million after deducting underwriting commissions of $1.9 million and offering costs of $0.3 million. The proceeds included the underwriters’ full exercise of their overallotment option. Interest on these 2020 Notes is paid quarterly in arrears on February 15, May 15, August 15 and November 15, at a rate of 7.50% per year, beginning August 15, 2013. The 2020 Notes mature on May 31, 2020 and since May 31, 2016, may be redeemed in whole or in part at any time or from time to time at our option. The 2020 Notes are listed on the NYSE under the trading symbol “SAQ” with a par value of $25.00 per share.

On April 2, 2015, the SBA issued a “green light” letter inviting the Company to continue the application process to obtain a license to form and operate its second SBIC subsidiary. On September 27, 2016, the SBA informed us that as part of their continued review of our application for a second license, and in order to ensure that they were reviewing the most current information available, we would need to update all previously submitted materials and invited us to reapply. As a result of this request, with which we are in the process of complying, the existing “green light” letter that the SBA issued to us will expire. If approved in the future, a second SBIC license would provide us an incremental source of long-term capital by permitting us to issue up to $150.0 million of additional SBA-guaranteed debentures in addition to the $150.0 million already approved under the first license.

On May 29, 2015, we entered into a Debt Distribution Agreement with Ladenburg Thalmann & Co. through which we may offer for sale, from time to time, up to $20.0 million in aggregate principal amount of the 2020 Notes through an At-the-Market (“ATM”) offering. As of November 30, 2016, the Company sold 539,725 bonds with a principal of $13,493,125 at an average price of $25.31 for aggregate net proceeds of $13,385,766 (net of transaction costs).

On December 21, 2016, we issued $74.5 million in aggregate principal amount of our 6.75% fixed-rate notes due 2023 (the “2023 Notes”) for net proceeds of $72.1 million after deducting underwriting commissions of approximately $2.0 million and

 

36


Table of Contents

offering costs of approximately $0.5 million. The issuance included the exercise of substantially all of the underwriters’ option to purchase an additional $9.8 million aggregate principal amount of 2023 Notes within 30 days. Interest on the 2023 Notes is paid quarterly in arrears on March 15, June 15, September 15 and December 15, at a rate of 6.75% per year, beginning March 30, 2017. The 2023 Notes mature on December 20, 2023, and commencing December 21, 2019, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering will be used to repay all of the outstanding indebtedness under the 2020 Notes, which amounts to $61.8 million, and for general corporate purposes in accordance with our investment objective and strategies.

Critical Accounting Policies

Basis of Presentation

The preparation of financial statements in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make certain estimates and assumptions affecting amounts reported in the Company’s consolidated financial statements. We have identified investment valuation, revenue recognition and the recognition of capital gains incentive fee expense as our most critical accounting estimates. We continuously evaluate our estimates, including those related to the matters described below. These estimates are based on the information that is currently available to us and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions. A discussion of our critical accounting policies follows.

Investment Valuation

The Company accounts for its investments at fair value in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold at the balance sheet date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from Saratoga Investment Advisers, the audit committee of our board of directors and a third party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors.

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

 

  Each investment is initially valued by the responsible investment professionals of Saratoga Investment Advisors and preliminary valuation conclusions are documented and discussed with our senior management; and

 

  An independent valuation firm engaged by our board of directors reviews a selection of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least once each fiscal year.

In addition, all our investments are subject to the following valuation process:

 

  The audit committee of our board of directors reviews and approves each preliminary valuation and Saratoga Investment Advisors and an independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

  Our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of Saratoga Investment Advisors, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

Our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in

 

37


Table of Contents

collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by SIA and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.

Revenue Recognition

Income Recognition

Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortization of premiums on investments.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Payment-in-Kind Interest

The Company holds debt investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

Capital Gains Incentive Fee

The Company records an expense accrual relating to the capital gains incentive fee payable by the Company to its investment adviser when the unrealized gains on its investments exceed all realized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the investment adviser if the Company were to liquidate its investment portfolio at such time. The actual incentive fee payable to the Company’s investment adviser related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains for the period.

Revenues

We generate revenue in the form of interest income and capital gains on the debt investments that we hold and capital gains, if any, on equity interests that we may acquire. We expect our debt investments, whether in the form of leveraged loans or mezzanine debt, to have terms of up to ten years, and to bear interest at either a fixed or floating rate. Interest on debt will be payable generally either quarterly or semi-annually. In some cases, our debt investments may provide for a portion of the interest to be PIK. To the extent interest is paid-in-kind, it will be payable through the increase of the principal amount of the obligation by the amount of interest due on the then-outstanding aggregate principal amount of such obligation. The principal amount of the debt and any accrued but unpaid interest will generally become due at the maturity date. In addition, we may generate revenue in the form of commitment, origination, structuring or diligence fees, fees for providing managerial assistance or investment management services and possibly consulting fees. Any such fees will be generated in connection with our investments and recognized as earned. We may also invest in preferred equity securities that pay dividends on a current basis.

On January 22, 2008, we entered into a collateral management agreement with Saratoga CLO, pursuant to which we act as its collateral manager. The Saratoga CLO was initially refinanced in October 2013 and its reinvestment period ended in October 2016. On November 15, 2016, we completed the second refinancing of the Saratoga CLO. The Saratoga CLO refinancing, among other

 

38


Table of Contents

things, extended its reinvestment period to October 2018, and extended its legal maturity date to October 2025. Following the refinancing, the Saratoga CLO portfolio remained at the same size and with a similar capital structure of approximately $300.0 million in aggregate principal amount of predominantly senior secured first lien term loans. In addition to refinancing its liabilities, we also purchased $4.5 million in aggregate principal amount of the Class F notes tranche of the Saratoga CLO at par, with a coupon of LIBOR plus 8.5%.

The Saratoga CLO remains 100% owned and managed by Saratoga Investment Corp. Following the refinancing, we receive a base management fee of 0.10% and a subordinated management fee of 0.40% of the fee basis amount at the beginning of the collection period, paid quarterly to the extent of available proceeds. We are also entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return paid in cash equal to or greater than 12.0%.

We recognize interest income on our investment in the subordinated notes of Saratoga CLO using the effective interest method, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Expenses

Our primary operating expenses include the payment of investment advisory and management fees, professional fees, directors and officers insurance, fees paid to independent directors and administrator expenses, including our allocable portion of our administrator’s overhead. Our investment advisory and management fees compensate our investment adviser for its work in identifying, evaluating, negotiating, closing and monitoring our investments. We bear all other costs and expenses of our operations and transactions, including those relating to:

 

  organization;

 

  calculating our net asset value (including the cost and expenses of any independent valuation firm);

 

  expenses incurred by our investment adviser payable to third parties, including agents, consultants or other advisers, in monitoring our financial and legal affairs and in monitoring our investments and performing due diligence on our prospective portfolio companies;

 

  expenses incurred by our investment adviser payable for travel and due diligence on our prospective portfolio companies;

 

  interest payable on debt, if any, incurred to finance our investments;

 

  offerings of our common stock and other securities;

 

  investment advisory and management fees;

 

  fees payable to third parties, including agents, consultants or other advisers, relating to, or associated with, evaluating and making investments;

 

  transfer agent and custodial fees;

 

  federal and state registration fees;

 

  all costs of registration and listing our common stock on any securities exchange;

 

  federal, state and local taxes;

 

  independent directors’ fees and expenses;

 

  costs of preparing and filing reports or other documents required by governmental bodies (including the Securities and Exchange Commission (“SEC”) and the SBA);

 

  costs of any reports, proxy statements or other notices to common stockholders including printing costs;

 

  our fidelity bond, directors and officers errors and omissions liability insurance, and any other insurance premiums;

 

  direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors and outside legal costs; and

 

  administration fees and all other expenses incurred by us or, if applicable, the administrator in connection with administering our business (including payments under the Administration Agreement based upon our allocable portion of the administrator’s overhead in performing its obligations under an administration agreement, including rent and the allocable portion of the cost of our officers and their respective staffs (including travel expenses)).

 

39


Table of Contents

Pursuant to the investment advisory and management agreement that we had with GSCP (NJ), L.P., our former investment adviser and administrator, we had agreed to pay GSCP (NJ), L.P. as investment adviser a quarterly base management fee of 1.75% of the average value of our total assets (other than cash or cash equivalents but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters and an incentive fee.

The incentive fee had two parts:

 

  A fee, payable quarterly in arrears, equal to 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of the net assets at the end of the immediately preceding quarter, that exceeded a 1.875% quarterly hurdle rate measured as of the end of each fiscal quarter. Under this provision, in any fiscal quarter, our investment adviser received no incentive fee unless our pre-incentive fee net investment income exceeded the hurdle rate of 1.875%. Amounts received as a return of capital were not included in calculating this portion of the incentive fee. Since the hurdle rate was based on net assets, a return of less than the hurdle rate on total assets could still have resulted in an incentive fee.

 

  A fee, payable at the end of each fiscal year, equal to 20.0% of our net realized capital gains, if any, computed net of all realized capital losses and unrealized capital depreciation, in each case on a cumulative basis, less the aggregate amount of capital gains incentive fees paid to the investment adviser through such date.

We deferred cash payment of any incentive fee otherwise earned by our former investment adviser if, during the then most recent four full fiscal quarters ending on or prior to the date such payment was to be made, the sum of (a) our aggregate distributions to our stockholders and (b) our change in net assets (defined as total assets less liabilities) (before taking into account any incentive fees payable during that period) was less than 7.5% of our net assets at the beginning of such period. These calculations were appropriately pro-rated for the first three fiscal quarters of operation and adjusted for any share issuances or repurchases during the applicable period. Such incentive fee would become payable on the next date on which such test had been satisfied for the most recent four full fiscal quarters or upon certain terminations of the investment advisory and management agreement. We commenced deferring cash payment of incentive fees during the quarterly period ended August 31, 2007, and continued to defer such payments through the quarterly period ended May 31, 2010. As of July 30, 2010, the date on which GSCP (NJ), L.P. ceased to be our investment adviser and administrator, we owed GSCP (NJ), L.P. $2.9 million in fees for services previously provided to us; of which $0.3 million has been paid by us. GSCP (NJ), L.P. agreed to waive payment by us of the remaining $2.6 million in connection with the consummation of the stock purchase transaction with Saratoga Investment Advisors and certain of its affiliates described elsewhere in this Quarterly Report.

The terms of the investment advisory and management agreement with Saratoga Investment Advisors, our current investment adviser, are substantially similar to the terms of the investment advisory and management agreement we had entered into with GSCP (NJ), L.P., our former investment adviser, except for the following material distinctions in the fee terms:

 

  The capital gains portion of the incentive fee was reset with respect to gains and losses from May 31, 2010, and therefore losses and gains incurred prior to such time will not be taken into account when calculating the capital gains fee payable to Saratoga Investment Advisors and, as a result, Saratoga Investment Advisors will be entitled to 20.0% of net gains that arise after May 31, 2010. In addition, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 equal the fair value of such investment as of such date. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P., the capital gains fee was calculated from March 21, 2007, and the gains were substantially outweighed by losses.

 

  Under the “catch up” provision, 100.0% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income that exceeds 1.875% but is less than or equal to 2.344% in any fiscal quarter is payable to Saratoga Investment Advisors. This will enable Saratoga Investment Advisors to receive 20.0% of all net investment income as such amount approaches 2.344% in any quarter, and Saratoga Investment Advisors will receive 20.0% of any additional net investment income. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P. only received 20.0% of the excess net investment income over 1.875%.

 

  We will no longer have deferral rights regarding incentive fees in the event that the distributions to stockholders and change in net assets is less than 7.5% for the preceding four fiscal quarters.

To the extent that any of our leveraged loans are denominated in a currency other than U.S. Dollars, we may enter into currency hedging contracts to reduce our exposure to fluctuations in currency exchange rates. We may also enter into interest rate hedging agreements. Such hedging activities, which will be subject to compliance with applicable legal requirements, may include the use of interest rate caps, futures, options and forward contracts. Costs incurred in entering into or settling such contracts will be borne by us.

 

40


Table of Contents

New Accounting Pronouncements

In August 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”), which is intended to reduce the existing diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The guidance is effective for annual periods beginning after December 15, 2017, and interim periods therein. Early adoption is permitted. Management is currently evaluating the impact ASU 2016-15 will have on the Company’s consolidated financial statements and disclosures.

In February 2016, the FASB issued ASU 2016-02, Amendments to the Leases (“ASC Topic 842”), which will require for all operating leases the recognition of a right-of-use asset and a lease liability, in the statement of financial position. The lease cost will be allocated over the lease term on a straight-line basis. This guidance is effective for annual and interim periods beginning after December 15, 2018. Management is currently evaluating the impact these changes will have on the Company’s consolidated financial statements and disclosures.

In January 2016, the FASB issued ASU 2016-01, Financial Instruments — Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities (“ASU 2016-01”). ASU 2016-01 retains many current requirements for the classification and measurement of financial instruments; however, it significantly revises an entity’s accounting related to (1) the classification and measurement of investments in equity securities and (2) the presentation of certain fair value changes for financial liabilities measured at fair value. ASU 2016-01 also amends certain disclosure requirements associated with the fair value of financial instruments. This guidance is effective for annual and interim periods beginning after December 15, 2017, and early adoption is not permitted for public business entities. Management is currently evaluating the impact the adoption of this standard has on our consolidated financial statements and disclosures.

In August 2014, the FASB issued new accounting guidance that requires management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. The amendments provide a definition of the term “substantial doubt” and include principles for considering the mitigating effect of management’s plans. The amendments also require an evaluation every reporting period, including interim periods for a period of one year after the date that the financial statements are issued (or available to be issued), and certain disclosures when substantial doubt is alleviated or not alleviated. The amendments in this update are effective for reporting periods ending after December 15, 2016. Management does not believe these changes will have a material impact on the Company’s consolidated financial statements and disclosures.

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in Revenue Recognition (Topic 605). Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In May 2016, ASU 2016-12 amended ASU 2014-09 and deferred the effective period to December 15, 2017. Management is currently evaluating the impact these changes will have on the Company’s consolidated financial statements and disclosures.

Portfolio and investment activity

Corporate Debt Portfolio Overview

 

   At November 30,
2016
   At February 29,
2016
 
   ($ in millions)   ($ in millions) 

Number of investments(1)

   52     59  

Number of portfolio companies(1)

   30     34  

Average investment size(1)

  $5.1    $4.6  

Weighted average maturity(1)

   3.4 yrs     3.8 yrs  

Number of industries(3)

   11     11  

Average investment per portfolio company(1)

  $8.9    $8.0  

Non-performing or delinquent investments(1)

  $0.0    $0.0  

Fixed rate debt (% of interest bearing portfolio)(2)

  $46.7(18.3%)    $97.9(40.0%)  

Weighted average current coupon(2)

   11.9%     11.5%  

Floating rate debt (% of interest bearing portfolio)(2)

  $  208.5(81.7%)    $  146.8(60.0%)  

Weighted average current spread over LIBOR(2)

   10.1%     9.1%  

 

(1)Excludes our investment in the subordinated notes of Saratoga CLO.
(2)Excludes our investment in the subordinated notes of Saratoga CLO and equity interests.
(3)Excludes our investment in the subordinated notes of Saratoga CLO and Class F Note.

 

41


Table of Contents

During the three months ended November 30, 2016, we invested $30.1 million in new or existing portfolio companies and had $23.8 million in aggregate amount of exits and repayments resulting in net investments of $6.3 million for the period. During the three months ended November 30, 2015, we invested $15.3 million in new or existing portfolio companies and had $27.9 million in aggregate amount of exits and repayments resulting in net repayments of $12.6 million for the period.

During the nine months ended November 30, 2016, we invested $85.9 million in new or existing portfolio companies and had $94.7 million in aggregate amount of exits and repayments resulting in net repayments of $8.8 million for the period. During the nine months ended November 30, 2015, we invested $57.4 million in new or existing portfolio companies and had $62.7 million in aggregate amount of exits and repayments resulting in net repayments of $5.3 million for the period.

Our portfolio composition at November 30, 2016 and February 29, 2016 at fair value was as follows:

Portfolio composition

 

   At November 30, 2016  At February 29, 2016 
   Percentage
of Total
Portfolio
  Weighted
Average
Current
Yield
  Percentage
of Total
Portfolio
  Weighted
Average
Current
Yield
 

Syndicated loans

   3.5  5.4  4.2  8.2

First lien term loans

   57.8    10.5    50.9    10.6  

Second lien term loans

   28.9    11.7    31.1    11.5  

Structured finance securities

   5.5    12.2    4.5    16.4  

Equity interests

   4.3    0.7    9.3    N/A  
  

 

 

  

 

 

  

 

 

  

 

 

 

Total

   100.0  10.8  100.0  11.1
  

 

 

  

 

 

  

 

 

  

 

 

 

Our investment in the subordinated notes of Saratoga CLO represents a first loss position in a portfolio that, at November 30, 2016 and February 29, 2016 was composed of $297.5 million and $302.7 million, respectively, in aggregate principal amount of predominantly senior secured first lien term loans. This investment is subject to unique risks. (See “Risk Factors—Our investment in Saratoga CLO constitutes a leveraged investment in a portfolio of predominantly senior secured first lien term loans and is subject to additional risks and volatility” in our Annual Report on Form 10-K for the fiscal year ended February 29, 2016). We do not consolidate the Saratoga CLO portfolio in our consolidated financial statements. Accordingly, the metrics below do not include the underlying Saratoga CLO portfolio investments. However, at November 30, 2016, $286.1 million or 98.7% of the Saratoga CLO portfolio investments in terms of market value had a CMR (as defined below) color rating of green or yellow and there were no Saratoga CLO portfolio investments in default. At February 29, 2016, $283.3 million or 99.4% of the Saratoga CLO portfolio investments in terms of market value had a CMR (as defined below) color rating of green or yellow and one Saratoga CLO portfolio investment was in default with a fair value of $0.8 million.

Saratoga Investment Advisors normally grades all of our investments using a credit and monitoring rating system (“CMR”). The CMR consists of a single component: a color rating. The color rating is based on several criteria, including financial and operating strength, probability of default, and restructuring risk. The color ratings are characterized as follows: (Green)—strong credit; (Yellow)—satisfactory credit; (Red)—payment default risk, in payment default and/or significant restructuring activity.

The CMR distribution of our investments at November 30, 2016 and February 29, 2016 was as follows:

Portfolio CMR distribution

 

   At November 30, 2016  At February 29, 2016 

Color Score

  Investments
at
Fair Value
   Percentage
of Total
Portfolio
  Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 

Green

  $246,130     88.7 $240,623     84.7

Yellow

   8,423     3.0    4,058     1.4  

Red

   8     0.0    8     0.0  

N/A(1)

   23,009     8.3    39,307     13.9  
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $277,570     100.0 $283,996     100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

 

(1)Comprised of our investment in the subordinated notes of Saratoga CLO and equity interests.

 

42


Table of Contents

The CMR distribution of Saratoga CLO investments at November 30, 2016 and February 29, 2016 was as follows:

Portfolio CMR distribution

 

   At November 30, 2016  At February 29, 2016 

Color Score

  Investments
at
Fair Value
   Percentage
of Total
Portfolio
  Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 

Green

  $257,697     88.9 $251,570     88.3

Yellow

   28,425     9.8    31,752     11.1  

Red

   3,840     1.3    1,331     0.5  

N/A(1)

   37     0.0    192     0.1  
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $289,999     100.0 $284,845     100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

 

(1)Comprised of Saratoga CLO’s equity interests.

Portfolio composition by industry grouping at fair value

The following table shows our portfolio composition by industry grouping at fair value at November 30, 2016 and February 29, 2016:

 

   At November 30, 2016  At February 29, 2016 
   Investments
at
Fair Value
   Percentage
of Total
Portfolio
  Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 

Business Services

  $146,250     52.7 $105,976     37.3

Healthcare Services

   28,128     10.1    36,905     13.0  

Consumer Services

   20,737     7.5    43,109     15.2  

Media

   18,522     6.7    16,574     5.8  

Real Estate

   16,661     6.0    9,537     3.4  

Structured Finance Securities (1)

   15,266     5.5    12,828     4.5  

Education

   10,919     3.9    10,694     3.8  

Metals

   8,857     3.2    10,526     3.7  

Food and Beverage

   8,423     3.0    9,131     3.2  

Building Products

   2,000     0.7    6,367     2.2  

Aerospace and Defense

   1,020     0.4    —      —   

Consumer Products

   787     0.3    7,642     2.7  

Automotive Aftermarket

   —      —     14,707     5.2  
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $277,570     100.0 $283,996     100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

 

(1)Comprised of our investment in the subordinated notes and Class F Note of Saratoga CLO.

 

43


Table of Contents

The following table shows Saratoga CLO’s portfolio composition by industry grouping at fair value at November 30, 2016 and February 29, 2016:

 

   At November 30, 2016  At February 29, 2016 
   Investments
at
Fair Value
   Percentage
of Total
Portfolio
  Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 

Services: Business

  $41,241     14.2 $37,308     13.1

Healthcare & Pharmaceuticals

   30,765     10.6    28,339     9.9  

Chemicals/Plastics

   23,271     8.0    24,714     8.7  

High Tech Industries

   16,703     5.8    9,451     3.3  

Banking, Finance, Insurance & Real Estate

   15,678     5.4    10,175     3.6  

Retailers (Except Food and Drugs)

   14,664     5.1    18,898     6.6  

Aerospace and Defense

   13,008     4.5    12,580     4.4  

Conglomerate

   12,767     4.4    11,770     4.1  

Telecommunications

   11,741     4.0    11,364     4.0  

Media

   10,732     3.7    4,768     1.7  

Industrial Equipment

   9,921     3.4    11,777     4.1  

Leisure Goods/Activities/Movies

   9,198     3.2    8,009     2.8  

Electronics/Electric

   8,344     2.9    9,342     3.3  

Financial Intermediaries

   7,760     2.7    13,559     4.8  

Food Services

   5,872     2.0    5,944     2.1  

Automotive

   5,004     1.7    5,470     1.9  

Publishing

   4,938     1.7    3,029     1.1  

Lodging and Casinos

   4,352     1.5    4,958     1.8  

Capital Equipment

   3,989     1.4    —      —   

Technology

   3,883     1.3    7,774     2.7  

Food/Drug Retailers

   3,835     1.3    2,737     1.0  

Food Products

   3,150     1.1    5,694     2.0  

Beverage, Food & Tobacco

   3,005     1.0    984     0.3  

Insurance

   2,988     1.0    4,712     1.7  

Drugs

   2,936     1.0    2,873     1.0  

Utilities

   2,894     1.0    6,975     2.4  

Hotel, Gaming and Leisure

   2,604     0.9    1,917     0.7  

Oil & Gas

   2,519     0.9    2,273     0.8  

Brokers/Dealers/Investment Houses

   2,470     0.9    2,618     0.9  

Containers/Glass Products

   1,993     0.7    4,168     1.5  

Construction & Building

   1,958     0.7    2,869     1.0  

Cable and Satellite Television

   1,617     0.6    3,557     1.2  

Nonferrous Metals/Minerals

   1,207     0.4    1,505     0.5  

Transportation

   1,005     0.3    —      —   

Environmental Industries

   801     0.3    732     0.3  

Services: Consumer

   655     0.2    496     0.2  

Broadcast Radio and Television

   283     0.1    1,258     0.4  

Building and Development

   248     0.1    248     0.1  
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $289,999     100.0 $284,845     100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

 

44


Table of Contents

Portfolio composition by geographic location at fair value

The following table shows our portfolio composition by geographic location at fair value at November 30, 2016 and February 29, 2016. The geographic composition is determined by the location of the corporate headquarters of the portfolio company.

 

   At November 30, 2016  At February 29, 2016 
   Investments
at
Fair Value
   Percentage
of Total
Portfolio
  Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 

Southeast

  $113,621     40.9 $108,661     38.3

Midwest

   55,526     20.0    57,553     20.3  

Northeast

   41,973     15.1    52,875     18.6  

Southwest

   24,843     9.0    25,535     9.0  

West

   16,561     6.0    24,544     8.6  

Other(1)

   15,266     5.5    12,828     4.5  

Northwest

   7,780     2.8    —       —    

International

   2,000     0.7    2,000     0.7  
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $277,570     100.0 $283,996     100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

 

(1)Comprised of our investment in the subordinated notes and Class F Note of Saratoga CLO.

Results of operations

Operating results for the three and nine months ended November 30, 2016 and November 30, 2015 were as follows:

 

   For the three months ended 
   November 30,
2016
   November 30,
2015
 
   ($ in thousands) 

Total investment income

  $8,442    $6,936  

Total expenses

   5,023     4,786  
  

 

 

   

 

 

 

Net investment income

   3,419     2,150  

Net realized gains from investments

   260     448  

Net unrealized appreciation (depreciation) on investments

   (2,105   823  
  

 

 

   

 

 

 

Net increase in net assets resulting from operations

  $1,574    $3,421  
  

 

 

   

 

 

 
   For the nine months ended 
   November 30,
2016
   November 30,
2015
 
   ($ in thousands)  

Total investment income

  $24,799    $22,255  

Total expenses

   16,238     14,676  
  

 

 

   

 

 

 

Net investment income

   8,561     7,579  

Net realized gains from investments

   12,300     4,231  

Net unrealized appreciation (depreciation) on investments

   (10,728   239  
  

 

 

   

 

 

 

Net increase in net assets resulting from operations

  $10,133    $12,049  
  

 

 

   

 

 

 

 

45


Table of Contents

Investment income

The composition of our investment income for the three and nine months ended November 30, 2016 and November 30, 2015 were as follows:

 

   For the three months ended 
   November 30,
2016
   November 30,
2015
 
   ($ in thousands) 

Interest from investments

  $7,456    $6,227  

Management fee income

   375     369  

Interest from cash and cash equivalents and other income

   611     340  
  

 

 

   

 

 

 

Total

  $8,442    $6,936  
  

 

 

   

 

 

 
   For the nine months ended 
   November 30,
2016
   November 30,
2015
 
   ($ in thousands)  

Interest from investments

  $22,040    $19,978  

Management fee income

   1,124     1,121  

Interest from cash and cash equivalents and other income

   1,635     1,156  
  

 

 

   

 

 

 

Total

  $24,799    $22,255  
  

 

 

   

 

 

 

For the three months ended November 30, 2016, total investment income of $8.4 million, increased $1.5 million, or 21.7% compared to $6.9 million for the three months ended November 30, 2015. Interest income from investments increased $1.3 million, or 19.7%, to $7.5 million for the three months ended November 30, 2016 from $6.2 million for the three months ended November 30, 2015. This reflects an increase of 15.2% in total investments to $277.6 million at November 30, 2016 from $241.0 million at November 30, 2015, with the weighted average current coupon increasing from 11.3% to 11.9%.

For the nine months ended November 30, 2016, total investment income of $24.8 million, increased $2.5 million, or 11.4% compared to $22.3 million for the nine months ended November 30, 2015. Interest income from investments increased $2.0 million, or 10.3%, to $22.0 million for the nine months ended November 30, 2016 from $20.0 million for the nine months ended November 30, 2015. This reflects an increase of 15.2% in total investments to $277.6 million at November 30, 2016 from $241.0 million at November 30, 2015, with the weighted average current coupon increasing from 11.3% to 11.9%.

For the three months ended November 30, 2016 and November 30, 2015, total PIK income was $0.2 million and $0.04 million, respectively. For the nine months ended November 30, 2016 and November 30, 2015, total PIK income was $0.5 million and $1.0 million, respectively.

Operating expenses

The composition of our operating expenses for the three and nine months ended November 30, 2016 and November 30, 2015 was as follows:

 

46


Table of Contents

Operating Expenses

 

   For the three months ended 
   November 30,
2016
   November 30,
2015
 
   ($ in thousands) 

Interest and debt financing expenses

  $2,369    $2,129  

Base management fees

   1,220     1,092  

Professional fees

   330     348  

Administrator expenses

   342     325  

Incentive management fees

   395     404  

Insurance

   69     85  

Directors fees and expenses

   66     51  

General and administrative and other expenses

   232     352  

Excise tax expense (credit)

   —      —    
  

 

 

   

 

 

 

Total expenses

  $5,023    $4,786  
  

 

 

   

 

 

 

 

   For the nine months ended 
   November 30,
2016
   November 30,
2015
 
   ($ in thousands) 

Interest and debt financing expenses

  $7,107    $6,241  

Base management fees

   3,650     3,366  

Professional fees

   992     1,030  

Administrator expenses

   992     850  

Incentive management fees

   2,331     2,161  

Insurance

   210     260  

Directors fees and expenses

   192     153  

General and administrative and other expenses

   764     738  

Excise tax expense (credit)

       (123
  

 

 

   

 

 

 

Total expenses

  $16,238    $14,676  
  

 

 

   

 

 

 

For the three months ended November 30, 2016, total operating expenses increased $0.2 million, or 5.0% compared to the three months ended November 30, 2015. For the nine months ended November 30, 2016, total operating expenses increased $1.6 million, or 10.6% compared to the nine months ended November 30, 2015.

For the three and nine months ended November 30, 2016 and November 30, 2015, the increase in interest and debt financing expenses is primarily attributable to an increase in outstanding debt as compared to the prior year, with increased levels of outstanding SBA debentures, as well as additional notes being issued. Our SBA debentures increased from $79.0 million at November 30, 2015 to $112.7 million at November 30, 2016, and the 2020 Notes payable increased slightly from $61.4 million outstanding to $61.8 million outstanding for these same periods. For the three months ended November 30, 2016, the weighted average interest rate on our outstanding indebtedness was 4.66% compared to 5.07% for the three months ended November 30, 2015. For the nine months ended November 30, 2016, the weighted average interest rate on our outstanding indebtedness was 4.73% compared to 4.99% for the nine months ended November 30, 2015. For both periods, the decrease was primarily driven by an increase in SBA debentures that carry a lower interest rate and makes up a higher proportion of our overall debt this year partially offset by the increase in 2020 Notes payable that carry a higher interest rate. SBA debentures increased from 56.3% of overall debt as of November 30, 2015 to 64.6% as of November 30, 2016.

For the three months ended November 30, 2016, base management fees increased $0.1 million, or 11.8% compared to the three months ended November 30, 2015. For the nine months ended November 30, 2016, base management fees increased $0.3 million, or 8.4% compared to the nine months ended November 30, 2015. The increase in base management fees results from the 11.8% increase in the average value of our total assets, less cash and cash equivalents, from $250.1 million as of November 30, 2015 to $279.6 million as of November 30, 2016.

For the three and nine months ended November 30, 2016, professional fees decreased $0.02 million, or 5.0%, and decreased $0.04 million, or 3.8%, respectively, compared to the three and nine months ended November 30, 2015.

 

47


Table of Contents

For the three months ended November 30, 2016, incentive management fees decreased $0.01 million, or 2.4%, compared to the three months ended November 30, 2015. The first part of the incentive management fees increased this year from $0.2 million to $0.8 million reflecting higher pre-incentive fee net investment income for the three months ended November 30, 2016. For the three months ended November 30, 2016, there was a reduction of $0.4 million in incentive management fees related to capital gains compared to a $0.2 million increase in expense as compared to the three months ended November 30, 2015, reflecting a $1.3 million net gain on investments for the three months ended November 30, 2015, as compared to a $1.8 million net loss on investments for the three months ended November 30, 2016.

For the nine months ended November 30, 2016, incentive management fees increased $0.2 million, or 7.9%, compared to the nine months ended November 30, 2015. The first part of the incentive management fees increased this year from $1.7 million to $2.2 million for the nine months ended November 30, 2016, reflecting a higher pre-incentive fee net investment income this year. However, the total incentive management fees increase was only $0.2 million as the incentive management fees related to capital gains decreased from $0.5 million to $0.1 million compared to the nine months ended November 30, 2015, reflecting a $4.5 million net gain on investments for the nine months ended November 30, 2015, as compared to a $1.6 million net gain on investments for the nine months ended November 30, 2016.

As discussed above, the increase in interest and debt financing expenses for the three and nine months ended November 30, 2016 as compared to the three and nine months ended November 30, 2015 is primarily attributable to an increase in the amount of outstanding debt. For the three and nine months ended November 30, 2016, there were no outstanding borrowings under the Credit Facility. For the three and nine months ended November 30, 2015, the weighted average interest rate on the outstanding borrowings under the Credit Facility was 6.00%. For the three months ended November 30, 2016 and November 30, 2015, the weighted average interest rate on the outstanding borrowings of the SBA debentures was 3.08% and 3.25%, respectively. For the nine months ended November 30, 2016 and November 30, 2015, the weighted average interest rate on the outstanding borrowings of the SBA debentures was 3.12% and 3.21%, respectively.

Net realized gains/(losses) on sales of investments

For the three months ended November 30, 2016, the Company had $23.8 million of sales, repayments, exits or restructurings resulting in $0.3 million of net realized gains. For the nine months ended November 30, 2016, the Company had $94.7 million of sales, repayments, exits or restructurings resulting in $12.3 million of net realized gains. The most significant realized gains during the nine months ended November 30, 2016 were as follows (dollars in thousands):

Nine Months ended November 30, 2016

 

Issuer

  Asset Type  Gross
Proceeds
   Cost   Net
Realized
Gain
 

Take 5 Oil Change, L.L.C.

  Common Stock  $6,505    $481    $6,024  

Legacy Cabinets, Inc.

  Common Stock Voting A-1   2,320     221     2,099  

Legacy Cabinets, Inc.

  Common Stock Voting B-1   1,464     139     1,325  

The $6.0 million of realized gain on our investment in Take 5 Oil Change, L.L.C. was due to the completion of a sales transaction with a strategic acquirer.

The $3.4 million of realized gains on our investments in Legacy Cabinets, Inc. were due to a period of steadily improving performance, leading up to our sale of shares in Legacy Cabinets, Inc.

For the three months ended November 30, 2015, the Company had $27.9 million of sales, repayments, exits or restructurings resulting in $0.4 million of net realized gains. For the nine months ended November 30, 2015, the Company had $62.7 million of sales, repayments, exits or restructurings resulting in $4.2 million of net realized gains. The most significant realized gains during the nine months ended November 30, 2015 were as follows (dollars in thousands):

 

48


Table of Contents

Nine Months ended November 30, 2015

 

Issuer

  Asset Type Gross
Proceeds
   Cost   Net
Realized
Gain
 

Network Communications, Inc.

  Common Stock $3,206    $ —     $3,206  

Community Investors, Inc.

  Preferred Stock - A Shares 10%  464     135     329  

The $3.2 million of realized gain on our investments in Network Communications, Inc. is due to the sale of the company to a third party and reflects the realization value pursuant to that transaction.

Net unrealized appreciation/(depreciation) on investments

For the three months ended November 30, 2016, our investments had net unrealized depreciation of $2.1 million versus net unrealized appreciation of $0.8 million for the three months ended November 30, 2015. For the nine months ended November 30, 2016, our investments had net unrealized depreciation of $10.7 million versus net unrealized appreciation of $0.2 million for the nine months ended November 30, 2015. The most significant cumulative changes in unrealized appreciation and depreciation for the nine months ended November 30, 2016, were the following (dollars in thousands):

Nine Months ended November 30, 2016

 

Issuer

 Asset Type Cost  Fair
Value
  Total
Unrealized
Depreciation
  YTD Change
in Unrealized
Depreciation
 

Take 5 Oil Change, L.L.C.

 Common Stock $—    $—    $—    $(5,755

Legacy Cabinets, Inc.

 Common Stock Voting A-1  —     —     —     (2,456

Legacy Cabinets, Inc.

 Common Stock Voting B-1  —     —     —     (1,550

Elyria Foundry Company, L.L.C.

 Common Stock  9,217    357    (8,860  (1,669

The $5.8 million of change in unrealized depreciation in our investment in Take 5 Oil Change, L.L.C. was driven by the completion of a sales transaction with a strategic acquirer. In realizing this gain as a result of the sale, unrealized appreciation was adjusted to zero, which resulted in a $5.8 million change in unrealized depreciation for the period.

The $4.0 million of change in unrealized depreciation in our investments in Legacy Cabinets, Inc. were driven by the completion of a sales transaction. In realizing these gains as a result of the sale, unrealized appreciation was adjusted to zero, which resulted in a $4.0 million change in unrealized depreciation for the period.

The $1.7 million of change in unrealized depreciation in our investment in Elyria Foundry Company, L.L.C. was driven by a decline in oil and gas end markets since year-end, negatively impacting the company’s performance.

The most significant cumulative changes in unrealized appreciation and depreciation for the nine months ended November 30, 2015, were the following (dollars in thousands):

 

49


Table of Contents

Nine Months ended November 30, 2015

 

Issuer

  Asset Type  Cost   Fair
Value
   Total
Unrealized
Appreciation/
(Depreciation)
   YTD Change
in Unrealized
Appreciation/
(Depreciation)
 

Elyria Foundry Company, LLC

  Common Stock  $9,218    $3,266    $(5,952  $(3,497

Targus Group International, Inc.

  First Lien Term Loan   3,589     2,232     (1,357   (1,103

Saratoga CLO

  Other/Structured Finance
Securities
   13,668     15,776     2,108     1,030  

The $3.5 million unrealized depreciation in our investment in Elyria Foundry Company, LLC was primarily due to a decline in oil and gas end markets since year-end, negatively impacting the Company’s performance.

The $1.1 million unrealized depreciation in our investment in Targus Group International, Inc. was primarily due to a decline in earnings resulting from weakened demand in the company’s end markets.

The $1.0 million unrealized appreciation in our investment in the Saratoga CLO was primarily due to the quarterly distribution and a decline in the discount rate based on prevailing market conditions.

Changes in net assets resulting from operations

For the three months ended November 30, 2016 and November 30, 2015, we recorded a net increase in net assets resulting from operations of $1.6 million and $3.4 million, respectively. Based on 5,727,933 weighted average common shares outstanding as of November 30, 2016, our per share net increase in net assets resulting from operations was $0.27 for the three months ended November 30, 2016. This compares to a per share net increase in net assets resulting from operations of $0.61 for the three months ended November 30, 2015 based on 5,632,011 weighted average common shares outstanding as of November 30, 2015.

For the nine months ended November 30, 2016 and November 30, 2015, we recorded a net increase in net assets resulting from operations of $10.1 million and $12.0 million, respectively. Based on 5,735,443 weighted average common shares outstanding as of November 30, 2016, our per share net increase in net assets resulting from operations was $1.77 for the nine months ended November 30, 2016. This compares to a per share net increase in net assets resulting from operations of $2.18 for the nine months ended November 30, 2015 based on 5,533,094 weighted average common shares outstanding as of November 30, 2015.

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

We intend to continue to generate cash primarily from cash flows from operations, including interest earned from our investments in debt in middle market companies, interest earned from the temporary investment of cash in U.S. government securities and other high-quality debt investments that mature in one year or less, future borrowings and future offerings of securities.

Although we expect to fund the growth of our investment portfolio through the net proceeds from SBA debenture drawdowns and future equity offerings, including our dividend reinvestment plan (“DRIP”), and issuances of senior securities or future borrowings, to the extent permitted by the 1940 Act, we cannot assure you that our plans to raise capital will be successful. In this regard, because our common stock has historically traded at a price below our current net asset value per share and we are limited in our ability to sell our common stock at a price below net asset value per share, we have been and may continue to be limited in our ability to raise equity capital.

In addition, we intend to distribute to our stockholders substantially all of our taxable income in order to satisfy the distribution requirement applicable to RICs under the Code. In satisfying this distribution requirement, we have in the past relied on IRS issued private letter rulings concluding that a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20% of the aggregate declared distribution. We may rely on these IRS private letter rulings in future periods to satisfy our RIC distribution requirement.

Also, as a BDC, we generally are required to meet a coverage ratio of total assets, less liabilities and indebtedness not represented by senior securities, to total senior securities, which include all of our borrowings and any outstanding preferred stock, of at least 200%. This requirement limits the amount that we may borrow. Our asset coverage ratio, as defined in the 1940 Act, was 306.6% as of November 30, 2016 and 302.5% as of February 29, 2016. To fund growth in our investment portfolio in the future, we anticipate needing to raise additional capital from various sources, including the equity markets and other debt-related markets, which may or may not be available on favorable terms, if at all.

 

50


Table of Contents

Consequently, we may not have the funds or the ability to fund new investments, to make additional investments in our portfolio companies, to fund our unfunded commitments to portfolio companies or to repay borrowings. Also, the illiquidity of our portfolio investments may make it difficult for us to sell these investments when desired and, if we are required to sell these investments, we may realize significantly less than their recorded value.

Madison revolving credit facility

Below is a summary of the terms of the senior secured revolving credit facility we entered into with Madison Capital Funding LLC (the “Credit Facility”) on June 30, 2010.

Availability. The Company can draw up to the lesser of (i) $40.0 million (the “Facility Amount”) and (ii) the product of the applicable advance rate (which varies from 50.0% to 75.0% depending on the type of loan asset) and the value, determined in accordance with the Credit Facility (the “Adjusted Borrowing Value”), of certain “eligible” loan assets pledged as security for the loan (the “Borrowing Base”), in each case less (a) the amount of any undrawn funding commitments the Company has under any loan asset and which are not covered by amounts in the Unfunded Exposure Account referred to below (the “Unfunded Exposure Amount”) and (b) outstanding borrowings. Each loan asset held by the Company as of the date on which the Credit Facility was closed was valued as of that date and each loan asset that the Company acquires after such date will be valued at the lowest of its fair value, its face value (excluding accrued interest) and the purchase price paid for such loan asset. Adjustments to the value of a loan asset will be made to reflect, among other things, changes in its fair value, a default by the obligor on the loan asset, insolvency of the obligor, acceleration of the loan asset, and certain modifications to the terms of the loan asset.

The Credit Facility contains limitations on the type of loan assets that are “eligible” to be included in the Borrowing Base and as to the concentration level of certain categories of loan assets in the Borrowing Base such as restrictions on geographic and industry concentrations, asset size and quality, payment frequency, status and terms, average life, and collateral interests. In addition, if an asset is to remain an “eligible” loan asset, the Company may not make changes to the payment, amortization, collateral and certain other terms of the loan assets without the consent of the administrative agent that will either result in subordination of the loan asset or be materially adverse to the lenders.

Collateral. The Credit Facility is secured by substantially all of the assets of the Company (other than assets held by our SBIC subsidiary) and includes the subordinated notes (“CLO Notes”) issued by Saratoga CLO and the Company’s rights under the CLO Management Agreement (as defined below).

Interest Rate and Fees. Under the Credit Facility, funds are borrowed from or through certain lenders at the greater of the prevailing LIBOR rate and 2.00%, plus an applicable margin of 5.50%. At the Company’s option, funds may be borrowed based on an alternative base rate, which in no event will be less than 3.00%, and the applicable margin over such alternative base rate is 4.50%. In addition, the Company pays the lenders a commitment fee of 0.75% per year on the unused amount of the Credit Facility for the duration of the Revolving Period (defined below). Accrued interest and commitment fees are payable monthly. The Company was also obligated to pay certain other fees to the lenders in connection with the closing of the Credit Facility.

Revolving Period and Maturity Date. The Company may make and repay borrowings under the Credit Facility for a period of three years following the closing of the Credit Facility (the “Revolving Period”). The Revolving Period may be terminated at an earlier time by the Company or, upon the occurrence of an event of default, by action of the lenders or automatically. All borrowings and other amounts payable under the Credit Facility are due and payable in full five years after the end of the Revolving Period.

Collateral Tests. It is a condition precedent to any borrowing under the Credit Facility that the principal amount outstanding under the Credit Facility, after giving effect to the proposed borrowings, not exceed the lesser of the Borrowing Base or the Facility Amount (the “Borrowing Base Test”). In addition to satisfying the Borrowing Base Test, the following tests must also be satisfied (together with Borrowing Base Test, the “Collateral Tests”):

 

  Interest Coverage Ratio. The ratio (expressed as a percentage) of interest collections with respect to pledged loan assets, less certain fees and expenses relating to the Credit Facility, to accrued interest and commitment fees and any breakage costs payable to the lenders under the Credit Facility for the last 6 payment periods must equal at least 175.0%.

 

  Overcollateralization Ratio. The ratio (expressed as a percentage) of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets plus the fair value of certain ineligible pledged loan assets and the CLO Notes (in each case, subject to certain adjustments) to outstanding borrowings under the Credit Facility plus the Unfunded Exposure Amount must equal at least 200.0%.

 

51


Table of Contents
  Weighted Average FMV Test. The aggregate adjusted or weighted value of “eligible” pledged loan assets as a percentage of the aggregate outstanding principal balance of “eligible” pledged loan assets must be equal to or greater than 72.0% and 80.0% during the one-year periods prior to the first and second anniversary of the closing date, respectively, and 85.0% at all times thereafter.

The Credit Facility also requires payment of outstanding borrowings or replacement of pledged loan assets upon the Company’s breach of its representation and warranty that pledged loan assets included in the Borrowing Base are “eligible” loan assets. Such payments or replacements must equal the lower of the amount by which the Borrowing Base is overstated as a result of such breach or any deficiency under the Collateral Tests at the time of repayment or replacement. Compliance with the Collateral Tests is also a condition to the discretionary sale of pledged loan assets by the Company.

Priority of Payments. During the Revolving Period, the priority of payments provisions of the Credit Facility require, after payment of specified fees and expenses and any necessary funding of the Unfunded Exposure Account, that collections of principal from the loan assets and, to the extent that these are insufficient, collections of interest from the loan assets, be applied on each payment date to payment of outstanding borrowings if the Borrowing Base Test, the Overcollateralization Ratio and the Interest Coverage Ratio would not otherwise be met. Similarly, following termination of the Revolving Period, collections of interest are required to be applied, after payment of certain fees and expenses, to cure any deficiencies in the Borrowing Base Test, the Interest Coverage Ratio and the Overcollateralization Ratio as of the relevant payment date.

Reserve Account. The Credit Facility requires the Company to set aside an amount equal to the sum of accrued interest, commitment fees and administrative agent fees due and payable on the next succeeding three payment dates (or corresponding to three payment periods). If for any monthly period during which fees and other payments accrue, the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets which do not pay cash interest at least quarterly exceeds 15.0% of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets, the Company is required to set aside such interest and fees due and payable on the next succeeding six payment dates. Amounts in the reserve account can be applied solely to the payment of administrative agent fees, commitment fees, accrued and unpaid interest and any breakage costs payable to the lenders.

Unfunded Exposure Account. With respect to revolver or delayed draw loan assets, the Company is required to set aside in a designated account (the “Unfunded Exposure Account”) 100.0% of its outstanding and undrawn funding commitments with respect to such loan assets. The Unfunded Exposure Account is funded at the time the Company acquires a revolver or delayed draw loan asset and requests a related borrowing under the Credit Facility. The Unfunded Exposure Account is funded through a combination of proceeds of the requested borrowing and other Company funds, and if for any reason such amounts are insufficient, through application of the priority of payment provisions described above.

Operating Expenses. The priority of payments provision of the Credit Facility provides for the payment of certain operating expenses of the Company out of collections on principal and interest during the Revolving Period and out of collections on interest following the termination of the Revolving Period in accordance with the priority established in such provision. The operating expenses payable pursuant to the priority of payment provisions is limited to $350,000 for each monthly payment date or $2.5 million for the immediately preceding period of twelve consecutive monthly payment dates. This ceiling can be increased by the lesser of 5.0% or the percentage increase in the fair market value of all the Company’s assets only on the first monthly payment date to occur after each one-year anniversary following the closing of the Credit Facility. Upon the occurrence of a Manager Event (described below), the consent of the administrative agent is required in order to pay operating expenses through the priority of payments provision.

Events of Default. The Credit Facility contains certain negative covenants, customary representations and warranties and affirmative covenants and events of default. The Credit Facility does not contain grace periods for breach by the Company of certain covenants, including, without limitation, preservation of existence, negative pledge, change of name or jurisdiction and separate legal entity status of the Company covenants and certain other customary covenants. Other events of default under the Credit Facility include, among other things, the following:

 

  an Interest Coverage Ratio of less than 150.0%;

 

  an Overcollateralization Ratio of less than 175.0%;

 

  the filing of certain ERISA or tax liens;

 

  the occurrence of certain “Manager Events” such as:

 

  failure by Saratoga Investment Advisors and its affiliates to maintain collectively, directly or indirectly, a cash equity investment in the Company in an amount equal to at least $5,000,000 at any time prior to the third anniversary of the closing date;

 

52


Table of Contents
  failure of the Management Agreement between Saratoga Investment Advisors and the Company to be in full force and effect;

 

  indictment or conviction of Saratoga Investment Advisors or any “key person” for a felony offense, or any fraud, embezzlement or misappropriation of funds by Saratoga Investment Advisors or any “key person” and, in the case of “key persons,” without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed to replace such key person within 30 days;

 

  resignation, termination, disability or death of a “key person” or failure of any “key person” to provide active participation in Saratoga Investment Advisors’ daily activities, all without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed within 30 days; or

 

  occurrence of any event constituting “cause” under the Collateral Management Agreement between the Company and Saratoga CLO (the “CLO Management Agreement”), delivery of a notice under Section 12(c) of the CLO Management Agreement with respect to the removal of the Company as collateral manager or the Company ceases to act as collateral manager under the CLO Management Agreement.

Conditions to Acquisitions and Pledges of Loan Assets. The Credit Facility imposes certain additional conditions to the acquisition and pledge of additional loan assets. Among other things, the Company may not acquire additional loan assets without the prior written consent of the administrative agent until such time that the administrative agent indicates in writing its satisfaction with Saratoga Investment Advisors’ policies, personnel and processes relating to the loan assets.

Fees and Expenses. The Company paid certain fees and reimbursed Madison Capital Funding LLC for the aggregate amount of all documented, out-of-pocket costs and expenses, including the reasonable fees and expenses of lawyers, incurred by Madison Capital Funding LLC in connection with the Credit Facility and the carrying out of any and all acts contemplated thereunder up to and as of the date of closing of the stock purchase transaction with Saratoga Investment Advisors and certain of its affiliates. These amounts totaled $2.0 million.

On February 24, 2012, we amended our senior secured revolving credit facility with Madison Capital Funding LLC to, among other things:

 

  expand the borrowing capacity under the Credit Facility from $40.0 million to $45.0 million;

 

  extend the period during which we may make and repay borrowings under the Credit Facility from July 30, 2013 to February 24, 2015 (the “Revolving Period”). The Revolving Period may, upon the occurrence of an event of default, by action of the lenders or automatically, be terminated. All borrowings and other amounts payable under the Credit Facility are due and payable five years after the end of the Revolving Period; and

 

  remove the condition that we may not acquire additional loan assets without the prior written consent of the administrative agent.

On September 17, 2014, we entered into a second amendment to the Revolving Facility with Madison Capital Funding LLC to, among other things:

 

  extend the commitment termination date from February 24, 2015 to September 17, 2017;

 

  extend the maturity date of the Revolving Facility from February 24, 2020 to September 17, 2022 (unless terminated sooner upon certain events);

 

  reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%, and on LIBOR borrowings from 5.50% to 4.75%; and

 

  reduce the floor on base rate borrowings from 3.00% to 2.25%; and on LIBOR borrowings from 2.00% to 1.25%.

As of November 30, 2016, we had no outstanding borrowings under the Credit Facility and $112.7 million SBA-guaranteed debentures outstanding (which are discussed below). As of February 29, 2016, we had no outstanding borrowings under the Credit Facility and $103.7 million SBA-guaranteed debentures outstanding. Our borrowing base under the Credit Facility at November 30, 2016 and February 29, 2016 was $24.1 million and $21.8 million, respectively.

Our asset coverage ratio, as defined in the 1940 Act, was 306.6% as of November 30, 2016 and 302.5% as of February 29, 2016.

SBA-guaranteed debentures

In addition, we, through a wholly-owned subsidiary, sought and obtained a license from the SBA to operate an SBIC. In this regard, on March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP, received a license from the SBA to

 

53


Table of Contents

operate as an SBIC under Section 301(c) of the Small Business Investment Act of 1958. SBICs are designated to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses.

The SBIC license allows our SBIC subsidiary to obtain leverage by issuing SBA-guaranteed debentures. SBA-guaranteed debentures are non-recourse, interest only debentures with interest payable semi-annually and have a ten year maturity. The principal amount of SBA-guaranteed debentures is not required to be paid prior to maturity but may be prepaid at any time without penalty. The interest rate of SBA-guaranteed debentures is fixed on a semi-annual basis at a market-driven spread over U.S. Treasury Notes with 10-year maturities.

SBA regulations currently limit the amount that our SBIC subsidiary may borrow to a maximum of $150.0 million when it has at least $75.0 million in regulatory capital, receives a capital commitment from the SBA and has been through an examination by the SBA subsequent to licensing. As of November 30, 2016, our SBIC subsidiary had $75.0 million in regulatory capital and $112.7 million SBA-guaranteed debentures outstanding.

We received exemptive relief from the SEC to permit us to exclude the debt of our SBIC subsidiary guaranteed by the SBA from the definition of senior securities in the 200% asset coverage test under the 1940 Act. This allows us increased flexibility under the 200% asset coverage test by permitting us to borrow up to $150.0 million more than we would otherwise be able to absent the receipt of this exemptive relief.

On April 2, 2015, the SBA issued a “green light” letter inviting the Company to continue the application process to obtain a license to form and operate its second SBIC subsidiary. On September 27, 2016, the SBA informed us that as part of their continued review of our application for a second license, and in order to ensure that they were reviewing the most current information available, we would need to update all previously submitted materials and invited us to reapply. As a result of this request, with which we are in the process of complying, the existing “green light” letter that the SBA issued to us will expire. If approved in the future, a second SBIC license would provide us an incremental source of long-term capital by permitting us to issue up to $150.0 million of additional SBA-guaranteed debentures in addition to the $150.0 million already approved under the first license.

Unsecured notes

In May 2013, we issued $48.3 million in aggregate principal amount of our 2020 Notes for net proceeds of $46.1 million after deducting underwriting commissions of $1.9 million and offering costs of $0.3 million. The proceeds included the underwriters’ full exercise of their overallotment option. Interest on these 2020 Notes is paid quarterly in arrears on February 15, May 15, August 15 and November 15, at a rate of 7.50% per year, beginning August 15, 2013. The 2020 Notes mature on May 31, 2020 and since May 31, 2016, may be redeemed in whole or in part at any time or from time to time at our option. In connection with the issuance of the 2020 Notes, we agreed to the following covenants for the period of time during which the 2020 Notes are outstanding:

 

  we will not violate (whether or not we are subject to) Section 18(a)(1)(A) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to any exemptive relief granted to us by the SEC. Currently, these provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt or the sale of additional debt securities, unless our asset coverage, as defined in the 1940 Act, equals at least 200% after such borrowings.

 

  we will not violate (regardless of whether we are subject to) Section 18(a)(1)(B) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to (i) any exemptive relief granted to us by the SEC and (ii) no-action relief granted by the SEC to another BDC (or to the Company if it determines to seek such similar no-action or other relief) permitting the BDC to declare any cash dividend or distribution notwithstanding the prohibition contained in Section 18(a)(1)(B) as modified by Section 61(a)(1) of the 1940 Act in order to maintain the BDC’s status as a regulated investment company under the Code. Currently these provisions generally prohibit us from declaring any cash dividend or distribution upon any class of our capital stock, or purchasing any such capital stock if our asset coverage, as defined in the 1940 Act, is below 200% at the time of the declaration of the dividend or distribution or the purchase and after deducting the amount of such dividend, distribution or purchase.

The 2020 Notes are listed on the NYSE under the trading symbol “SAQ” with a par value of $25.00 per share.

On May 29, 2015, we entered into a Debt Distribution Agreement with Ladenburg Thalmann & Co. through which we may offer for sale, from time to time, up to $20.0 million in aggregate principal amount of the 2020 Notes through an ATM offering. As of November 30, 2016, we sold 539,725 bonds with a principal of $13,493,125 at an average price of $25.31 for aggregate net proceeds of $13,385,766 (net of transaction costs).

 

54


Table of Contents

On December 21, 2016, we issued $74.5 million in aggregate principal amount of our 2023 Notes for net proceeds of $72.1 million after deducting underwriting commissions of approximately $2.0 million and offering costs of approximately $0.5 million. The issuance included the exercise of substantially all of the underwriters’ option to purchase an additional $9.8 million aggregate principal amount of 2023 Notes within 30 days. Interest on the 2023 Notes is paid quarterly in arrears on March 15, June 15, September 15 and December 15, at a rate of 6.75% per year, beginning March 30, 2017. The 2023 Notes mature on December 20, 2023, and commencing December 21, 2019, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering will be used to repay all of the outstanding indebtedness under the 2020 Notes, which amounts to $61.8 million, and for general corporate purposes in accordance with our investment objective and strategies.

At November 30, 2016 and February 29, 2016, the fair value of investments, cash and cash equivalents and cash and cash equivalents, reserve accounts was as follows:

 

   At November 30, 2016  At February 29, 2016 
   Fair Value   Percentage
of
Total
  Fair Value   Percentage
of
Total
 
   ($ in thousands) 

Cash and cash equivalents

  $5,770     1.9 $2,440     0.8

Cash and cash equivalents, reserve accounts

   17,521     5.8    4,595     1.6  

Syndicated loans

   9,627     3.2    11,868     4.1  

First lien term loans

   160,460     53.3    144,643     49.7  

Second lien term loans

   80,195     26.7    88,178     30.3  

Structured finance securities

   15,266     5.1    12,828     4.4  

Equity interests

   12,022     4.0    26,479     9.1  
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $300,861     100.0 $291,031     100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

On September 24, 2014, we announced the approval of an open market share repurchase plan that allows it to repurchase up to 200,000 shares of our common stock at prices below our NAV as reported in its then most recently published consolidated financial statements, which was subsequently increased to 400,000 shares of our common stock. On October 5, 2016, our board of directors extended the open market share repurchase plan for another year to October 15, 2017 and increased the number of shares we are permitted to repurchase at prices below our NAV, as reported in its then most recently published consolidated financial statements, to 600,000 shares of our common stock. As of November 30, 2016, we purchased 214,391 shares of common stock, at the average price of $16.84 for approximately $3.6 million pursuant to this repurchase plan.

On October 5, 2016, our board of directors declared a dividend of $0.44 per share, which was paid on November 9, 2016, to common stockholders of record as of October 31, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,548 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.12 per share, which equaled the volume weighted average trading price per share of the common stock on October 27, 28, 31 and November 1, 2, 3, 4, 7, 8 and 9, 2016.

On August 8, 2016, our board of directors declared a special dividend of $0.20 per share, which was paid on September 5, 2016, to common stockholders of record as of August 24, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.7 million in cash and 24,786 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.06 per share, which equaled the volume weighted average trading price per share of the common stock on August 22, 23, 24, 25, 26, 29, 30, 31 and September 1 and 2, 2016.

On July 7, 2016, our board of directors declared a dividend of $0.43 per share, which was paid on August 9, 2016, to common stockholders of record as of July 29, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,167 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.32 per share, which equaled the volume weighted average trading price per share of the common stock on July 27, 28, 29 and August 1, 2, 3, 4, 5, 8 and 9, 2016.

On March 31, 2016, our board of directors declared a dividend of $0.41 per share, which was paid on April 27, 2016, to common stockholders of record as of April 15, 2016. Shareholders had the option to receive payment of the dividend in cash, or

 

55


Table of Contents

receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 56,728 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.43 per share, which equaled the volume weighted average trading price per share of the common stock on April 14, 15, 18, 19, 20, 21, 22, 25, 26 and 27, 2016.

On January 12, 2016, our board of directors declared a dividend of $0.40 per share, which was paid on February 29, 2016, to common stockholders of record as of February 1, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.4 million in cash and 66,765 newly issued shares of common stock, or 1.2% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.11 per share, which equaled the volume weighted average trading price per share of the common stock on February 16, 17, 18, 19, 22, 23, 24, 25, 26 and 29, 2016.

On October 7, 2015, our board of directors declared a dividend of $0.36 per share, which was paid on November 30, 2015, to common stockholders of record as of November 2, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 61,029 newly issued shares of common stock, or 1.1% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.53 per share, which equaled the volume weighted average trading price per share of the common stock on November 16, 17, 18, 19, 20, 23, 24, 25, 27 and 30, 2015.

On July 8, 2015, our board of directors declared a dividend of $0.33 per share, which was paid on August 31, 2015, to common stockholders of record as of August 3, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 47,861 newly issued shares of common stock, or 0.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.28 per share, which equaled the volume weighted average trading price per share of the common stock on August 18, 19, 20, 21, 24, 25, 26, 27, 28 and 31, 2015.

On May 14, 2015, our board of directors declared a special dividend of $1.00 per share, which was paid on June 5, 2015, to common stockholders of record as of May 26, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 126,230 newly issued shares of common stock, or 2.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.47 per share, which equaled the volume weighted average trading price per share of the common stock on May 22, 26, 27, 28, 29 and June 1, 2, 3, 4 and 5, 2015.

On April 9, 2015, our board of directors declared a dividend of $0.27 per share, which was paid on May 29, 2015, to common stockholders of record as of May 4, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.9 million in cash and 33,766 newly issued shares of common stock, or 0.6% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.78 per share, which equaled the volume weighted average trading price per share of the common stock on May 15, 18, 19, 20, 21, 22, 26, 27, 28 and 29, 2015.

On September 24, 2014, our board of directors declared a dividend of $0.22 per share, which was paid on February 27, 2015. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.8 million in cash and 26,858 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.97 per share, which equaled the volume weighted average trading price per share of the common stock on February 13, 17, 18, 19, 20, 23, 24, 25, 26 and 27, 2015.

Also on September 24, 2014, our board of directors declared a dividend of $0.18 per share, which was paid on November 28, 2014. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.6 million in cash and 22,283 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.37 per share, which equaled the volume weighted average trading price per share of the common stock on November 14, 17, 18, 19, 20, 21, 24, 25, 26 and 28, 2014.

On October 30, 2013, our board of directors declared a dividend of $2.65 per share, which was paid on December 27, 2013, to common stockholders of record as of November 13, 2013. Shareholders had the option to receive payment of the dividend in cash,

 

56


Table of Contents

shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.5 million or $0.53 per share. This dividend was declared in reliance on certain private letter rulings issued by the IRS concluding that a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution.

Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock, or 13.7% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.439 per share, which equaled the volume weighted average trading price per share of the common stock on December 11, 13 and 16, 2013.

On November 9, 2012, our board of directors declared a dividend of $4.25 per share, which was paid on December 31, 2012, to common stockholders of record as of November 20, 2012. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $3.3 million or $0.85 per share.

Based on shareholder elections, the dividend consisted of $3.3 million in cash and 853,455 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.444 per share, which equaled the volume weighted average trading price per share of the common stock on December 14, 17 and 19, 2012.

On November 15, 2011, our board of directors declared a dividend of $3.00 per share, which was paid on December 30, 2011, to common stockholders of record as of November 25, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.0 million or $0.60 per share.

Based on shareholder elections, the dividend consisted of $2.0 million in cash and 599,584 shares of common stock, or 18.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.117067 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2011.

On November 12, 2010, our board of directors declared a dividend of $4.40 per share to shareholders payable in cash or shares of our common stock, in accordance with the provisions of the IRS Revenue Procedure 2010-12, which allows a publicly-traded regulated investment company to satisfy its distribution requirements with a distribution paid partly in common stock provided that at least 10.0% of the distribution is payable in cash. The dividend was paid on December 29, 2010 to common shareholders of record on November 19, 2010.

Based on shareholder elections, the dividend consisted of $1.2 million in cash and 596,235 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 10.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.8049 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2010.

On November 13, 2009, our board of directors declared a dividend of $18.25 per share, which was paid on December 31, 2009, to common stockholders of record as of November 25, 2009. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.1 million or $0.25 per share.

Based on shareholder elections, the dividend consisted of $2.1 million in cash and 864,872.5 shares of common stock, or 104.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 13.7% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $1.5099 per share, which equaled the volume weighted average trading price per share of the common stock on December 24 and 28, 2009.

 

57


Table of Contents

We cannot provide any assurance that these measures will provide sufficient sources of liquidity to support our operations and growth.

Contractual obligations

The following table shows our payment obligations for repayment of debt and other contractual obligations at November 30, 2016:

 

       Payment Due by Period 
   Total   Less Than
1 Year
   1 - 3
Years
   3 - 5
Years
   More Than
5 Years
 
   ($ in thousands) 

Long-Term Debt Obligations

  $174,453    $—     $—     $61,793    $112,660  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Off-balance sheet arrangements

The Company’s off-balance sheet arrangements consisted of $3.0 million and $2.0 million of unfunded commitments to provide debt financing to its portfolio companies or to fund limited partnership interests as of November 30, 2016 and February 29, 2016, respectively. Such commitments are generally up to the Company’s discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company’s consolidated statements of assets and liabilities and are not reflected in the Company’s consolidated statements of assets and liabilities.

A summary of the composition of the unfunded commitments as of November 30, 2016 and February 29, 2016 is shown in the table below (dollars in thousands):

 

   As of 
   November 30, 2016  February 29, 2016 

Avionte Holdings, LLC

  $1,000   $1,000  

GreyHeller LLC

   2,000    —   

Identity Automation Systems

   —     1,000  
  

 

 

  

 

 

 

Total

  $3,000   $2,000  
  

 

 

  

 

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Our market risks have not changed materially from the risks reported in our Form 10-K for the year ended February 29, 2016.

ITEM 4. CONTROLS AND PROCEDURES

 

(a)As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer and our chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934). Based on that evaluation, our chief executive officer and our chief financial officer have concluded that our current disclosure controls and procedures are effective in facilitating timely decisions regarding required disclosure of any material information relating to us that is required to be disclosed by us in the reports we file or submit under the Securities Exchange Act of 1934.

 

(b)There have been no changes in our internal control over financial reporting that occurred during the quarter ended November 30, 2016 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

58


Table of Contents

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

On August 31, 2012, a complaint was filed in the United States Bankruptcy Court for the Southern District of New York by GSC Acquisition Holdings, LLC against us to recover, among other things, approximately $2.6 million for the benefit of the estates and the general unsecured creditors of GSC Group, Inc. and its affiliates, including the Company’s former investment adviser, GSCP (NJ), L.P. The complaint alleges that the former investment adviser made a constructively fraudulent transfer of $2.6 million in deferred incentive fees by waiving them in connection with the termination of the Management Agreement with us, and that the termination of the Management Agreement was itself a fraudulent transfer. These transfers, the complaint alleges, were made without receipt of reasonably equivalent value and while the former investment adviser was insolvent. The complaint has not yet been served, and the plaintiff’s motion for authority to prosecute the case on behalf of the estates was taken under advisement by the court on October 1, 2012. We opposed that motion. We believe that the claims in this lawsuit are without merit and, if the plaintiff is authorized to proceed, intend to vigorously defend against this action.

Except as discussed above, neither we nor our wholly-owned subsidiaries, Saratoga Investment Funding LLC and Saratoga Investment Corp. SBIC LP, are currently subject to any material legal proceedings.

Item 1A. Risk Factors

In addition to information set forth in this report, you should carefully consider the “Risk Factors” discussed in our annual report on Form 10-K for the year ended February 29, 2016, which could materially affect our business, financial condition and/or operating results. Additional risks or uncertainties not currently known to us or that we currently deem to be immaterial also may materially affect our business, financial condition and/or operating results.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Not applicable.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Not applicable.

 

59


Table of Contents

ITEM 6. EXHIBITS

Listed below are the exhibits which are filed as part of this report (according to the number assigned to them in Item 601 of Regulation S-K):

 

Exhibit

Number

  

Description of Document

31.1*  Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
31.2*  Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
32.1*  Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)
32.2*  Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)

 

*Submitted herewith.

 

60


Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  SARATOGA INVESTMENT CORP.
Date: January 11, 2017  By: 

/s/ CHRISTIAN L. OBERBECK

   Christian L. Oberbeck
   Chief Executive Officer
  By: 

/s/ HENRI J. STEENKAMP

   Henri J. Steenkamp
   Chief Financial Officer and Chief Compliance Officer

 

61